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ABSTRACT 
The observation that Nε-lysine acetylation occurs on a hundreds of proteins 
in bacteria is a recent discovery. To study the mechanisms that regulate acetylation 
and to determine if acetylation affects physiology, I studied the Escherichia coli 
response regulator and transcription factor RcsB, which was reported to be 
acetylated in vitro. To monitor RcsB activity, I measured transcription from the rprA 
promoter, which requires RcsB. I confirmed that RcsB is activated by 
phosphorylation through the Rcs phosphorelay and acetyl phosphate and showed 
that acetyl phosphate could phosphorylate RcsB. However, a mutant that 
accumulates acetyl phosphate (ackA) exhibited reduced rprA transcription instead 
of the predicted increase. To test if acetylation affected RcsB activity in vivo, I 
analyzed the effect of the only known E. coli protein deacetylase CobB on rprA 
transcription and RcsB acetylation and determined that the cobB mutant showed 
reduced rprA promoter activity and hyperacetylated RcsB. Perhaps more 
surprisingly, RcsB isolated from the ackA mutant was also hyperacetylated. Using a 
genetic approach, I identified an AckA- and CobB-sensitive RcsB lysine that controls 
its activity. Since RcsB acetylation increases when acetyl phosphate accumulates, we 
hypothesize that acetyl phosphate is a novel acetyl donor for protein acetylation.  
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CHAPTER ONE 
LITERATURE REVIEW 
Introduction 
After protein synthesis, a wide repertoire of post-translational modifications 
(PTMs) can alter the protein and its function. The Uniprot database currently lists 
435 PTMs (The UniProt Consortium, 2010). These PTMs are often mediated by 
enzymes and can change protein function through the addition of functional groups, 
chemical modifications, proteolytic cleavage, or protein isomerization. These 
modifications can impact protein function through changes in protein stability, 
interactions with other proteins, DNA, lipids, cofactors, or cellular localization. PTMs 
are critical regulators of physiology because PTMs can affect many cellular 
functions, including signaling pathways, gene expression, DNA repair, cell division, 
and metabolism. Dysfunctional regulation of PTMs can lead to various disease states 
in humans (1). 
PTMs can allow an organism to quickly respond to a stimulus by directly 
altering protein function, bypassing the otherwise necessary energy and time 
investments for DNA replication, transcription, and translation of appropriate 
effectors to carry out the altered biological function. Since PTMs can be reversible, 
the cell can also quickly turn off a response.  
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More than one PTM of the same or different type can alter protein function 
by modifying one or more sites on a protein. Since a protein can adopt these various 
PTM combinations, a single protein has multiple distinct protein isoforms, and thus 
has the potential to have more than one biological output. PTMs have been 
considered “nature’s escape from genetic imprisonment” (2) by expanding the 
functional potential of an organism’s genome.  
 The following sections focus on acetylation, one of the most common PTMs. I 
will discuss the types of acetylation, the mechanisms of acetylation, and the effects 
of acetylation. The purpose will be to gain an understanding of acetylation in 
eukaryotes and apply this knowledge towards acetylation in bacteria.  
Acetylation 
The Chemical Reaction 
 Two types of acetylation exist. Acetylation occurs through the transfer of an 
acetyl functional group onto either the amino terminus of the first amino acid of a 
protein, called Nα-acetylation, or onto the epsilon amino group of a lysine side 
chain, called Nε-acetylation.  
Both Nα- and Nε-acetylation require the proper microenvironment. 
Acetylation requires that the acetyl donor, e.g. acetyl-coenzyme A (AcCoA), be 
brought into close proximity to the amino group of the substrate. This step can be 
facilitated either by an acetyltransferase that can interact with both the acetyl donor 
and the target of acetylation or by a high local concentration of the acetyl donor. 
Acetylation also requires a neutral amino group, which can undergo nucleophilic 
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attack of the carbonyl group. Deprotonation of the amino group can occur by the 
presence of an acetyltransferase, an amino acid that can act as a general base, or by 
an increase in pH. Nucleophilic attack of the carbonyl carbon of AcCoA forms an 
unstable tetrahedral intermediate and the electron dense oxygen expels the thiolate 
group, resulting in an acetylated amino group and free CoASH (Figure 1; (3,4)). 
Nα-Acetylation 
While the focus of my dissertation is Nε-acetylation, understanding what is 
known concerning Nα-acetylation could help direct analyses of the regulation and 
effect of Nε-acetylation in bacteria.  
Nα-acetylation was discovered by Phillips in 1963 (5). He found that acetyl 
groups were present on histones and that the amino terminus of the histone 
polypeptide chain was acetylated.  
Nα-acetylation occurs either on the deformylated N-terminal methionine or, 
following cleavage of the N-terminal methionine, on the newly exposed amino acid. 
These reactions are irreversible modifications that are extremely common in 
eukaryotes, but rare in bacteria. While 60% of yeast and 80% of human proteins 
exhibit Nα-acetylation (6), in bacteria, only some ribosomal proteins are known to 
be Nα-acetylated (7).  
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Figure 1. Electron transfer during direct Nε-acetylation from acetyl-CoA.  
At neutral pH, the ε-amino group is positively charged. This residue is deprotonated 
by a base (not shown in figure). (I) The lysine ε-amino group can now act as a 
nucleophile to attack the electrophilic carbonyl carbon of acetyl-CoA (II) forming a 
tetrahedral intermediate. The electron dense oxygen expels the thiolate group (-
SCoA). (III) A base (:B) deprotonates the amino group (IV), resulting in an acetylated 
lysine side chain and CoASH. The figure is from Hu et. al., 2010, which was adapted 
from Walsh 2006.  
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While Nα-acetylation in bacteria occurs post-translationally, in eukaryotes, 
acetylation is primarily co-translational, occurring on nascent polypeptides. This co-
translational modification is facilitated by the direct interaction of ribosomes with 
the required acetyltransferases (8-11).  
There are several known Nα acetyltransferases (NATs or more recently 
called Naa (12)). NatA-F are found in all domains of life (13). NATs are known to 
differ in their substrate specificity, depending on the first few amino acids of the 
target: the most common NatA substrates include Ser- and Thr-N termini, while 
NatB and NatC prefer Met-N termini. Two analyses of the acetylated and non-
acetylated N-termini in yeast, human, bovine, and rat (13) or in yeast alone (14) 
found a strong preference for the acidic aspartyl and glutamyl residues adjacent to 
the acetylated first amino acid residue. N-termini with the sequences X-Asp or X-Glu 
were acetylated more often than N-termini with the sequences X-Lys or X-Arg, while 
X-Pro was not acetylated (13,14). This information has been used to develop 
computer programs to predict acetylation (13,14); however, these acetylation 
prediction programs have not been reliable. One possible explanation is that that 
the sequence alone is not the sole determinant for acetylation. It is unclear whether 
a motif for either Nα-acetylation or Nε-acetylation exists in E. coli.  
The best understood function of Nα-acetylation is to regulate protein 
stability. The earliest function attributed to Nα-acetylation was to inhibit protein 
degradation by the ubiquitin system (15). Recently, however, Nα-acetylation is 
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proposed to promote protein degradation by generating signals that a certain 
ubiquitin ligase can recognize (16). Since a large percentage of eukaryotic proteins 
are Nα-acetylated, global degradation of these proteins is non-intuitive. Instead, 
there are likely additional, unknown regulators that control protein stability in 
addition to the effect of Nα-acetylation.  
Nε -Lysine Acetylation 
 While the first Nε-acetylated bacterial protein was reported in 1992 (17), the 
discovery of Nε-acetylation was made by Allfrey and colleagues 30 years earlier in 
1964 on histones (18). They analyzed the effect of incubating calf thymus nuclei 
with radioactive acetate and found that “…the radioactive material was N-acetyl-
lysine. Since lysine does not occur in the NH2-terminal or COOH-terminal positions 
of the f2a1 [histone 4], the site of substitution was presumably on the ε-amino 
nitrogen of the dibasic amino acid.” Allfrey verified this conclusion by 
demonstrating that the radioactivity in the samples co-eluted with an ε-acetyllysine 
standard on an amino acid analyzer column. Because of this influential paper and 
his subsequent contributions, Allfrey is considered a founding father of epigenetics. 
In contrast to Nα-acetylation, Nε-acetylation is reversible, making this form 
of acetylation dynamic. Nε-acetylation only targets lysine residues, increasing the 
length and neutralizing the charge of the lysine side chain. These changes can alter 
the protein, including changing protein conformation, activity, stability, interactions 
7 
 
 
 
with other molecules, and localization (4). Since Nε-acetylation is the focus of this 
dissertation, I will refer to it as ‘acetylation,’ unless otherwise noted.  
Histone acetylation was identified almost 50 years ago (5,19). Since then, we 
have learned that histones are subject to a myriad of PTMs, leading to the concept 
that PTMs can generate a molecular language on histones (20,21). The ‘histone code 
hypothesis’ has been generalized to a PTM code, describing the effect of 
combinations of PTMs on protein function.  
p53 is a prototype for both the PTM code and non-histone acetylation. p53 is 
a transcription factor that also has cytosolic, transcription-independent functions 
(22) with at least 50 sites that are known to be posttranslationally modified (23). 
These PTMs include phosphorylation, ubiquitylation, and acetylation. Although 
intricate, complex, and incomplete, there are aspects of p53 regulation that are 
understood. p53 may be regulated by single ‘off-on’ modifications. For instance, 
acetylation of lysine-317 is proposed to turn off DNA damage-induced, p53-
dependent apoptosis (24). p53 also may be regulated by sequential multiple 
modifications. Under stress, phosphorylation of serine-15 appears to start a 
sequential PTM pathway, leading to the phosphorylation of several residues, 
phosphorylation recruits the acetyltransferases CBP and p300, which acetylate and 
increase p53 affinity for DNA targets (23,25-27). Lastly, different combinations of 
simultaneous modifications have been demonstrated, correlating to changes in p53 
activity (28). A similar PTM code appears to exist on the E. coli signal transduction 
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protein CheY (discussed in detail later), but it is unknown if other bacterial proteins 
are regulated by a PTM code. 
Recent reports show that protein acetylation extends far beyond these few 
examples. The mammalian acetylome includes more than 2700 acetylated proteins 
that are involved in almost every aspect of cellular physiology, including central 
metabolism, mRNA splicing, protein synthesis and degradation, cell morphology and 
cell division (29-31). In these studies, it was evident that many mitochondrial 
proteins are acetylated. Since mitochondria are closely related to α-proteobacteria 
(32,33), could global protein acetylation exist in bacteria? 
The Discovery and Impact of Nε-Lysine Acetylation in Bacteria 
Before 2008, lysine acetylation was believed to be rare in bacteria. However, 
the first bacterial global proteomic analysis identified 85 E. coli proteins with 125 
lysine-acetylated sites (34). Yu and colleagues grew E. coli W3110 in nutrient rich 
LB medium to mid-exponential and stationary phase. Upon harvesting samples, they 
added 50 mM nicotinamide, a lysine deacetylase inhibitor, lysed the cells, and 
digested the proteins with trypsin. Affinity immunoprecipitation with anti-
acetyllysine antibody enriched for acetylated peptides and nano-HPLC/MS/MS 
analysis identified acetylated lysines. This study revealed different E. coli acetylation 
profiles in exponential phase and stationary phase, suggesting that acetylation for 
some proteins is dependent on growth phase. The majority of the proteins (68%) 
were acetylated specifically in stationary phase, 23% were acetylated only in 
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exponential phase, and the remaining 11% were detected as acetylated in both 
conditions. A functional classification of the acetylated proteins suggested the 
cellular processes that may be regulated by acetylation. Most of the acetylated 
proteins are involved in protein synthesis (28%), carbohydrate metabolism (19%), 
nucleotide (11%) or amino acid (8%) biosynthesis, the TCA cycle (8%), and 
transcription (7%). The remaining acetylated proteins are involved in protein 
folding, detoxification, and energy or fatty acid metabolism. Since this seminal 
article, several global proteomic analyses have followed, adding to this growing field 
of bacterial protein acetylation. 
Zhang and coworkers published the second E. coli global protein acetylation 
study. E. coli DH5α was aerated in LB medium at 37°C and grown to exponential 
phase (35). An analysis of the functional annotations of the 91 proteins and 138 
acetylated sites confirmed the previously reported functional classifications of 
acetylated E. coli proteins (35). Acetylation is sensitive to hypoxic growth 
conditions, suggesting that lysine acetylation is a stress response. Since 24% of the 
acetylated E. coli proteins have at least 25% sequence identity to a mammalian 
protein and acetylation is a prominent modification in mitochondria, the authors 
proposed that lysine acetylation is an evolutionarily conserved mechanism of 
regulation. Additionally, the acetylated peptides showed a preference for histidines 
and tyrosines in the C-terminal direction adjacent to the acetylated lysine, which is 
similar to what was reported for mitochondrial lysine acetylation (30).  
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Wang and colleagues reported that lysine acetylation is abundant (191 
proteins and 235 acetylated sites) in Salmonella enterica (36). Of these acetylated 
proteins, 90% of the central metabolic enzymes were targeted. They tested the 
effect of metabolic flux on the acetylation profiles of these enzymes. On the basis of a 
comparison of cells grown in defined medium supplemented with the glycolytic 
carbon source glucose to the same cells grown on the gluconeogenic carbon source 
citrate, the authors proposed that the acetylation of metabolic enzymes changes in 
response to the carbon source and that the lysine acetyltransferase (KAT) Pat and 
the lysine deacetylase (KDAC) CobB are involved in regulating these changes. 
Acetylation is not limited to Gram-negative bacteria. An extensive 
acetylproteome was identified in the Gram-positive organism Bacillus subtilis with 
185 proteins and 332 acetylated sites (37). There is some conservation of acetylated 
proteins. The B. subtilis acetylproteome was 30% and 12% conserved compared to 
the E. coli and S. enterica acetylproteomes, respectively. Since 10% of B. subtilis 
proteins are modified by both acetylation and serine/threonine/tyrosine 
phosphorylation, a bacterial PTM code involving phosphorylation and acetylation 
may exist. An analysis of the acetylated sites revealed that glutamic acid, proline, 
aspartic acid, and lysine were frequently in the +1 position relative to the acetylated 
lysine residue, suggesting that a consensus acetylation motif may exist in B. subtilis. 
Consensus acetylation motifs of five bacterial and eukaryotic acetylproteomes were 
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compared and there was no one common signature sequence, which may indicate 
that the mechanisms that regulate the acetylproteomes are different. 
Bacterial PTMs may also form a protein modification code through 
phosphorylation and acetylation. In Mycoplasma pneumoniae, combinations of 
lysine acetylation and serine/threonine/tyrosine phosphorylation form a complex 
regulatory network (38,39).  In total, 72 proteins with 93 phosphorylated sites and 
221 proteins with 719 acetylated sites were identified. Consistent with the 
hypothesis that lysine acetylation is an evolutionarily conserved mechanism of 
protein regulation, many lysines that were acetylated in M. pneumoniae proteins 
were conserved within three amino acids in eukaryotic orthologs. The 
phosphoproteome and the acetylproteome affect one another. Deleting the kinases 
(or the phosphatase) or the acetyltransferase changed the profiles of the opposing 
proteome, i.e. the acetylproteome or the phosphoproteome, respectively. It is 
possible that phosphorylation and acetylation affect one another in E. coli.   
A global proteomic study coupled to a structural analysis provided insight 
into the effect of acetylation in Thermus thermophilus and possibly other organisms 
(40). 127 proteins with 197 acetylated lysines and 4 Nα-acetylation sites were 
identified. Of these proteins, 20% of the proteins had more than one site modified. 
Almost all (94%) of the acetylated T. thermophilus proteins have orthologs in 
archaea (Sulfolobus solfataricus), bacteria (E. coli, B. subtilis, Halobacterium 
salinarum, and Deinococcus radiodurans), or eukaryotes (Saccharomyces cerevisiae, 
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Arabidopsis thaliana, Mus musculus, and Homo sapiens), suggesting that acetylation 
may regulate conserved proteins. In fact, 22% of acetylated T. thermophilus proteins 
are conserved in all 9 organisms. Since 56% of the acetylated T. thermophilus lysines 
were conserved in the orthologous proteins, acetylation may occur on these 
proteins and possibly have an effect on protein function. An analysis of the primary 
amino acid sequences flanking acetylated lysines demonstrated a high frequency of 
negatively charged amino acids. Most of the acetylated lysines were on the surface 
of tertiary or quaternary structures while some acetylation occurred in positions 
that are important for binding to ligands or enzyme activity. 56% of the surface-
exposed acetylated lysines were near acidic amino acids or oxygen atoms. 
Neutralization of the positively charged lysine may disrupt these stabilizing 
electrostatic interactions or hydrogen bonds, leading to possible changes in protein 
conformation and protein function. 
Before the global proteomic analyses that identified hundreds of acetylated 
proteins in bacteria, acetylation was known to regulate bacterial chemotaxis and 
acetate metabolism by affecting two proteins, the chemotaxis response regulator 
(RR) CheY and acetyl-coenzyme A synthetase (Acs; Acs will be discussed in detail 
later). In contrast to Acs in which acetylation ‘turns off’ Acs activity, acetylation of 
CheY is more complex, with multiple lysines acetylated and more than one 
mechanism of acetylation and deacetylation. CheY acetylation was detected in vivo 
on six lysinyl residues (41,42). These acetylated lysines reside on the CheY surface 
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and reduce CheY binding to three proteins: the CheY kinase CheA, the CheY 
phosphatase CheZ, and the switch of the flagellar motor FliM (43,44). CheY 
acetylation can occur through autoacetylation using AcCoA as the acetyl donor or 
through an Acs-mediated reaction using either AcCoA or acetate (and ATP) as the 
acetyl donors (17,45,46). Acetylation of CheY is reversible; acetylated CheY is 
deacetylated by Acs or by the KDAC CobB (45).  
Acetylation of neighboring lysines on the exposed surface of the α subunit of 
RNA polymerase (RNAP) elicits opposite effects on RNAP activity. RNAP is a multi-
subunit enzyme, consisting of two α subunits, β, β’, and ω. WT E. coli cells exposed to 
moderate amount of glucose (0.4% or 22 mM) activate the stress responsive cpxP 
promoter (47). This glucose-induced activation requires the KAT YfiQ and is 
inhibited by the KDAC CobB. Consistent with the hypothesis that acetylation of Lys-
298 of the α subunit of RNAP activates cpxP transcription, glucose-induced cpxP 
transcription required Lys-298, and acetylation of Lys-298 was dependent on both 
glucose and YfiQ. In contrast, acetylation of Lys-291 appears to reduce cpxP 
transcription. This occurs when the intracellular concentration of the metabolic 
intermediate and signaling molecule acetyl phosphate (AcP) accumulates, either in 
ackA mutant cells exposed to moderate concentrations of glucose (0.4%) or in WT 
cells grown in the presence of a large amount of glucose (4%) (48). Compared to WT 
cells exposed to 0.4% glucose, the ackA mutant exposed to the same concentration 
of glucose exhibited a reduced cpxP promoter response, suggesting that an 
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accumulation of AcP inhibits glucose-induced transcription. Acetylation of Lys-291 
of the α subunit of RNAP appears to inhibit RNAP activity at the cpxP promoter 
because Lys-291 required for the inhibitory behavior, Lys-291 was acetylated in the 
ackA mutant exposed to glucose, and WT cells overexpressing a genetic mimic of 
constitutively acetylated Lys-291 (K291Q) inhibited cpxP transcription even in the 
absence of glucose. 
Acetylation may regulate transcription factor activity. To identify substrates 
of the S. enterica KAT Pat, a chip mounted with E. coli proteins was incubated with 
purified Pat and radiolabeled AcCoA. Pat acetylated RcsB, McbR, RpsD, MltD, YcjR, 
and YbaB (49). Thao et al. showed that RcsB was acetylated by both S. enterica Pat 
and E. coli YfiQ and acetylation was detectable on only one residue, Lys-180. Lys-
180 is in the DNA-binding domain of RcsB. Acetylation of Lys-180 reduced binding 
to the flhDC promoter in vitro and Lys-180 was required for RcsB-mediated 
inhibition of flhDC promoter activity. These results demonstrated that this residue 
was critical for RcsB function. Site-directed acetylation of Lys-180 on RcsB was 
performed and it was determined that CobB can deacetylate acetyl-Lys-180, 
indicating that RcsB is reversibly modified. While RcsB was found to be reversibly 
acetylated by Pat/YfiQ and CobB in vitro, it was not demonstrated whether RcsB 
was acetylated in vivo and if acetylation affected RcsB activity.  
Acetylation may regulate protein stability in bacteria. RNase R is an E. coli 
exoribonuclease that is acetylated on Lys-544 by the E. coli KAT YfiQ (50,51). 
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Acetylated RNase R can bind to trans-translation machinery RNA tmRNA and the 
tmRNA binding protein SmpB (52). This complex promotes an interaction with 
proteases HslUV and Lon and leads to RNase R degradation (53). 
These examples of acetylated proteins provide us with valuable information 
concerning the regulation and the effect of bacterial acetylation. However, the scope 
of knowledge is still very limited if one considers the hundreds of known acetylated 
bacterial proteins. Therefore, there is a necessity for studies on either other 
acetylated bacterial proteins or a more complete, global analysis into the function of 
acetylation.  
Acetyltransferases 
Acetylation can occur enzymatically, through the action of acetyltransferases. 
Acetyltransferases were originally identified in the 1970-1980s as required for 
modification of aminoglycoside antibiotics and were the basis for the first sequence 
comparison that led to the identification of the general control non-derepressible 5 
(Gcn5)-related acetyltransferase (GNAT) family (54,55).  
The GNAT and MYST families are the largest groups of acetyltransferases. 
GNATs include NATs and PCAF (p300/CBP-associated factor). Other 
acetyltransferases are p300/CBP (adenoviral E1A-associated protein of 300 kDa 
and CREB-binding protein), SRC, and the TAFII group of transcription factors (56-
59).  
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Acetyltransferases have a conserved catalytic core of three-beta sheets and a 
helix. While the core is structurally conserved, there is little to no sequence 
similarity between the acetyltransferase sub-families. The GNAT core has three 
conserved sequence motifs (A, B, and D) and some GNAT members also have a 
fourth conserved sequence motif C (60). Motif A is the most conserved and binds 
AcCoA (61,62). Members of the MYST sub-family have homology to motif A only. 
The acidic, negatively charged residues of Motif B accommodate a positively charged 
substrate, such as a lysine side chain. The core is flanked by variable helices and 
loops on the N- and C-termini. Together, the core and the variable regions form a 
groove that accommodates their respective protein targets and possible 
coactivators. 
 The mechanism through which acetyl transfer occurs has been described for 
GNATs (63) and MYSTs (64,65). These families of acetyltransferases are proposed to 
catalyze acetylation by directly transferring an acetyl group onto the substrate, in 
which a ternary complex between AcCoA, the substrate, and the acetyltransferase is 
formed (64-66). At neutral pH, the epsilon amino group of the lysine side chain is 
protonated due to its high pKa of 10 and does not undergo nucleophilic attack of 
AcCoA. The acetyltransferase can deprotonate and thus activate the lysine for 
acetylation using a catalytic general base such as aspartic or glutamic acid. 
Structural and mutational analyses of Gcn5 suggest that deprotonation occurs 
through a conserved glutamate residue (Glu-173) in the core (67,68). Mutational 
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analysis of Gcn5 Glu-173 determined that the residue was not involved in binding to 
AcCoA or the histone substrate. Instead, Glu-173 was involved in catalysis because 
Glu-173 was not required at high pH, a condition that non-enzymatically 
deprotonates lysine. These results indicate that the function of Glu-173 is to act as a 
general base to deprotonate lysine for nucleophilic attack of AcCoA at neutral pH. 
Several other divergent acetyltransferases have residues that are required 
for catalytic activity and could act as general bases and deprotonate the lysine target 
(64,67,69,70). For example, human NAT Naa50p catalysis depends on tyrosine and 
histidine (Tyr-73 and His-112) to act as general bases (69) and cAMP-regulated 
Mycobacterium Rv0998 catalytic acitivity depends on Glu-235 positioned where the 
conserved Glu-173 is in Gcn5 (70). Instead of a catalytic general base, some 
acetyltransferases have a series of residues that may form a water channel or a 
‘proton wire,’ shuttling protons from the active site to internal proton acceptors or 
to the solvent (63,71,72).  
Thus, there are multiple approaches to accomplish lysine deprotonation, 
which suggests that this step is critically important for acetylation to occur. 
Acetylation can also occur non-enzymatically. For example, non-enzymatic 
acetylation of CheY occurs in the presence of AcCoA or acetic anhydride (44,46). 
Although the GCN5-like 1 protein is an indirect regulator of mitochondrial protein 
acetylation (73), a mitochondrial KAT has not yet been identified and such an 
enzyme has proven to be elusive. Therefore, non-enzymatic acetylation is also 
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suspected to occur in the mitochondria. The mechanism of non-enzymatic 
acetylation is unknown but could involve this critical step of deprotonation of lysine 
residues prior to acetyl transfer. 
Lysine Deacetylases 
 Lysine acetylation is reversible through the action of deacetylases. The first 
histone deacetylase (HDAC), called HDA1, was identified in 1996. It was reported 
that cytostatic agent and deacetylase inhibitor trapoxin enhanced histone 
acetylation and blocked cell cycle progression in mammalian cells (74). Schreiber 
and co-workers used trapoxin to purify HDA1 (75). Since then, four deacetylase 
classes I-IV have been identified based on sequence homology and phylogenetic 
analyses (76-80). Homologs of these four classes have been found in bacteria (80).  
Classes I, II, and IV are commonly referred to as either zinc-dependent 
deacetylases or the classical HDACs. However, it is important to mention that class 
III deacetylases are also zinc-dependent. Furthermore, while these enzymes are 
historically referred to HDACs, they have functions that do not involve histones; 
several members of classes I, II, and IV can shuttle between the nuclear and 
cytoplasmic compartments (80) and some HDACs can deacetylate nonhistone 
proteins, such as tubulin (81) and p53 (82). Classes I and II are the largest groups of 
deacetylases with 10 members. Class IV consists of one member (HDAC 11) that 
shares some similarity to classes I and II, but a phylogenetic analysis of the catalytic 
core region of HDAC-like genes in all fully sequenced organisms showed that HDAC 
19 
 
 
 
IV-related genes form a distinct group (77). Class III is comprised of the NAD+-
dependent deacetylases, typically called sirtuins, after the yeast silent mating type 
information regulator 2 (Sir2)(83). The following will describe some of what is 
known about the classical HDACs and sirtuins. 
Classical HDACs 
While its function remains unknown, the structure of the histone 
deacetylase-like protein (HDLP) isolated from the hyperthermophilic bacterium 
Aquifex aeolicus provided the first model for the classical HDAC structure and 
function (84-86). HDLP structure consists of an eight-stranded parallel beta sheet 
flanked by four alpha helices. On one side of the beta sheet is a cluster of alpha 
helices and loops on the C-terminal ends of the beta sheet. These helices and loops 
form a hydrophobic channel with the bound zinc ion at the base, near the end of the 
channel. The carbon chains of two HDAC inhibitors, which are structurally similar to 
an acetylated lysine, can bind within this channel, suggesting that this channel is the 
acetyl-lysine binding pocket on HDACs, (84). Further highlighting the importance of 
this region, highly conserved residues of the class I and II HDACs map to the channel 
of the HDLP structure (86).  
Structural variations to this channel may regulate substrate binding. A 
comparison of a class I HDAC (HDAC8) with HDLP identified some structural 
variations that appear to provide a more accessible substrate binding pocket that is 
both wider and longer (87,88). Substrate specificity may be regulated by the loops 
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that line the channel since a comparison of HDLP, HDAC8, and an amidohydrolase 
from a Bordetella/Alcaligenes strain revealed the most structural variability in the 
loops (85). 
These enzymes utilize Zn-dependent hydrolysis of the acetyl-amide bond. Zn 
is coordinated by conserved aspartyl and histidinyl residues in the channel and 
HDAC inhibitors vorinostat and trichostatin A (87,88). Zn coordinates with the 
hydroxymate moiety of these inhibitors, suggesting that Zn is important because Zn 
coordinates with the acetyl group of an acetylated substrate. Once the acetylated 
substrate is positioned properly, a water molecule can hydrolyze the acetyl-lysine 
bond by attacking the carbonyl carbon of the acetyl group. 
Sirtuins 
Organisms from all three domains of life and in some viruses possess sirtuins 
(89). Sirtuins are structurally, functionally, and evolutionarily unrelated to the 
‘classical’ HDACs. Unlike the HDACs that catalyze the hydrolysis of an acetyllysine, 
these enzymes require nicotinamide adenine dinucleotide (NAD+) as a co-substrate 
in deacetylation. Certain sirtuins exhibit more general functions than just 
deacetylating lysines. Some of the human sirtuins deacetylate proteins in vitro 
poorly. One of these sirtuins is human SIRT5, which can de-succinylate and de-
malonylate (90). Therefore, it has been proposed that sirtuin deacetylases would be 
better referred to as sirtuin de-acylases (83). 
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Sir2 is the founding member of the sirtuin family of deacetylases. A 
spontaneous sir2 mutant (originally called mar1 for mating type regulator) led to 
sterility of yeast and transcriptional inhibition of mating information loci (91). This 
finding contributed to the current popular concept of transcriptional silencing by 
acetylation. 
 A comparison of over 40 sirtuin structures revealed a conserved two domain 
catalytic core (92). One is a structural motif called a Rossmann fold that is 
responsible for recognizing the NAD+ cofactor. The second domain binds zinc and is 
a less conserved structure amongst the sirtuins. A channel is formed between these 
two domains and connecting loops. This cleft binds the acylated substrate and the 
NAD+. The channel is composed of conserved and variable residues that are 
responsible for substrate binding and reaction catalysis (93).   
 Sirtuins are proposed to catalyze a direct reaction that transfers an acetyl 
group from acetyllysine to NAD+ (Figure 2, (92,94)). Unlike many NAD+-dependent 
metabolic reactions that reduce NAD+ to produce NADH, sirtuins actually couple 
deacetylation to NAD+ hydrolysis. Except for SIRT6, sirtuin enzymes require binding 
to acetyllysine prior to NAD+ binding (95,96). In the absence of acetyllysine 
substrate, NAD+ binds in a non-productive conformation. Once an acetyllysine 
substrate is present, NAD+ binds in a productive conformation within the conserved 
catalytic pocket. The carbonyl oxygen undergoes nucleophilic attack on NAD+, 
cleaving NAD+ and releasing nicotinamide as a byproduct. A peptidylimidate  
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Figure 2. The proposed mechanism of NAD+-dependent sirtuin catalyzed 
deacetylation.  The carbonyl oxygen of the acetylated lysine attacks C1’ of the 
nicotinamide ribose ring. Nicotinamide (NAM) is expelled and an alkylamidate 
intermediate is formed. In the presence of NAM, the intermediate can reverse back 
to reactants. Otherwise, a conserved histidine in the active site can directly or 
indirectly deprotonate the C2’ hydroxyl group. The activated oxygen reacts with the 
alkylamidate carbon to form a cyclic intermediate. A base activates a water 
molecule, which disrupts the tetrahedral intermediate. A deacetylated lysine is 
released along with O-acetyl-ADP-ribose (OAADPr), which isomerizes between 3’-
OAADPr and 2’-OAADPr. This figure was adapted from Feldman, et al. 2012.   
 
intermediate (also called an alkylamidate intermediate) is formed. This reactive 
intermediate is essentially an acetylated lysine covalently bound to the NAD+ ribose 
ring. The intermediate is subject to intramolecular reactions that can reverse the 
reaction or, driven by conserved catalytic base residues that activate nucleophilic 
reactions, proceed forward to the products, producing a deaceylated lysine and a 
mix of 2’- and 3’-O-acetyl-ADP ribose (97). The physiological function of these 
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acetyl-ADP ribose metabolites is yet unclear, but some evidence exists that they 
might be signaling molecules (98). 
Sirtuins are widely distributed in nature. Phylogenetic analyses of the 
conserved core domain have classified sirtuins into five classes (78,79). Classes I, II, 
and -IV are eukaryotic and class U, for ‘undifferentiated,’ represent bacterial and 
archaeal sirtuins.  
Class III is a mix, composed of eukaryotic, bacterial, and archaeal sirtuins 
(78). Human SIRT 5 is a member of class III, suggesting that SIRT5 may be 
evolutionarily the most ancient of the seven human sirtuins. This is consistent with 
the localization of SIRT5 predominately to the mitochondria. Class IIIa, which 
includes SIRT5, is mostly eukaryotic, Class IIIb is mostly archaeal, while class IIIc, 
which includes the one known E. coli deacetylase CobB, is mostly bacterial.  
 The phylogenetic analyses suggested that CobB is the only sirtuin in E. coli 
and thus the only regulator of protein deacetylation. The identification of the 
bacterial SIR2 homolog CobB arose from analyzing the regulation of cobalamin 
(vitamin B12) biosynthesis in Salmonella typhimurium LT2 (99,100). 
Phosphoribosyltransferase CobT transfers the phosphoribosyl group from 
nicotinate mononucleotide to 5,6-dimethylbenzimidazole (Me2Bza), making α-
ribazole-5’-phosphate, a required precursor for the nucleotide loop assembly step in 
cobalamin biosynthesis. Unexpectedly, the cobT mutant requires Me2Bza for growth. 
Another pathway in cobalamin biosynthesis that can compensate for the loss of 
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CobT was proposed to be activated by the presence of high concentrations of 
Me2Bza. The cobT cobB double mutant was deficient in cobalamin biosynthesis, 
suggesting that CobB provides this alternative to CobT. E. coli CobB has inefficient 
NAD+-dependent ADP-ribosyltransferase activity using Me2Bza (101) but can 
efficiently deacetylate acetylated histones in an NAD+-dependent manner (102). 
These results suggest that protein acetylation is present in bacteria and that some of 
the regulation of acetylation is similar to eukaryotic organisms.  
Due to the implicated functions of sirtuins in the regulation of metabolism 
and aging (103), there is great interest in the development of small molecule 
modulators of sirtuin activity (104). Nicotinamide, a product of deacetylation, is a 
well-known inhibitor of sirtuin activity (105). Nicotinamide is a non-competitve 
inhibitor of sirtuins with an IC50 of 150 µM. It functions by interacting with a 
deacetylation intermediate. Through a process called nicotinamide base-exchange, 
the reaction is reversed, regenerating NAD+ and acetyllysine.  
Therefore, nicotinamide has provided insight into the mechanism of sirtuin 
catalysed deacetylation. Nicotinamide and other deacetylase inhibitors could prove 
to be useful in organisms in which the understanding of the function of acetylation is 
incomplete. 
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E. coli metabolism 
Glucose Metabolism and the Effects on Coenzyme A Pools 
 It was recently discovered that the level of protein acetylation is sensitive to 
the metabolic status of the cell. For instance, acetylation increases in the presence of 
glucose (36). The addition of glucose in growth media has therefore been a method 
to enrich for acetylated proteins and may be a useful approach to understand the 
regulation and effect of acetylation in bacteria. The following section on E. coli 
metabolism will address bacterial glucose metabolism and its effect on the acyl 
carrier molecule coenzyme A (CoASH).  
 When bacteria are exposed to multiple carbon sources, the preferred and 
quickly metabolizable carbon source (like glucose) will be assimilated first. This 
occurs by repressing the genes that encode enzymes that are required for uptake 
and metabolism. This phenomenon is called carbon catabolite repression (CCR) and 
the phosphoenolpyruvate (PEP):carbohydrate phosphotransferase system (PTS) 
plays a significant role in regulating CCR in both the Gram-negative 
Enterobacteriaceae and the Gram-positive Firmicutes (106-108). 
The PTS transports and phosphorylates carbon sources using PEP as the 
phosphoryl group donor. E. coli has more than 15 different carbohydrate specific 
PTSs (107). Each PTS uses a common signal transduction pathway, consisting of two 
cytoplasmic proteins (enzyme I and histidine phosphocarrier protein HPr) and a 
carbohydrate specific, membrane-bound protein (enzyme II (EII)), which can be 
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either one or two proteins. In E. coli, the glucose-specific EII consists of a 
cytoplasmic EIIA(Glc) protein and a two-domain, membrane-bound protein 
EIIBC(Glc). Transport of glucose occurs via a phosphorylation cascade that proceeds 
from PEP  enzyme I  HPr  EIIA(Glc)  EIIB(Glc). Phosphorylated EIIB(Glc) 
phosphorylates glucose as EIIC(Glc) transports it across the membrane. The result is 
cytoplasmic glucose-6-phosphate.  
Glucose-exposed E. coli cells inhibit alternative sugar transport systems. The 
inhibitory mechanism takes advantage of the fact that glucose transport increases 
the levels of both non-phosphorylated EIIA(Glc) and non-phosphorylated 
EIICB(Glc). The non-phosphorylated EIIA(Glc) affects the activity of global 
transcription regulators and inhibits transporters of alternative sugars. Bacterial 
catabolic enzymes are commonly not synthesized unless the substrate is present; 
therefore, phosphorylated EIIA(Glc) indirectly decreases transcription of catabolic 
operons by inhibiting the transportation of their inducers. Non-phophorylated 
EIICB(Glc) binds and limits a global repressor of sugar metabolism Mlc. The Mlc 
regulon includes ptsG, which encodes EIICB(Glc). Consequently, glucose uptake 
relieves transcriptional repression of ptsG. Additionally, phosphorylated EIIA(Glc) 
activates adenylate cyclase activity. The result is accumulation of cAMP, which binds 
to the cAMP receptor protein (CRP, also known as CAP or the catabolite activator 
protein). The cAMP-CRP complex binds to hundreds of DNA sites within the E. coli 
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chromosome and regulates transcription from hundreds of promoters (109). 
Therefore, CCR impacts global transcription (107,108). 
Under these catabolite repressing or under oxygen limiting conditions, the 
tricarboxylic acid cycle (TCA) is limited and acetogenesis occurs (108). The 
mechanism through which CCR limits respiration not completely understood. 
However, it is known that oxygen limiting conditions can activate the oxygen-
sensitive transcription factors ArcA and FNR, repressing the sdh-suc operon that 
encodes three enzymes in the TCA cycle succinate dehydrogenase, succinyl-CoA 
synthetase complex, and 2-ketoglutarate dehydrogenase. Instead of fully oxidizing 
AcCoA to carbon dioxide and generating energy, an altered TCA cycle synthesizes 
succinyl-CoA and 2-ketoglutarate and, thus, functions as a biosynthetic system. 
Under these conditions, glycolysis and acetogenesis via the phosphotransacetylase 
(Pta) and acetate kinase (AckA) pathway is critical to supply energy to the cell.  
Non-esterified CoASH acts as a monitor, sensing the extracellular and 
intracellular changes. For example, CoASH is sensitive to environmental stresses, 
including pH, temperature and osmotic stress. CoASH and AcCoA pools were 
reduced at pH 9. AcCoA synthesis is high at 40°C, but is not detectable at 50°C (110).  
However, CoASH is best known for its capacity to act as an efficient monitor 
of nutrient status in E. coli. Because CoASH functions as an acyl carrier, CoASH is 
important for many biosynthetic and metabolic pathways; therefore, CoASH and its 
thioesters are intermediates in many essential metabolic pathways.  
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According to a sensitive method that can detect various CoA species (111), 
the concentration of CoASH is tightly regulated and thus maintained within a range 
of 0.30-0.52 mM (110). This regulation of the intracellular level of CoASH is due to a 
combination of CoASH degradation (112) and a negative feedback loop on CoASH 
biosynthesis (113,114). The negative feedback loop involves pantothenate kinase 
(CoaA), encoded by an essential gene (114). CoaA catalyzes the first step in CoA 
biosynthesis, a rate-controlling reaction of phosphorylating the vitamin pantothenic 
acid. This reaction is inhibited by CoASH and its thioester derivatives with CoASH 
being a stronger inhibitor of pantothenate kinase activity than its esterified 
derivatives.  
The limited pool of CoASH responds quickly to metabolizable carbon sources 
like glucose; almost 70% of CoASH is acylated to AcCoA within 10 minutes (115). 
These results are consistent with a previous study in which a mutant strain of E. coli 
was griwb in the presence of the radiolabelled CoASH precursor β-alanine, and 
determined that glucose-exposed E. coli converts the majority of CoASH into AcCoA 
(80%) and succinyl-CoA (5%), restricting the free CoASH pool (116). CoASH is 
sensitive to the presence of glucose because the conversion of CoASH to AcCoA 
saturates at 0.5 mM glucose. When these carbon sources are depleted, AcCoA is 
quickly deacylated to free CoASH (115).  
 Therefore, changes in the composition of the CoA pools reflect the metabolic 
state of the cell. Since the CoASH response to assimilable carbon sources is 
29 
 
 
 
predominately conversion to AcCoA, the changes to the AcCoA and CoASH 
concentrations are inversely related. Chohnan and coworkers thus proposed that 
the AcCoA-to-CoASH ratio is “an important index of facultative anaerobes that 
reflects the state of carbon and energy metabolism in vivo” (110). Since AcCoA is a 
conventional acetyl group donor for acetylation, it is possible that manipulating the 
AcCoA-to-CoASH ratio could alter the acetyl donor pool and, thus, protein 
acetylation.  
The Pta-AckA Pathway and Acetyl Phosphate 
 Short chain fatty acids (SCFA) are available in high concentrations (70-130 
mM) in the human gastrointestinal tract, a region of the body that is colonized by a 
rich and complex community of bacteria (117,118). Acetate, propionate, and 
butyrate constitute the dominant SCFA species. Bacteria have evolved mechanisms 
to scavenge and activate these abundant carbon sources (108,119). Two pathways 
perform this function: the Pta-AckA pathway and the Acs pathway. This section will 
discuss the Pta-AckA pathway and focus on its regulation of the metabolic 
intermediate AcP. The following section will introduce the function and regulation 
of the Acs pathway. 
Pta and AckA, encoded by the ackA pta operon, comprise a reversible, low 
affinity pathway, identified in many bacteria, some archaea and in lower eukaryotes, 
including fungi, green algae Chlamydomonas and water mold Phytophthora (120). 
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Pta interconverts AcCoA and orthophosphate with AcP and CoASH, while AckA 
interconverts AcP and ADP with excreted acetate and ATP (Figure 3).  
 
Figure 3. The Pta-AckA and Acs pathways. 
Glucose is metabolized to AcCoA. Pta reversibly converts inorganic phosphate and 
AcCoA to generate AcP and CoASH. AckA reversibly converts AcP and ADP to ATP 
and excreted acetate. Acs activates acetate to AcCoA by converting acetate and ATP 
to an Acs-bound acetyl-AMP intermediate that produces AcCoA and AMP in the 
presence of CoASH. 
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Pta and AckA have Km values for substrates between 7 and 10 mM (121).   
Therefore, unless the concentration of environmental acetate is high, such as during 
high cell density fermentation, the Pta-AckA pathway is predominantly an acetate 
dissimilation pathway. The Pta-AckA pathway produces or consumes acetate, 
recycles the limited CoASH, generates ATP, and modulates the metabolites and 
signaling molecules AcCoA and AcP levels.  
AcP is the high-energy intermediate of the pathway. Compared to the ΔG° of 
hydrolysis for ATP (-30.5 kJ/mol in complex with Mg2+), AcP stores more energy 
with a ΔG° of hydrolysis of -43.3 kJ/mol) (122). AcP can be present at high 
concentrations in bacteria and is considered a critical signaling molecule. The level 
of intracellular AcP was estimated to reach between 3 and 4.5 mM in WT cells and 
15 mM in the ackA mutant during exponential growth (123). AcP is involved in 
regulating the expression of 100 genes (124) and multiple bacterial phenotypes, 
including chemotaxis, flagella biosynthesis and capsule production (125), 
respiratory or fermentative metabolism (126), protein folding and degradation 
(127), and biofilm formation (124). 
 Like AcCoA, AcP is regulated by to metabolism. In particular, the 
intracellular concentration of AcP is influenced by the carbon source. For example, 
the levels of AcP correlate with the acetogenicity of the carbon source. When E. coli 
grown in minimal growth medium supplemented with the non-acetogenic carbon 
source glycerol, the level of intracellular AcP was <40 µM. When the carbon source 
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was the acetogenic glucose or pyruvate, the AcP concentration was 300 µM and 
1500 µM, respectively (128). Thus, it is possible that glucose induces protein 
acetylation due to either an accumulation of the conventional acetyl donor AcCoA 
and/or AcP. 
Function and Regulation of Acetyl Coenzyme A Synthetase 
Activation of acetate by Acs is a conserved mechanism found in all three 
domains. Acs is a high affinity acetate assimilation pathway. Acs has a Km of 200 µM 
for acetate (129) and is important when cells are grown on low concentrations of 
acetate (<2.5 mM) (121). ADP-forming Acs reversibly converts acetate and ATP to 
ADP, orthophosphate, and AcCoA in one step (Figure 3). AMP-forming Acs converts 
acetate to AcCoA in a two step process. In the first step, acetate is activated to acetyl-
AMP. Acs converts acetate and ATP to pyrophosphate and an acetyl-AMP-bound Acs 
intermediate. The second step converts acetyl-AMP to AcCoA. CoASH and 
acetyladenylate react to produce AcCoA and AMP (Figure 3). Although Acs activity 
is reversible in vitro, pyrophosphatases remove pyrophosphate in vivo, a necessary 
substrate for the acetyladenylate-bound Acs to generate acetate and ATP, and thus 
their action limits Acs reversibility.  
 The KDAC CobB directly activates Acs by deacetylating acetylated Acs. On 
low acetate concentrations, both the acs and cobB mutants grow poorly. When Acs 
was purified from the cobB mutant, there was reduced AcCoA synthetase activity in 
vitro (130,131). Activity was restored when inactive Acs was incubated with both 
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purified CobB and NAD+ (131). These results are consistent with an inactive form of 
Acs in the absence of CobB deacetylation. Starai and coworkers determined if this 
inactive form of Acs is acetylated Acs, and found that Acs was acetylated in the cobB 
mutant on one site Lys-609 (131). This acetylation event blocks the first step of 
acetate assimilation that activates acetate to acetyl-AMP while not affecting the 
second step, the conversion of acetyl-AMP to AcCoA (131).  
 A member of the GNAT family of acetyltransferases Pat (protein 
acetyltransferase) acetylates and inhibits Acs. Starai and Escalante-Semerena 
discovered Pat through a random transposon mutagenesis of the cobB pta double 
mutant and identified a pat cobB pta triple mutant that could grow on low 
concentrations of acetate (132). Reversible acetylation of Lys-609 of Acs by Pat and 
CobB was demonstrated: Pat can acetylate Lys-609 of Acs using AcCoA and CobB 
can deacetylate Pat-acetylated Acs in vitro.  
Pat consists of two domains, a smaller domain with sequence homology to 
acetyltransferases and a second domain that is found in NDP-forming acetyl-CoA 
synthetases. Starai and Escalante-Semerena proposed that Pat homologs evolved 
from NDP-forming Acs’s (132). NDP-forming Acs homologs have a conserved 
catalytic histidine. The authors suggest that Pat was not able to activate acetate to 
AcCoA in vitro because of the substitution of the conserved catalytic histidine with 
an asparagine residue in Pat. A thorough analysis of this hypothesis has not yet been 
performed. 
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Two-component Signal Tranduction in Bacteria 
The focus of my dissertation was to analyze the regulation and effect of 
acetylation in bacteria. I studied the transcription factor RcsB, a two-component 
response regulator that has been reported to be reversibly acetylated in vitro. This 
section will introduce the function and regulation of two-component systems 
(TCSs).  
Bacteria coordinate gene transcription in response to a wide spectrum of 
environmental stimuli. The transcriptional response allows the bacterium to adapt 
effectively and thus survive external pressures. Stimuli that can affect transcription 
include pH, temperature, osmotic stress, and nutrition availability. Bacteria organize 
responses to each of these stimuli, in part, through phosphorylation-dependent 
signal transduction pathways. These pathways, called two-component systems 
(TCS), are critical in coupling environmental stimuli to the transcriptional response 
(133-137).  
Most bacterial genomes encode multiple TCSs, which consist of two core 
signaling transduction proteins (Figure 4A): a sensor protein (aka histidine kinase 
(HK) or sensor kinase (SK)) and a RR (133,134). The E. coli genome encodes 62 
putative TCS proteins (138), consisting of 30 SKs and 32 RRs. The numbers of 
hypothetical TCS genes vary amongst bacteria with 366 in Ktedonobacter racemifer 
DSM 44963, 70 in Bacillus subtilis, and 0 in Mycoplasma (139,140). TCSs appear to 
be less common in eukaryotes with only a few known examples, including in the  
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Figure 4. Two component signaling, the Rcs phosphorelay, and the domains of 
RcsB. 
A. Two-component signal transduction. A sensor kinase (SK) can detect cytoplasmic, 
periplasmic, extracellular signals. The SK autophosphorylates on a conserved 
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histidine using ATP as a phosphoryl group donor. The response regulator (RR) 
catalyzes the phosphoryl transfer from the SK onto a conserved aspartate on the 
receiver domain (REC) of the RR. 
B. The Rcs phosphorelay. The hybrid SK RcsC can detect signals and 
autophosphorylate on a conserved histidine residue using ATP as the phosphoryl 
group donor. The phosphoryl group is transferred onto an aspartate residue on an 
attached REC domain. The histidine-containing phosphotransmitter RcsD transfers 
the phosphoryl group to a conserved aspartate residue on the REC domain of RcsB. 
Alternatively, acetyl phosphate (AcP) can donate phosphoryl groups to RcsB. RcsB 
can then homodimerize or heterodimerize with proteins, including the co-activator 
RcsA. 
C. Depiction of RcsB REC and effector domains separated by a linker and the sites 
that were most acetylated under in vivo and in vitro conditions. The phosphoryl 
acceptor site D56 is marked in the REC domain. The numbers below the drawing are 
based on the domain cut-offs reported in Gottesman, 2005. The rotated numbers 
above the drawing represent the five alpha helices that were identified by 
crystallization of the RcsB carboxy terminus by Pristovek et al., 2003. Pristovek 
reported that α6 is a linker helix, α7 is a supporting helix, α8 is the scaffold helix, α9 
is the DNA recognition helix, and α10 may be involved in protein dimerization. The 
black, grey, and white circles indicate the strain conditions (cobB, ackA, and yfiQ, 
respectively) under which certain RcsB lysines were more acetylated relative to the 
level of acetylation in WT cells (Tables 2-4). The sites that were more acetylated 
from in vitro acetylation (with AcCoA alone or with AcCoA + YfiQ) are indicated with 
red dots (Table 5).  
 
budding yeast Saccharomyces serevisiae, the fungus Candida albicans, and the plant 
Arabidopsis thaliana (134). 
 Most, but not all, TCS sensor proteins possess N-terminal transmembrane 
regions and are, thus, positioned to sense and gather information about the 
environment while others are cytoplasmic sensor proteins (141). Sensor proteins 
consist of a conserved kinase core and a variable sensing domain. The sensing 
domain recognizes specific stimuli and, in response, autophosphorylates at a 
conserved histidine residue using ATP as the phosphoryl donor. 
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Autophosphorylation occurs through a bimolecular reaction within sensor kinase 
homodimers in which each monomer catalyzes the phosphorylation of the 
conserved histidine on its partner (134). The RR then catalyzes the phosphotransfer 
reaction from the phosphorylated sensor protein to a conserved aspartate residue 
on the RR receiver (REC) domain, which can mediate a wide variety of functions.  
The interaction between the sensor and the RR is specific. In vitro studies of 
various combinations of sensor proteins and RRs revealed a 1000-fold increase in 
phosphotransfer between cognate SKs and RRs relative to non-cognate pairs, 
indicating that SKs possess a strong preference for their partner RR (142). However, 
‘cross-talk’ or signaling between non-cognate sensor proteins and RRs is known to 
occur in the absence of the cognate histidine kinase. 
TCS RRs usually consist of a conserved N-terminal regulatory or REC domain 
that catalyzes autophosphorylation and a C-terminal effector domain. These 
domains can interact in diverse ways to regulate the function of the effector (143). 
The REC domain is composed of a five-stranded parallel β sheet located between 
two helical components made of two and three helices. This structurally conserved 
domain contains the conserved aspartic acid that is the site of phosphorylation. The 
REC domain also contains critical catalytic residues that are important in 
positioning a divalent metal ion that is necessary for phosphorylation. Finally, this 
domain contains residues required for auto-dephosphorylation (144).  
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 RRs regulate diverse functions. Through their variable C-terminal effector 
domains, RRs can regulate diverse functions. The majority of RRs are known or 
putative transcription factors: 65% of the 9000 RRs from 400 sequenced bacterial 
and archaeal genomes contain DNA-binding domains (139,143). However, some 
RRs contain enzymatic (11%), protein binding (2%), or RNA binding domains (1%). 
 RRs also can autophosphorylate, in the absence of its cognate sensor kinase 
(123,125,128,145-150). AcP can function as a global signal in bacteria due to its 
ability to donate phosphoryl groups to certain RRs (128,149,151). The efficiency 
and kinetics of phosphorylation are different between RRs and the phosphoryl 
group donors and the stability of phosphorylation can vary between RRs, suggesting 
that there are differences in catalysis or substrate binding amongst the RRs. For 
instance, CheY rapidly autophosphorylated with AcP while PhoB did so much more 
slowly (128). 
Phosphotransfer from a sensor protein is more rapid than RR 
autophosphorylation by AcP and other small molecule phosphodonors. For example, 
characterizations of the chemotaxis RR CheY with AcP demonstrated that the 
affinity for AcP is very low (Ks>>0.1 M) and the rate of autophosphorylation does 
not saturate; therefore, it was proposed that RRs catalyze autophosphorylation and 
sensor proteins somehow contribute to the rate of catalysis, possibly by increasing 
the effective concentration of phosphate (152,153). The stability of the 
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phosphorylated-aspartate residue may be limited by RR auto-dephosphorylation, 
phosphatase activity of the sensor protein, or a dedicated phosphatase (134).  
The phosphorylation of a RR is proposed to induce conformational changes 
that increase the pool of active RRs (143). Phosphorylation of the REC domain forms 
a high energy acyl-phosphate bond. The energy stored within this bond is proposed 
to induce changes in protein conformation. Phosphorylation brings a conserved 
phenylalanine/tyrosine residue from an outward facing position near the 
hydrophobic environment of the active site. This change leads to a subtle alteration 
in the α4-β5-α5 surface of the REC domain. In many TCS, this surface of the REC 
domain is important in signal transduction by forming homodimers or by 
interactions with other proteins. Despite the high structural conservation of the REC 
domain, dimerization via the α4-β5-α5 surface can occur in many ways, depending 
on the direction and the nature of the secondary structures involved in the 
interaction. 
The role of phosphorylation in activation depends on the RR. Generally, 
phosphorylation is thought to act as a simple switch to turn on RR activity. However, 
activation is not necessarily dependent on phosphorylation. Volkman and co-
workers in 2001 compared the NMR analyses of an unphosphorylated, inactive NtrC 
and a carbamoylphosphate-activated NtrC and identified activated NtrC in the 
unphosphorylated NtrC (154). This finding suggested that RRs are dynamic and may 
exist in equilibrium between active and inactive states, and phosphorylation that 
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stabilizes the active conformation, shifting the equilibrium in favor of the activated 
state. 
The Rcs Phosphorelay: A complex TCS 
A more complex form of the TCS is the phosphorelay. The flow of phosphoryl 
groups in the conventional TCS is HisAsp. Phosphorelays transfer phosphoryl 
groups through the pattern HisAspHisAsp, providing more steps to be 
regulated. In the presence of an activating signal, the SK of a phosphorelay 
autophosphorylates a conserved histidine residue and then transfers the 
phosphoryl group to an aspartate residue that is located in a REC domain that may 
or may not be attached to the SK. The phosphoryl group is then passed to a 
conserved histidine residue in a domain called a histidine phosphotransferase (HPt). 
The HPt acts as a phosphorylated intermediate, passing its phosphoryl group to the 
conserved aspartyl residue in the REC domain of the cognate RR.  
One example of a well-studied phosphorelay is the regulator of capsule 
synthesis (Rcs) phosphorelay (Figure 4B). The Rcs phosphorelay is an envelope 
stress response pathway that can sense extracytoplasmic signals, such as changes in 
temperature, changes in osmolarity, or peptidoglycan disruption (155,156).  The 
pathway consists of the hybrid SK RcsC, the HPt RcsD, the RR RcsB, the outer 
membrane lipoprotein RcsF, and the accessory regulator RcsA (156). RcsC is a 
hybrid protein composed of the SK and the first REC domain. RcsC is proposed to be 
functionally conserved throughout the Enterobacteriaceae and possesses both 
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kinase and phosphatase activities to regulate RcsB phosphorylation and 
dephosphorylation (125,157,158). RcsF-dependent or –independent mechanisms 
can activate RcsC (157,159,160). RcsC undergoes autophosphorylation on 
conserved His-475 and transfers the phosphoryl group to conserved Asp-875 on 
RcsC. Via its conserved histidinyl residue, RcsD shuttles the phosphoryl group from 
RcsC to conserved Asp-56 on the phosphoreceiver domain of RcsB. Alternatively, 
RcsB can receive a phosphoryl group from AcP (125) (Figure 4B).  
RcsB regulates the transcription of 5% of the E. coli genome and 20% of the S. 
enterica genome. RcsB can either homodimerize or heterodimerize with other 
proteins, including RcsA, a RR-like transcription factor that lacks the conserved 
aspartate. Instead of phosphorylation regulating RcsA activity, the steady state level 
of RcsA is regulated by the protease Lon under certain growth conditions (156,161-
163) 
The RcsB homodimer regulation of transcription is best understood at three 
E. coli promoters: osmCp1, rprA, and flhDC. osmCp1 is one of two overlapping 
promoters that encodes the peroxiredoxin OsmC (164-166). The activity of this 
promoter is regulated by two transcription factors, NhaR and RcsB. Osmotic or 
membrane stresses activate osmC transcription through either NhaR or RcsB, 
respectively. The rprA promoter requires RcsB and encodes a small RNA RprA. RprA 
activates translation of the stationary phase sigma factor RpoS by disrupting a 
translation initiation inhibitory stem-loop in the untranslated region of the rpoS 
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mRNA (158,167,168). The flhDC promoter encodes the flagellar master regulator, a 
hexameric transcription factor that controls flagellar gene expression. flhDC 
transcription is controlled by a complex network of several transcription factors 
that together sense a large variety of environmental signals. One of these 
transcription factors is RcsB. Upon activation, RcsB represses flhDC transcription 
(163). At the osmC and rprA promoters, the RcsB homodimer binds a 14-nucleotide 
sequence adjacent to the -35 region of the promoter. From this position, RcsB likely 
activates transcription by contacting RNAP. In contrast, RcsB binds about 10 
nucleotides downstream of the transcription start site of the flhDC promoter (163). 
From this location, RcsB would be expected to interfere with the binding of RNAP to 
DNA. 
RcsB is a 216 amino acid protein. The REC domain (amino acids 1-124) is 
separated from the helix-turn-helix (HTH)-containing effector domain (amino acids 
144-209) by a linker region (amino acids 125-143) (Figure 4C; (156)). The linker 
provides conformational flexibility and was demonstrated to be involved in RR 
interdomain signaling (169). A functional analysis of the RcsB linker has not been 
performed but such an analysis has been done on OmpR and PhoB, representative 
RRs with a winged HTH-containing effector domain and a structurally conserved RR 
REC domain. OmpR has a linker length of 15 amino acids and the PhoB linker is 6 
amino acids long. An analysis of chimeras that fused OmpR and PhoB REC domains, 
linkers, and effector domains found that the unstructured linkers are important for 
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DNA binding, activation of the effector domain in transcription, and conformational 
changes that mediate interdomain interactions. Such intrinsically unstructured 
regions are commonly involved in targets for post-translational regulation (170). 
For example, a recent proteomic analysis in mice revealed of the 500+ 
phosphorylation sites identified, 86% of the sites were mapped to unstructured 
regions of proteins (171). Therefore, linkers and unstructured regions of proteins 
may be critical regulators of protein activity. If the unstructured regions of RcsB and 
other E. coli proteins are enriched for acetylation was unknown. 
The effector domain of RcsB binds to DNA through a HTH structure that is 
typical of the NarL/FixJ and LuxR/UhpA subfamilies of RRs. The crystal structure of 
the carboxy terminus of RcsB is characteristic for members of these groups 
(172,173). RcsB has a four helix (α7-α10) effector domain, a helical linker (α6), and 
a 7-amino acid polypeptide chain. The linker and the chain would connect the REC 
domain to the effector domain. α8-α9 form the HTH. The scaffolding helix α8 is 
connected by a sharp turn to α9, the DNA recognition helix. Titration analysis 
determined that several RcsB residues are involved in RcsA-independent DNA 
binding to an RcsA-RcsB heterdimer target called an RcsAB box (Lys-154, Val-158, 
Leu-167, Thr-169, Arg-177, Ser-178, Ile-179, Thr-181, Ile-182). Based on structural 
homology to a B. subtilus sporulation transcriptional regulator GerE (174) and the 
Agrobacterium tumefaciens quorum-sensitive transcriptional regulator TraR (175), 
the authors proposed that α10 may be involved in dimerization. Suggesting that a 
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conformational change is necessary for RcsB activation, the α6 linker helix 
interfered with this putative dimerization helix. α7 is a supporting structure that 
appears to stabilize several hydrophobic interactions between α7, α8, and α9 and 
between RcsB and DNA via Lys-154. The involvement of the amino terminus of α7 in 
secondary interactions with DNA through a basic patch is a common feature of 
several HTH containing proteins (176). Therefore, there are several critical 
regulatory regions of RcsB and modifications to these structures may affect its 
activity.
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CHAPTER TWO 
MATERIALS AND METHODS 
Bacterial strains, bacteriophage, plasmids, and primers.  
All bacterial strains, bacteriophage, plasmids, and primers used in this dissertation 
are listed in Table 1. Mutant strains were constructed by generalized transduction 
with P1kc (for details, see Generalized P1 transduction). Construction of 
monolysogens using λ bacteriophage carrying various transcriptional fusions was 
performed and verified as described previously (177,178). Plasmid derivatives were 
constructed either via cloning or by site-directed mutagenesis (for details, see 
Plasmid Construction and Site-Directed Mutagenesis). 
Culture conditions.  
For strain construction, cells were grown in Luria Broth (LB) containing 1% (w/v) 
tryptone, 0.5% (w/v) yeast extract, and 0.5% (w/v) sodium chloride; LB plates also 
contained 1.5% agar. For promoter activity assays, cells were grown in either 
tryptone broth with potassium chloride (TBK, containing 1% (w/v) tryptone and 
0.5% (w/v) potassium chloride) or tryptone broth buffered at pH 7 (TB7, containing 
1% (w/v) tryptone, no salt, buffered with 100 mM potassium phosphate). For TBK, 
potassium chloride was used instead of sodium chloride because sodium has a 
negative effect on the survivability of WT cells at alkaline pH (179). Cell growth was 
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monitored spectrophotometrically (DU640; Beckman Instruments, Fullerton, CA) by 
determining the optical density at 600 nm (OD600). 
The working concentrations of antibiotics were as follows: ampicillin, 100 
μg/mL; kanamycin, 40 μg/mL; spectinomycin 100 μg/mL; tetracycline, 15 μg/mL 
and chloramphenicol, 25 μg/mL or 17.5 µg/mL. Stock solutions were typically 
prepared at 1000 times the working concentration. Stock solutions of ampicillin, 
kanamycin and spectinomycin were dissolved in water and filter sterilized. 
Optimally, the filter has been pre-rinsed with water before sterilizing the antibiotic 
solution because E. coli can grow on the filtrate, suggesting the presence of some 
carbon source that primes the filter (Marvin Whitely from The University of Texas at 
Austin, personal communication, October 11, 2012). Stock solutions of tetracycline 
and chloramphenicol were dissolved in 50% and 100% ethanol, respectively, and 
filter sterilized. All antibiotic stocks were stored at -20°C. When necessary, 
isopropyl β-D-1-thiogalatopyranoside (IPTG) was added to the media at the 
indicated concentration to induce gene expression from a plasmid vector.  
Generalized P1 transduction.  
A single colony was inoculated in LB and grown overnight at 37°C aerobically with 
agitation at 250 RPM. In the morning, 50 μL of overnight culture were added to 5 mL 
of TB for transduction (TBT) (TB containing 0.2% [w/v] glucose from a 20% [w/v] 
stock solution, 10 mM CaCl2, 10 mM MgSO4, and 0.4 mM FeCl3). The culture was 
grown until it reached an OD600 of approximately 0.5. One mL of cells was infected 
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with 10-100 μL of phage lysate and incubated statically at 37°C for 30 minutes. After 
incubation, 200 μL of 1M sodium citrate (pH 5.5) was added to prevent a second 
round of phage absorption. The cells were pelleted using a table-top centrifuge at 
16000 RCF for 1 minute at room temperature. The supernatant was decanted and 
the pellet resuspended with 500 μL LB and 200 μL 1M sodium citrate. The cells 
were then incubated aerobically at 37°C with agitation at 250 RMP for 70 minutes to 
give them time to develop antibiotic resistance. After the second round of 
incubation, the cells were pelleted as described before. The supernatant was 
decanted and the pellet was resuspended with 50 μL 1 M sodium citrate. The entire 
cell suspension was plated onto LB agar plates with appropriate antibiotics required 
for the desired selection. 
Plasmid construction.  
Plasmid pPHB1 was constructed by Shaun R. Brismaide (UW-Madison) as follows.  
Alleles phbCAB+ were amplified from Ralstonia solanacearum strain GMI1000 (a gift 
from Caitilyn Alen, UW-Madison) using forward primer 5’—ATC GAA CCC GGG ATG 
GCA TCG CGT CAC AA—3’ and reverse primer 5’—AGC ATG AGT GCC CCG GGT CAG 
CCC ATG T—3’. Bases underlined indicate the SmaI restriction site engineered into 
each primer.  The resulting ~4-kb fragment was A-tailed and gel-purified using the 
QIAquick gel extraction kit (Qiagen). This product was ligated into the multiple 
cloning site of plasmid pGEM-T-Easy (Promega).  The resulting plasmid was ~7-kb 
and was named pPHB1. 
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Plasmid pPHB3 was constructed by Shaun R. Brismaide (UW-Madison) as follows.  
The Rs phbCAB+ genes were cut out of pPHB1 using SmaI.  The resulting ~4-kb 
fragment was gel-extracted and ligated into plasmid pTAC-85 (180) that had been 
cut with NcoI and the resulting single-stranded DNA overhangs blunted with mung 
bean nuclease and dephosphorylated using shrimp alkaline phosphatase.  The 
resulting plasmid was ~9.1-kb and was named pPHB3. 
Plasmid pLIH002. To construct a single copy plasmid that permits expression of 
moderate amounts of WT RcsB, we constructed a derivative of CopyControlTM 
pCC1TM (EpiCentre) that carries the WT rcsB allele. We began with pVEC, a 
derivative of pCC1TM, in which the plasmid-encoded lacZα is disrupted by an 
approximately 1360-bp kanamycin resistance cassette (Table 1, (181)). To replace 
the kanamycin resistance cassette with the WT rcsB allele, we first constructed a 
derivative of pVEC that lacked the kanamycin cassette. pVEC was BamHI-digested, 
ligated, transformed into TransforMaxTM EPI300TM-T1R Chemically Competent E. 
coli (EpiCentreR), and plated onto an LB plate containing chloramphenicol (17 
µg/ml) and 5-bromo-4-chloro-indolyl-β-D-galactopyranoside (X-gal). A blue 
transformant was verified and designated pLIH001 (Table 1). We then amplified 
the WT rcsB allele from the chromosome of strain AJW3759 (Table 1), using 
primers rcsBFBamHI (5’-GGATCCAGGAAGGTAGCCTATTACATGAAC-3’) and 
rcsBRBamHI (5’- GGATCCTTAGTCTTTATCTGCCGGACTTAAGG-3’). The resulting 
amplicon was purified using the CloneJETTM PCR Purification Kit (Thermo Scientific) 
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and cloned into pJET1.2 using the CloneJETTM PCR Cloning Kit (Thermo Scientific). 
The ligated product was transformed into competent DH5 and plated onto LB 
ampicillin plates. WT rcsB allele was excised from pJET1.2 with BamHI, gel 
extracted, subcloned into BamHI-digested pLIH001, transformed into EPI300 cells, 
and plated onto LB plates containing chloramphenicol and X-gal. White colonies 
were used to inoculate LB supplemented with chloramphenicol (17 µg/ml) to 
maintain the plasmid and CopyControlTM BAC Autoinduction Solution (EpiCentreR) 
to amplify the plasmid and shaken overnight at 37°C. Plasmid DNA was purified and 
sequenced using primer pCC1RBZ (5’- GTAAAACGACGGCCAGTGAATTG-3’). The 
resulting plasmid was named pLIH002. For experiments that involved pLIH002 or 
derivatives, pVEC functioned as the negative control.   
Site Directed Mutagenesis.  
Site-directed mutagenesis of rcsB in pLIH002 was conducted using QuikChangeR 
Lightning Multi Site-Directed Mutagenesis Kit (Agilent Technologies) in accordance 
with the manufacturer’s instructions using the mutagenic primers listed in Table 1. 
The mutations were confirmed by sequence analysis of the purified mutagenized 
plasmids. 
Transformation.  
Three distinct transformation methods were used: transformation buffers (TBF), 
transformation storage solution (TSS), and electroporation. 
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TBF – 50 µL of an overnight culture of the recipient cells was diluted into 5 
mL of LB. The culture was incubated with aeration rotating at 250 RPM at 37°C until 
OD600 reached 0.4-0.6. 1 mL of the culture was chilled on ice and then pelleted at 
4°C for 1 minute at 16000 RCF using a tabletop centrifuge. The pellet was 
resuspended with 400 µL of ice cold TBF1 and pelleted. The pellet was resuspended 
with 40 µL of ice cold TBF2. 0.5 - 3 µL of plasmid DNA was mixed with the 
chemically competent cells and incubated on ice for 30 minutes. The DNA-cell 
mixture was heat shocked for 1 minute at 42°C and immediately placed on ice for 2 
minutes. 300 µL of room temperature LB was added to the DNA-cell mixture. The 
cells were incubated at room temperature or 37°C, rotating at 250 rpm for 30 
minutes to 1 hour. After incubation, typically 50 – 100 µL of cells were plated onto 
LB agar plates containing the appropriate concentration of antibiotic required for 
selection of transformants. For poor efficiency transformations, the entire 300 µL of 
cells was pelleted, resuspended with 50 µL of LB, and plated onto LB plates 
containing the appropriate antibiotic. Outgrowth was often, but not always, carried 
out overnight at 37°C. 
TSS – 1 ml of overnight cell culture was pelleted at room temperature for 1 
minute at 16000 RCF using a tabletop centrifuge. The pellet was resuspended with 
100 µl TSS [10% (w/v) poly(ethylene glycol), 5% (v/v) DMSO and 50 mM MgSO4 or 
MgCl2 in LB]. After resuspension, 50 ng of plasmid DNA was added to the 
resuspended cells, the mixture was incubated on ice for 30 minutes.  After ice 
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incubation, 0.9 mL of LB was added, and the cells were incubated for 1 hour at 37°C 
with aeration. After 37°C incubation, the cells were pelleted one more time as 
described above, the supernatant was decanted, and the cells were resuspended in 
250 μL LB. 25-100 µl of the resuspended cells were used for plating on an LB agar 
plate containing the appropriate antibiotic for selection. 
Electroporation - For electroporation, the recipient cells were made 
competent by inoculating 30 mL of LB in a 250 mL baffled flask with 500 µL of 
overnight culture. The culture was incubated with aeration rotating at 250 RPM at 
37°C until OD600 reached 0.4-0.6. The culture was transferred into Oakridge tubes 
and spun down at 14000 RCF for 15 minutes at 4°C. After pelleting the cells, the 
supernatant was aspirated, and the cell pellet was gently resuspended with 1 mL of 
ice-cold sterile water. After resuspension, an additional 9 mL of ice cold water was 
added to the tube, bringing the total volume to 10 mL and the cells were spun one 
more time at 14000 RCF for 15 minutes at 4°C. At the end of the second spin, the 
supernatant was gently decanted immediately, as the pellet is not very compact and 
stable at this point. The pellet then was resuspended one more time with 1 mL of ice 
cold water, transferred to a 1.5 mL eppendorf tube, and spun down at 16000 RCF for 
1 minute, using a table top centrifuge at 4°C. The supernatant was aspirated, the 
pellet was resuspended with 200 µl of ice cold water, divided into 50 µl aliquots and 
stored at -80°C for future use. 
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Transformation began by mixing 50 ng of purified plasmid DNA with 50 µL of 
electro-competent cells. The DNA-cell mixture was then transferred to a chilled 1 
mm electroporation cuvette and electroporated at 1.8 KV. After electroporation, the 
cells were immediately rescued by the addition of 1 mL of room temperature LB, 
transferred to a small test tube or 1.5 mL eppendorf tube, and incubated at 37°C, 
rotating at 250 RPM for 30 minutes to 1 hour. After incubation, 20-100 µL of cells 
were plated onto LB agar plates containing the appropriate concentration of 
antibiotic required for selection of transformants. Outgrowth was often, but not 
always, carried out overnight at 37°C. 
Promoter activity assays.  
To monitor promoter activity from λ(PrprA-lacZ), λ(PosmC-lacZ), λ(PflhDC-lacZ), or 
λ(PosmB-lacZ)cells that were frozen at -80°C were grown on LB plates containing 
the appropriate concentration of antibiotic and incubated at 37°C overnight. Three 
independent colonies representing three biological replicates were used to 
inoculate 5 mL of TB unbuffered (TB) or TB that was buffered at pH 7.0 (TB7) and 
grown aerobically with agitation at 250 rpm at 37°C. The overnight cultures were 
diluted into 20 – 25 mL of TB or TB7 in 250 mL flasks to final OD600 of 0.03 – 0.05. 
At regular intervals, 50 µL aliquots were harvested and added to 50 µL of All-in-One 
β-galactosidase reagent (Pierce Biochemical). β -galactosidase activity was 
determined quantitatively Y-PER β-galactosidase assay kit (Pierce 
Biochemical), using a microtiter format. Three microtiter wells containing 50 µL of 
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TB or TB7 and 50 µL of All-in-One β-galactosidase reagent (Pierce Biochemical) was 
included on each microtiter plate as a negative control. The microtiter plates were 
incubated at 37°C until a light yellow color was visible. Promoter activity was 
plotted versus time or OD600. For some experiments, only the peak activity is 
shown. Each experiment included three independent measurements and was 
repeated at least once. 
Hydroxylamine assay to measure AcP.  
A standard curve was constructed by diluting known concentrations of AcP in in 
vitro acetylation buffer (150 mM Tris-HCl pH 7.3, 10mM MgCl2, 150 mM NaCl, and 
10% glycerol) to a final volume of 300 µl per reaction. 50 µl of neutralized 
hydroxylamine HCl solution (2M Hydroxylamine HCl neutralized with KOH pellets 
can be stored at room temperature for ~30 days or 4°C for ~90 days) was added 
and incubated at 60°C for 5 minutes. 100 µl of development solution (50:50 
FeCl3/HCl:TCA = 0.5 M FeCl3 in 5 M HCl + 30% TCA) was added and immediately, 
color change is visible. The reactions were transfered into plastic cuvettes, bubbles 
were removed because they seemed to affect the readings, and the reactions were 
analyzed at 540 nm using a spectrophotometer. Absorbance was compared to the 
known AcP concentration. Readings from experimental samples were compared to 
the standard curve to extrapolate the concentration of AcP in the experimental 
samples. This protocol was based on a published method to measure AcP (182). 
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Nile Red.  
Nile Red was used to detect the production and accumulation of 
polyhydroxybutyrate (PHB) on LB agar plates by E. coli cells carrying plasmid 
pPHB3. pPHB3 carries three  genes (phbCAB) under the control of an IPTG-inducible 
promoter and confers ampicillin resistance. A single colony was streaked onto LB 
agar plate containing 25 µg/ml Nile Red, 50 µM IPTG, and 25 µg/ml ampicillin. The 
plates were incubated overnight at 37°C. After incubation, PHB accumulation was 
detected by exposing the plates to ultraviolet light (λ=312 nm).  
LTQ-Orbitrap Velos-LC-MS/MS Spectrometry and Protein Identification.  
For identification of in vivo acetylation sites, cells transformed with pHis6rcsB 
(which expresses His-tagged RcsB) were grown aerobically at 37°C at 250 rpm in 
TB7 until stationary phase and cell lysates were prepared. For identification of in 
vitro acetylation sites, His-tagged RcsB and YfiQ proteins were purified from E. coli 
cells (see below).  The proteins in the in vivo and in vitro samples were separated by 
SDS-polyacrylamide gel electrophoresis. To normalize the number of cells to lyse 
per milliliter, the inverse of the culture A600 was used (183). To avoid cross-
contamination, we electrophoresed the samples from each strain and/or condition 
on separate SDS-polyacrylamide gels with bioreplicates separated by an empty 
lane(s). Electrophoresis was terminated before proteins could run off the bottom of 
the gel. The gel was cut down the middle of the empty lane to separate the 
bioreplicates. Each half of the gel was stained with SimplyBlueTM SafeStain 
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(Invitrogen) and destained with water. The bands were then excised and subjected 
to tryptic digestion, as described previously (184). Peptides eluted from tryptic 
digests of gel pieces were subjected to reversed phase column chromatography 
(self-packed C18 column, 100 μm diameter x 200 mm length) operated on an Easy-
nLC II (Thermo Fisher Scientific, Waltham, MA). Elution was performed using a 
binary gradient of buffer A (0.1% (v/v) acetic acid) and buffer B (99.9 % (v/v) 
acetonitrile; 0.1% (v/v) acetic acid) over a period of 100 min with a flow rate of 300 
nl/min. MS and MS/MS data were acquired with the LTQ-Orbitrap-Velos mass 
spectrometer (Thermo Fisher Scientific) equipped with a nanoelectrospray ion 
source. The Orbitrap Velos was operated in data-dependent MS/MS mode using the 
lock-mass option for real time recalibration. After a survey scan in the Orbitrap (r = 
30,000), MS/MS data were recorded for the 20 most intensive precursor ions in the 
linear ion trap. For MS/MS analysis, singly charged ions were not taken into account.  
Post-translational lysine acetylation sites on proteins were identified by 
searching all MS/MS spectra in .dta format against an E. coli database (extracted 
from the Uniprot-KB database: 
http://www.uniprot.org/uniprot/?query=Escherichia+coli+K12&sort=score), using 
Sorcerer™-SEQUEST® (Sequest v. 2.7 rev. 11, Thermo Electron including 
Scaffold_3_00_05, Proteome Software Inc., Portland, OR). The Sequest search was 
carried out considering the following parameters: a parent ion mass tolerance - 10 
ppm, fragment ion mass tolerance of 1.00 Da. Up to two tryptic mis-cleavages were 
56 
 
 
 
allowed. Methionine oxidation (+15.99492 Da), cysteine carbamidomethylation 
(+57,021465 Da) and lysine acetylation (+42.010571 Da) were set as variable 
modifications. Proteins were identified by at least two peptides applying a stringent 
SEQUEST filter. Sequest identifications required deltaCn scores of greater than 0.10 
and XCorr scores of greater than 2.2, 3.3 and 3.8 for doubly, triply and quadruply 
charged peptides. Acetylated peptides that passed these filter criteria were 
examined manually and accepted only when b- or y- ions confirmed the acetylation 
site. 
Cloning, Recombinant Expression, and Purification.  
For in vitro studies, we transformed the chloramphenicol resistant ASKA plasmids 
that encode YfiQ or RcsB with a noncleavable N-terminal polyhistidine tag (185) 
into kanamycin resistant BL21 Magic cells (186). The ASKA-encoded, polyhistidine 
tagged protein was expressed in the presence of 34 μg/ml chloramphenicol and 35 
μg/ml kanamycin and purified with IMAC followed by size exclusion 
chromatography as described (Kuhn et al., submitted, (187)).  
Dynamic light scattering.  
For characterization of molecular size in solution, dynamic light scattering (DLS) 
provides a measure of the translational diffusion coefficient of protein in solution. 
All DLS measurements were performed on a Zetasizer Nano-S Zen 1600 DLS 
instrument with a 633 nm wavelength laser. The fluctuations in light intensity, due 
to the Brownian motion of the molecules, were measured by a photodiode at a 90° 
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angle. Photons were counted and the time dependence of the light intensity 
fluctuations was analyzed by autocorrelation. Assumptions include a solution 
viscosity equal to 1.019 and that the proteins are spherical in nature. The proteins 
were centrifuged for 5 min with 14,000 x g prior to collecting scattering data. 
Experiments were run at 25°C and at least 6 measurements were taken at each 
condition. Regularization histogram analyses of samples were carried out using the 
Zetasizer Nano software. 
 
In vitro acetylation.  
In vitro acetylation of proteins was conducted with two distinct acetyl donors: 
acetyl-CoA (AcCoA) and acetylphosphate (AcP).  
AcCoA. Two different methods were used to detect in vitro acetylated proteins using 
AcCoA as the acetyl group donor: detection by anti-acetylated lysine western 
immunoblot and detection of AcCoA hydrolysis. 
In vitro acetylation followed by anti-acetyllysine Western immunoblot.  
20 µM RcsB, 2 µM YfiQ, and 0.4 mM AcCoA were incubated at 37°C for 1 hour in 50 
mM Tris HCl (pH 8), 10% glycerol, 1 mM DTT, 10 mM sodium butyrate, and 0.1 mM 
EDTA (36). The reaction was stopped by the addition of equal volume of 2X SDS 
loading buffer (120 mM Tris-Cl [pH 6.8], 4% SDS, 0.2% bromophenol blue, 20% 
glycerol and 10% 2-Mercaptoethanol, which was added immediately prior to use). 
The EDTA was left out when in vitro acetylation preceded phosphorylation, because 
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EDTA chelates the zinc needed to perform Phos-TagTM SDS-PAGE. The samples were 
heated at 95°C for 2 minutes, resolved using a 12% acrylamide SDS-PAGE gel, and 
subject to an anti-acetylated lysine western immunoblot. 
In vitro acetylation followed by measurement of AcCoA hydrolysis.  
Compared to the in vitro acetylation assay described previously (36), this 
biochemical in vitro assay detects acetylation by measuring the hydrolysis of AcCoA. 
Biochemical assays were performed as described previously (188) with some 
modifications. First, reactions were performed in the presence of 150 mM NaCl at 
25°C for 1 hr to prevent protein precipitation during the reaction. Additionally, after 
stopping the reactions with guanidine HCl, samples were transferred to Nanosep 
10K MWCO centrifugation devices (Pall Life Sciences, VWR) and centrifuged at 
13,000 rpm for 10 minutes to separate CoA and the protein. The Ellman’s reagent 
was then added to the flow-through and monitored as described (188). This 
biochemical in vitro acetylation assay was performed in the absence of DTT because 
it generates false positive signals. Reactions reached completion within one hour, 
and a saturating concentration of RcsB was determined to be 0.15 mM. High 
concentrations of YfiQ (100 μg) were necessary to detect activity. Several 
possibilities exist, including competition for binding between AcCoA and the 
polyhistidine tag (188).   
AcP. In vitro acetylation of purified LpdA with AcP was carried out by mixing 1.25 
µM LpdA peak 1 with AcP at concentrations ranging from 0-80 mM in buffer 
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containing 150 mM Tris-HCl pH ranging from 7.1 – 8.0, 10mM MgCl2, 150 mM NaCl, 
and 10% glycerol. The reaction was incubated at 37°C for 0 to 7 hours. The reaction 
was stopped by the addition of 2X SDS loading buffer. Protein acetylation by AcP 
was detected by Western immunoblot analysis using an antibody against acetylated 
lysine (Cell Signaling) at a ratio of 1:1000. 
In vitro phosphorylation.  
In vitro phosphorylation was carried out by incubating lithium potassium AcP 
(Sigma) with purified His-tagged RcsB at 30°C for 30 min in buffer containing 40 
mM Tris-HCl pH 8.0, 10 mM MgCl2, 40 mM KCl and 1 mM DTT (48). The reaction was 
quenched by the addition of SDS loading buffer. 
Detection of phosphorylated RcsB.  
Similar to a previously reported procedure (48), phosphorylated RcsB from in 
vitro phosphorylation was separated from non-phosphorylated RcsB using zinc(II) 
Phos-TagTM SDS-PAGE (10% acrylamide (37.5:1), 350 mM Tris, pH 6.8, 0.1% SDS, 75 
M Phos-Tag (NARD Institute LTD), and 150 M Zn(NO3)2). Purified protein was 
detected either by staining the gel with SimplyBlueTM (Invitrogen) or by Western 
immunoblot analysis. If the protein was detected by Western immunoblot analysis, 
the gel is incubated at room temperature with gentle shaking for 15 minutes in 
Towbin buffer (50 mM tris and 40 mM glycine) containing 1 mM EDTA to chelate 
the zinc and then for another 15 minutes in only Towbin buffer prior to transfer of 
the proteins onto a membrane. 
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Western immunoblot analysis.  
The protein samples were resolved by electrophoresis on a SDS-PAGE 10%, 12%, or 
15% polyacrylamide gel. The gel and PVDF or nitrocellulose membrane were 
equilibrated in transfer buffer for 15 minutes at room temperature with shaking. 
The proteins were transferred to the membrane either at 25 V for 16 hours at 4°C or 
using TurboTransfer at 25V for 30 minutes at room temperature. The membrane 
was blocked for 1 hour with 5% milk in Phosphate-buffered saline with Tween-20 
(PBS/T: 0.136 M NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.7 mM KH2PO4, 0.05% Tween) 
or Tris-buffered saline with Tween-20 (TBS/T: 20 mM Tris base, 0.136 M NaCl, 0.1% 
Tween) at room temperature with gentle shaking. The membrane was briefly 
washed with PBS/T or TBS/T prior to incubation with the primary antibody. 
The conditions used for primary antibody incubation varied depending on 
whether acetylation, RcsB protein, or His-tagged fusion proteins were detected. 
Acetylation was detected by incubating the membrane with anti-acetyllysine 
primary antibody (Cell Signaling Technology® #9441L) diluted 1:1000 in 5% BSA 
(w/v) TBS/T solution.. Detection of RcsB protein occurred by incubating the 
membrane with rabbit anti-RcsB antibody (Jorge Escalante-Semerena, UW-
Madison) diluted 1:10,000 in 5% milk (w/v) PBS/T solution for 3 hours at room 
temperature with gentle shaking. The histidine tag was detected by incubating the 
membrane with 5 µg HRP-conjugated anti-His6 antibody (GenScript A00612) per 1 
ml of PBS/T for 1 hour at room temperature with gentle shaking. The membrane 
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was washed three times, 5 minutes each, with PBS/T or TBS/T at room temperature 
with gentle shaking. Secondary goat anti-rabbit (Cell Signaling Technology®) 
immunoglobulin G antibody conjugated to horseradish peroxidase diluted 1:1000 
dilution in 5% milk (w/v) PBS/T was used for 1 hour at room temperature with 
gentle shaking. The membrane was again washed three times. Enhanced 
chemiluminescence Western immunoblotting reagents (Cell Signaling Technology®) 
were used for visualization, according to the manufacturer’s instructions.  
When necessary, the membrane was stripped with OneMinute® Western Blot 
Stripping Buffer (GM Biosciences), according to the manufacturer’s instructions. 
 
Motility assays.  
Three independent colonies representing three biological replicates were used to 
inoculate 5 mL of TB and grown aerobically at 250 rpm at room temperature. The 
overnight cultures were diluted into 5-8 mL of TB in test tubes to final OD600 of 0.1. 
5 μl was inoculated on the surface of tryptone motility plates [TB supplemented 
with 0.25% (w/v) agar] and incubated at 28°C and the diameter was measured over 
time. Each experiment included at least three replicates and was repeated at least 
once.  
 
 
 
 
 
 
Table 1. Bacterial strains, bacteriophage, plasmids, and primers used in this study. 
Strain, phage, 
plasmid, or primer 
Relevant Characteristic Source/Reference 
Strains   
BW25113 
F- λ- Δ(araD-araB)567 Δ(rhaD-rhaB)568 ΔlacZ4787 rrnB3 rph-1 
hsdR514 
(189) 
AJW678 thi-1 thr-1(Am) leuB6 metF159(Am) rpsL136 ΔlacX74 (190) 
AJW3759 BW25113 λΦ(PrprA142-lacZ) λ: λrprA142  BW25113 
AJW2628 BW25113 λΦ(PosmC-lacZ) λ: λosmC  BW25113 
AJW2634 BW25113 λΦ(PosmB-lacZ) λ: λosmB  BW25113 
AJW2640 BW25113 λΦ(PflhD4-lacZ) λ: λflhD4  BW25113 
AJW3331 AJW678 λΦ(PrprA142-lacZ) λ: λrprA142  AJW678 
AJW4884 AJW3759 ΔrcsB::FRT 
P1: JW2205 (191)  AJW3759, 
then removed antibiotic marker 
AJW3976 AJW3759 ΔrcsC::tet P1: MZ63 (192)  AJW3759 
AJW3981 AJW3759 ΔackA::FRT-kan-FRT P1: JW2293 (191)  AJW3759 
AJW4533 AJW3759 ΔspeE::FRT P1: JW0117 (191)  AJW3759 
AJW4589 AJW3759 ΔspeG::FRT P1: JW1576 (191)  AJW3759 
AJW4592 AJW3759 ΔspeG::FRT ΔspeE::FRT-kan-FRT P1: JW0117 (191)  AJW4589 
JE8659 ΔcobB::cat Escalante-Semerena (U. of Georgia) 
AJW5011 AJW3759 ΔcobB::cat P1: JE8659  AJW3759 
AJW3797 AJW3759 ΔyfiQ:: FRT-kan-FRT P1: JW2568 (191)  AJW3759 
EPI300TM-T1R 
F− mcrA Δ(mrr-hsdRMS-mcrBC) φ80dlacZΔM15lacX74 recA1 endA1 
araD139 (ara-leu)7697 galU galK rpsL nupG trfA tonA dhfr 
EpicentreR Biotechnologies 
BL21 (DE3) Magic a derivative of BL21 cells carrying a plasmid encoding rare tRNAs  (186) 
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Phages 
  
λrprA142 142 bp rprA promoter region transcriptionally fused to lacZ  (158) 
λflhD4 flhD promoter region (-1057 to +34) transcriptionally fused to lacZ (163) 
λosmC osmC promoter region (-95 to +420) transcriptionally fused to lacZ  (193) 
λosmB 
465 bp osmB promoter region, includes osmBp1 and osmBp2, 
transcriptionally fused to lacZ 
(194) 
 
Plasmids 
  
pVEC 
Single-copy, lacZ null derivative of pCC1 (EpicentreR), control for 
pLIH002 and pLIH003 CmR 
(181) 
pLIH001 pVEC derivative with kanamycin cassette removed This study 
pLIH002 pLIH001 carrying rcsB(WT) CmR This study 
pLIH003 pLIH001 carrying rcsBD56A allele CmR This study 
pLIH004 pLIH001 carrying rcsBK154Q allele CmR This study 
pLIH005 pLIH001 carrying rcsBK154R allele CmR This study 
pLIH006 pLIH001 carrying rcsBK154A allele CmR This study 
pTrc99a Vector control for pPSG980 ApR (195) 
pPSG980 pTrc99a carrying Φ(PlacUV5–rcsC) ApR (196,197) 
pMH300 pTrc99a carrying Φ(PlacUV5–rcsF) ApR (157) 
pREII-rpoA Expresses WT rpoA or Lys-to-Ala substitutions of RpoA ApR (198) 
pREII-ΔαCTD Expresses the amino terminus of RpoA ApR 
R. Gourse (U. of Wisconsin-
Madison) 
pTAC-85 Vector control for pPHB3 ApR 
J. Escalante-Semerena (U. of 
Georgia) 
pPHB3 pTAC-85 expressing 3 genes (phbCAB) from an IPTG-inducible J. Escalante-Semerena (U. of 
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promoter ApR Georgia) 
pCA24n Control plasmid CmR (185) 
pCA24n-rcsB pCA24n expressing 6xHis-RcsB from an IPTG-inducible promoter CmR (185) 
pCA24n-coaA pCA24n expressing 6xHis-CoaA from an IPTG-inducible promoter CmR (185) 
pCA24n-speG pCA24n expressing 6xHis-SpeG from an IPTG-inducible promoter CmR (185) 
pHis6rcsB 
pIM10 vector expressing 6xHis-RcsB from an IPTG-inducible 
promoter, KnR SpR 
(199) 
Primers (5’-3’)   
rcsBFBamHI GGATCCAGGAAGGTAGCCTATTACATGAAC This study 
rcsBRBamHI GGATCCTTAGTCTTTATCTGCCGGACTTAAGG This study 
pCC1RBZ GTAAAACGACGGCCAGTGAATTG This study 
rcsBK154Q ACAAGCGTCTCTCGCCACAGGAGAGTGAAGTTCTGCG, AAACAG This study 
rcsBK154A TGACAAGCGTCTCTCGCCAGCAGAGAGTGAAGTTCTGC, AAAGCA This study 
rcsBK154R ACAAGCGTCTCTCGCCAAGAGAGAGTGAAGTTCTG, AAAAGA This study 
rcsBD56A CATGTGTTGATTACCGCTCTCTCCATGCCTGGC, GATGCT This study 
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CHAPTER THREE 
RESULTS 
Analysis of the RcsB-regulated osmC promoter 
Introduction 
Previous studies established that activity of the E. coli RR RcsB could be 
regulated by phosphorylation (156,200) and, more recently, by acetylation (49). 
Biochemical evidence suggests that the KAT YfiQ can acetylate RcsB in the presence 
of the acetyl group donor AcCoA (49). Despite this finding, however, there is no 
evidence that acetylation of RcsB occurs in vivo.  Equipped with RcsB-regulated 
promoters transcriptionally fused to lacZ and the means to genetically manipulate in 
vivo protein acetylation levels and the AcCoA-to-CoA ratio, I tested my hypothesis 
that acetylation can regulate RcsB activity in vivo. I first identified RcsB-regulated 
phenotypes that appear to be regulated by acetylation and then analyzed the 
mechanism. 
Promoter screen for putative regulation by acetylation 
There is evidence to support the hypothesis that glucose metabolism 
regulates protein acetylation in bacteria. This includes the observations that E. coli 
cells exposed to glucose rapidly increase intracellular concentrations of AcP (123) 
and AcCoA (110), and that both AcP (201,202) and AcCoA (132,203-205) could be
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acetyl group donors for protein acetylation. Furthermore, exposure to glucose is 
reported to increase acetylation of RNA polymerase in E. coli (47,48) and global 
protein acetylation in Salmonella enterica (36).  
We therefore reasoned that growth of E. coli in the presence of glucose might 
induce an acetylated RcsB-regulated phenotype. Given that RcsB is a transcription 
factor that regulates approximately 5% of the E. coli genome (156,206) and 20% of 
the Salmonella enterica genome (207), we screened several RcsB-regulated 
promoters for their response to glucose. To do so, I introduced λ hybrids carrying 
these promoters transcriptionally fused to lacZ into the λ attachment site of strain 
BW25113, a commonly used E. coli reference strain that is deleted for the 
endogenous lacZ gene (178). By colony PCR, I verified that the resultant lysogens 
were present in single copy (177). I grew these lysogens at 37°C in 1% tryptone 
buffered at pH 7 with 0.1 M potassium phosphate buffer (TB7) with or without 0.4% 
(w/v) glucose (22 mM). At regular intervals, samples were harvested for analysis of 
growth (monitored as optical density at 630 nM; OD630) and promoter activity 
(monitored in terms of β-galactosidase activity in Miller units). When grown in TB7 
supplemented with glucose (closed symbols), cells of the BW25113 reference strain 
(herein called wild-type, WT) appeared to grow better than cells grown in the 
absence of glucose (open symbols) (Figure 5A). In the absence of glucose, all 
reporter strains showed a similar low level of promoter activity as they transitioned 
into stationary phase (i.e., between 300 and 400 minutes (Figure 5B and 5C).  
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Figure 5. The effect of glucose on RcsB-regulated promoters.  
ΔlacZ cells carrying chromosomal transcriptional promoter-lacZ fusions (AJW2628: 
osmC; AJW2634: osmB; AJW2640: flhD; AJW3759: rprA promoters) were aerated 
overnight at 37°C in TB7 growth medium supplemented with or without 0.4% 
(w/v) glucose. Samples were harvested at regular intervals assayed for OD630 (A) 
and β-galactosidase activity (B).  
C. A histogram was constructed showing average maximum promoter activity in the 
presence (black bars) and absence of glucose (white bars). The values represent the 
means +/- standard deviations of triplicate independent cultures.  
 
 
In the presence of glucose, however, the osmC promoter (hereafter denoted PosmC) 
and the rprA promoter (PrprA) were activated strongly, and the flhD promoter 
(PflhD) activated moderately, while the osmB promoter (PosmB) did not activate 
detectably.  
To test if induction of promoter activity was specific to glucose or not, I grew 
the WT cells lysogenized with the osmC promoter fusion (strain AJW2628) in TB7 in 
the presence or absence of either 0.8% (w/v) pyruvate or 0.4% (w/v) glucose. The 
difference in the percentages normalizes for the amount of carbon (3 carbons in 
pyruvate and 6 carbons in glucose) in the medium. Both pyruvate and glucose 
induced PosmC activity, but pyruvate induced a weaker response than did glucose 
(Figure 6). Since induction, at least from the osmC promoter, is not specific to 
glucose, then induction of promoter activity may be dependent on some factor that 
is common to both glucose and pyruvate. Why exposure to glucose yields a stronger 
response than pyruvate remains unknown. 
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Figure 6. Comparing the effects of glucose and pyruvate at the osmC promoter. 
WT (AJW2628) and the isogenic rcsC (AJW3389) and rcsB (AJW3391) mutants were 
grown in TB7 in the presence and absence of 0.8% (w/v) pyruvate or 0.4% (w/v) 
glucose. Samples were harvested throughout growth and maximum promoter 
activity is plotted. These values represent the means of triplicate independent 
cultures and standard deviation.  
 
Determining whether phase of growth affects the response to glucose 
Since each glucose-responsive promoter exhibited peak responses as the 
cultures transitioned to stationary phase (Figure 5) and since each strain had been 
exposed to glucose throughout growth, I tested if the timing of glucose exposure 
regulates glucose-induced transcription. I grew WT cells lysogenized with the rprA 
promoter fusion (strain AJW3759) in TB7 alone and, at every hour starting at time 
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zero, added 0.4% glucose. As negative and positive controls, I grew cells grown in 
TB7 alone or TB7 plus 0.4% glucose. Samples were harvested throughout growth to 
analyze growth and PrprA activity. There were subtle differences in growth patterns 
(Figure 7A). Cells exposed to glucose earlier in growth, between 0 and 2 hours of 
inoculation (darker symbols), grew slightly faster during exponential phase and 
reached a maximum OD600 that was moderately greater than cells grown in the 
absence of glucose (white symbols). Cells exposed to glucose later, between 3 and 6 
hours after inoculation (lighter symbols), reached a maximum OD600 that was 
greater than the other cultures. Consistent with our previous observations (Figure 
5B), in the absence of glucose, WT cells (Figure 7B, shown as open symbols and ‘no 
glc’) exhibited exponential phase PrprA activity; when glucose was added at 0 hours, 
the cells exhibited PrprA activity in both exponential and stationary phase (Figure 
7B, shown as black symbols with ‘0’). Consistent with stationary phase PrprA 
activity being dependent on exposure to glucose early in growth, cultures that were 
supplemented with glucose after 5 or 6 hours (i.e., when cultures were in mid-
exponential phase or transitioning into stationary phase) exhibited little to no PrprA 
response to glucose (Figure 7B, shown as lighter gray symbols and ‘5’ or ‘6’). 
Cultures that were supplemented with glucose early in growth (i.e., within 3 hours 
or when cultures were in lag to mid-exponential phase (Figure 7B, shown as darker 
gray symbols and ‘1-3’)) exhibited PrprA responses similar to those observed when 
glucose was added at 0 hours. Adding glucose to the medium at 4 hours, when 
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cultures were in mid-exponential phase, had an intermediate effect on PrprA activity 
(Figure 7B, ‘4’). Thus, exposure to glucose early in the growth curve appears to be 
required for a response in stationary phase. This observation suggests that a trait 
associated with lag to mid-exponential phase is important. The identity of this trait 
remains unknown. 
 
 
Figure 7. The effect of exposing cells to glucose at various points in the growth phase. 
In triplicate, I grew 8 sets of λrprA lysogens (AJW3759) at 37˚C in TB7 overnight. In the 
morning, I diluted the overnight cultures to an OD600 of 0.03 in fresh TB7. The cells were 
exposed 0.4% glucose at each subsequent hour, symbolized by gradually lighter shading. 
One set of triplicates was grown in the absence of glucose (white symbols, ‘no glc’) and 
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another triplicate set was grown in the presence of 0.4% (w/v) glucose (black symbols). For 
each of the remaining 6 triplicate sets, I added an appropriate volume of 20% (w/v) glucose 
to achieve a final concentration of 0.4% (w/v) glucose in one hour intervals. The numbers 
indicate at which hour glucose was added. I harvested samples at regular intervals for 
growth (A) and β-galactosidase assays (B). These values represent the averages and 
standard deviations of triplicate independent cultures. 
 
 
 Analysis of the AcCoA:CoA ratio in glucose-induced PosmC and PrprA activities 
Two effects of glucose is to elevate levels of both AcCoA and AcP (110,128), 
both of which can be acetyl donors for protein acetylation. An increase in AcCoA 
occurs at the expense of the limited CoA (112,113), resulting in an increase in the 
AcCoA-to-CoA (AcCoA:CoA) ratio (110). If the glucose-induced transcription 
involved acetylation, we predicted that reducing the AcCoA:CoA ratio (by genetic 
means) would decrease the intensity of glucose-induced promoter activity. To 
determine if the response to glucose depended on a large AcCoA:CoA ratio, we 
obtained the plasmid pPHB3 from the laboratory of Jorge Escalante-Semerena. 
When exposed to IPTG, pPHB3 expresses a three enzyme pathway (PhbC, PhbA, and 
PhbB) that uses AcCoA to produce the bioplastic polyhydroxybutyrate (PHB) with 
the release of free CoA (208). Thus, expression of the PHB pathway should cause the 
AcCoA:CoA ratio to decrease by draining acetyl groups from AcCoA, while also 
increasing the free CoA pool.  
I used transformation to introduce this PHB synthetic pathway into E. coli 
cells that carried the promoter fusions. When exposed to IPTG, the resultant pPHB3 
transformants expressed the PHB synthetic pathway, producing large, cytoplasmic 
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PHB aggregates visible by microscopy (Figure 8A-C, performed by my colleagues 
Dr. Bruno P. Lima and Noriko Shibata) and formed fluorescent colonies when grown 
on agar plates containing the stain Nile Red (Figure 8D and 8E, (209,210)). 
 
 
 
Figure 8. Visualizing PHB biosynthesis. 
TEM images of PHB granules in cells. Cells were transformed with the IPTG-
inducible PHB expression plasmid and grown at 37°C in TB7 supplemented with 50 
µM IPTG, which either lacked (A) or contained 0.4% (w/v) glucose (B).  
C) Higher magnification of cells in Panel B. TEM images were taken by Noriko 
Shibata and Dr. Bruno Lima.  
D and E) Visualizing PHB production by UV fluorescence. Strains transformed with 
either the IPTG-inducible PHB expression plasmid or the vector control were grown 
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at 37°C on LB plates buffered at pH 7 with 0.1 M Tris containing 2% (w/v) glucose 
and Nile Red. Images were taken on a visible light box (D) and on a UV light box (E).  
 
 
 
Once I knew that the PHB plasmid worked, I grew the transformants in the 
presence or absence of 0.4% glucose, with and without IPTG. I harvested samples at 
regular intervals to monitor growth and β-galactosidase activity and plotted the 
maximum promoter activities. While IPTG-induced PHB expression alone had 
limited effects on promoter activities (Figure 9A, light gray hatched bars), PHB 
expression substantially reduced glucose-induced PosmC, PrprA, and PflhD activities 
(Figure 9A, black hatched bars). Therefore, the AcCoA:CoA ratio may regulate osmC, 
rprA, and flhD transcription. 
Since glucose induced the strongest responses from the osmC and rprA 
promoters, it is possible that they are more sensitive to a signal that is upregulated 
in the presence of glucose. Furthermore, these two promoters are relatively simple 
compared to the flhD promoter, which is complex and responsive to a large number 
of environmental variables. To reduce complications in our investigation into the 
nature of the glucose response, I chose to use PosmC and PrprA as the means to 
measure RcsB activity in vivo. I will first describe the glucose-induced regulation of 
PosmC.  
While the PHB pathway would directly decrease AcCoA and increase CoA 
pools, the accumulation of PHB could interfere with promoter activity. Another 
genetic approach to test if transcription is regulated by the AcCoA:CoA ratio would 
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be to increase the CoA level. By overexpressing coaA, which encodes enzyme 
pantothenate kinase, the first enzyme in the CoA biosynthetic pathway, we increase 
the CoA pool in the cell (211). I began by transforming the IPTG-inducible coaA 
expression plasmid (pcoaA from the ASKA collection, (185)) or the vector control 
(pCA24n) into the WT strain that carries PosmC (strain AJW2628). My colleague Dr. 
Bruno Lima grew the resultant transformants in TB7 in the presence or absence of 
0.4% glucose and 50 µM IPTG. He harvested samples at regular intervals to monitor 
growth and β-galactosidase activity and plotted the maximum PosmC activity 
(Figure 9B). Compared to VC-transformed cells grown in the presence of glucose 
(Figure 9B, bar 5), pcoaA transformed cells exhibited a moderate reduction in 
PosmC activity (Figure 9B, bar 6). A similar reduction in glucose-induced PosmC 
activity was observed with IPTG alone (Figure 9B, bar 7). Glucose-induced PosmC 
activity was reduced to the basal level when the coaA expression plasmid was 
induced with IPTG (Figure 9B, bar 8). These data support the hypothesis that 
excess carbon, in the form of glucose, activates osmC transcription through a high 
AcCoA:CoA ratio.  
Determining the roles of RcsC and RcsB in glucose-induced osmC transcription 
To determine if RcsB or the sensor protein RcsC were required, I grew WT, 
rcsB, and rcsC strains in TB7 in the presence or absence of glucose. Glucose-induced 
PosmC activity occurred whether or not RcsB or RcsC was present (Figure 10A). 
Pyruvate-induced PosmC activity also occurred in an RcsB- and RcsC-independent  
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Figure 9. The effect of the AcCoA:CoA pool on promoter activity. 
A) Testing if glucose-induced transcription is sensitive to PHB induction. λosmC, 
λrprA, λflhD, and λosmB cells (AJW2628, AJW3759, AJW2640, AJW2634, 
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respectively) were transformed with the IPTG-inducible PHB expression plasmid 
and aerated at 37°C in TB7 supplemented with 0.4% glucose (w/v) and 50 µM IPTG 
where indicated. The values represent the average maximum β-galactosidase 
activities +/- standard deviations of triplicate independent cultures. 
B) Testing if glucose-induced transcription is sensitive to an increase in the CoA 
pool. λosmC cells (AJW2628) transformed with either an IPTG-inducible vector 
carrying coaA (black bars) or the vector control (white bars) were aerated at 37°C in 
TB with 0.5% KCl, pH 7 buffered with 0.1 M Tris with 0.4% (w/v) glucose and 50 µM 
IPTG where indicated. β-galactosidase activity was assayed from samples harvested 
at regular intervals. The values represent the average maximum β-galactosidase 
activities +/- standard deviations of triplicate independent cultures. The coaA 
overexpression experiment was performed by Dr. Bruno Lima and the data are 
reproducible. 
 
 
manner (Figure 6). To determine whether PHB induction affected RcsB-
independent, glucose-induced PosmC activity, I compared the effect of glucose in WT 
cells and in an rcsB null mutant and found that the response to glucose was reduced 
when pPHB3 expression was induced regardless of RcsB status (Figure 10B). These 
results suggest that a high AcCoA:CoA ratio activates osmC transcription 
independently of RcsB. Given that the rcsB null exhibited PosmC activity that is 
either equal to or greater than WT cells, RcsB may even be an inhibitor of glucose-
induced osmC transcription.  
Analysis of αCTD lysines in the regulation of glucose-induced osmC 
transcription 
The high AcCoA:CoA ratio-mediated PosmC activity suggests that another 
regulator of osmC transcription is sensitive to the glucose-induced, high AcCoA:CoA 
ratio. Dr. Lima reported that, in the presence of 0.4% glucose, several subunits of  
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Figure 10. The effect of RcsC, RcsB, and the AcCoA:CoA ratio in glucose-induced 
osmC transcription.  
A) Testing if RcsC or RcsB are required for the osmC response to glucose. WT 
(AJW2628) and isogenic rcsC (AJW3389) or rcsB (AJW3391) λosmC lysogens were 
aerated at 37˚C in TB7 supplemented with (open bars) or without 0.4% glucose 
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(black bars). The values represent the average maximum β-galactosidase activity 
+/- standard deviations of triplicate independent cultures. 
B) Determining if RcsB is required for PHB-mediated reduction in glucose-induced 
osmC transcription. WT (AJW2628) and isogenic rcsB (AJW3391) λosmC lysogens 
were transformed with either the VC (pTAC-85) or a PHB expression plasmic 
(pPHB3). Transformants were aerated at 37˚C in TB7 supplemented with (open 
bars) or without 0.4% glucose (black bars) and in the presence (+) or absence (-) of 
50 µM IPTG. The values represent the average maximum β-galactosidase activity +/- 
standard deviations of triplicate independent cultures. 
 
RNA polymerase (RNAP) were acetylated and that acetylation of the α subunit, in 
particular, appeared to regulate the cpxP response to glucose (47,48). Additionally, 
the carboxyl terminal domain of α (αCTD) of RNAP has been shown by proteomic 
analysis to be acetylated ((34) and Kuhn et al., in preparation), and the αCTD is 
frequently a target for transcriptional regulation (212). We therefore hypothesized 
that glucose-induced PosmC activity involved the acetylation of the α subunit of 
RNAP.  
RNAP is a large multi-component complex consisting of two α subunits, one β 
subunit, one β’ subunit, and one σ factor. Since α subunits are required for 
initializing the assembly of the RNAP, rpoA, the gene that encodes α, is essential for 
viability (213,214). To circumvent this problem, we used a partial diploid system 
consisting of an λosmC lysogen carrying transformed with either a WT or 
mutagenized rpoA gene cloned onto a multicopy plasmid (described in (198) and 
generously provided by Dr. Richard Gourse). These cells would overexpress either a 
WT or mutant rpoA. If glucose-induced transcription required a lysine on the αCTD, 
then overexpressing a lysine-to-alanine mutant of the rpoA gene would repress 
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glucose-induced promoter activity. Cells transformed with either the plasmid-
encoded WT (prpoA(WT)) or the lysine-to-alanine αCTD derivatives (prpoA(K271A, 
K291A, K297A, K298A, or K304A) were grown in TB7 supplemented with or 
without 0.4% glucose. Of the five lysine residues on the αCTD, WT cells carrying 
prpoA(K271A) exhibited the weakest response to glucose (Figure 11A). This 
RpoA(K271)-regulated, glucose-induced PosmC activity was RcsB-independent 
(Figure 11B), consistent with our previous observations that the PosmC response to 
glucose is independent of RcsB. These results suggest that Lys-271 of the αCTD is 
important for glucose-induced osmC transcription.  
Although these results suggest that Lys-271 of the αCTD is important for 
glucose-induced osmC transcription, the αCTD is not required for the PosmC 
response to glucose as overexpression of a truncated derivative of α that lacks both 
the flexible linker and the CTD does not interfere with glucose-induced PosmC 
activity (Figure 12B). This K271A-dependent inhibition may be a general 
phenomenon at RcsB-regulated promoters given that PrprA lysogens also exhibited 
rpoA(K271A)-inhibited,  αCTD-independent glucose-induced activity (Figure 12 A 
and B). The function of K271 is unknown but we infer that Lys-271 of the αCTD may 
overcome an inherent inhibition of the αCTD and/or RcsB. 
The effect of the CobB and YfiQ on glucose-induced PosmC activity 
The high AcCoA:CoA ratio-mediated PosmC activity is consistent with the 
hypothesis that the activation of osmC transcription involves acetylation.   
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Figure 11. The function of the αCTD of RNA polymerase and RcsB in glucose-
induced osmC transcription. 
A) Analysing the requirement for αCTD lysine residues. WT cells carrying λosmC 
(AJW2628) were transformed with either a multi-copy plasmid that expressed WT 
rpoA or rpoA(K-to-A) mutants. Transformants were grown in TB7 in the presence 
(black and gray bars) or absence of glucose (white bars). Values represent the 
average maximum osmC promoter activity of triplicate independent cultures +/- 
standard deviations. 
B) osmC promoter activity of WT (AJW2628) and the isogenic rcsB null mutant 
(AJW3391) transformed with a multi-copy plasmid that expressed WT rpoA, 
rpoA(K271A), or rpoA(K291A) mutants, grown in TB7, with (black symbols) and 
without glucose (white symbols). Values represent the average osmC promoter 
activity of triplicate independent cultures +/- standard deviations.  
 
 
 
Therefore, to determine if glucose-induced PosmC activity was regulated by 
acetylation, I mutated the known effectors of acetylation and deacetylation, the KAT 
YfiQ and the KDAC CobB, by growing WT, yfiQ, and cobB strains in the presence or 
absence of glucose. PosmC in the yfiQ mutant responded to glucose (~6-fold) at a 
level similar to the WT response; therefore, YfiQ is not required for glucose-induced 
osmC transcription (Figure 13A). However, the basal level of PosmC activity was 
diminished in the yfiQ mutant; thus, YfiQ appears to regulate glucose-independent 
osmC transcription. The effect of CobB on PosmC activity is unclear. In the 
experiment that compared the yfiQ mutant to WT, the cobB mutant did not respond 
to glucose (Figure 13A), consistent with the hypothesis that CobB-mediated 
deacetylation of some protein is required for glucose-induced osmC transcription. 
However, when the experiment was repeated approximately 7 months later, the  
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Figure 12. The function of the αCTD of RNA polymerase and RcsB in glucose-
induced rprA transcription. 
A) Analysing the requirement for αCTD lysine residues. WT cells carrying λrprA 
(AJW3759) were transformed with either a multi-copy plasmid that expressed WT 
rpoA or rpoA(K-to-A) mutants. Transformants were grown in TB7 in the presence 
(black and gray bars) or absence of glucose (white bars). Values represent the 
average maximum rprA promoter activity of triplicate independent cultures +/- 
standard deviations. 
B) Analysing the requirement for the αCTD in glucose-induced osmC and rprA 
transcription. WT cells carrying λosmC (AJW2628) or λrprA (AJW3759) were 
transformed with plasmids encoding either WT (prpoA(WT), squares) or αCTD 
derivatives that lack the linker and the αCTD (prpoA(Δlinker&CTD), triangles). Cells 
were aerated at 37˚C in TB7 either in the presence (black symbols) or absence 
(white symbols) of 0.4% glucose. Values represent the average osmC promoter 
activity of triplicate independent cultures +/- standard deviations. 
 
 
cobB mutant exhibited a WT-like response to glucose (Figure 13B). Therefore, the 
manner in which CobB regulates osmC transcription remains unclear. 
Analyzing the role of Acs in glucose-induced osmC transcription 
 While Acs function is typically associated with scavenging acetate from the 
environment and activating the acetate to AcCoA (108,119), Acs also was reported 
to acetylate the RR CheY when incubated with AcCoA or with acetate and ATP (45), 
suggesting that it possesses protein acetyltransferase activity. I tested if Acs was 
involved in the PosmC response to glucose. I grew WT cells in the AJW678 strain 
background (AJW3487) and the acs mutant in TBK buffered with 0.1 M Tris pH 7, in 
the presence and absence of glucose. The acs mutant response to glucose was weak, 
in contrast to its WT parent, which exhibited a strong increase in PosmC activity 
when glucose was present (Figure 14A). This effect of Acs appears to have some  
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Figure 13. The function of the αCTD of RNA polymerase and RcsB in glucose-
induced rprA transcription. 
A) Testing if the osmC response to glucose required the KDAC CobB or the KAT YfiQ. 
β-galactosidase activity of WT (AJW2628) and isogenic cobB (AJW3529) and yfiQ 
(AJW3530) λosmC lysogens aerated at 37˚C in TBK buffered at pH 7 with 0.1 M Tris 
in the presence (black bars) or absence (white bars) of 0.4% glucose. Values 
represent maximum average β-galactosidase activity +/- standard deviation of 
triplicate independent cultures.  
B) Results from a repeat, testing if the osmC response to glucose required the KDAC 
CobB. The experiment was performed as described in A.  
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Figure 14. Testing if glucose-induced osmC and rprA responses require Acs. 
A) β-galactosidase activity of WT (AJW3487) and acsA λosmC in the 678 strain 
background aerated at 37˚C in TBK buffered with 0.1 M Tris pH 7 in the presence or 
absence of 0.4% glucose. Values represent maximum average β-galactosidase 
activity +/- standard deviation of triplicate independent cultures. 
B) WT (AJW3759) and isogenic acsA mutant (AJW3800) λrprA lysogens in the 
BW25113 strain background aerated at 37˚C in TBK buffered with 0.1 M Tris pH 7 in 
the presence or absence of 0.4% glucose. Values represent maximum average β-
galactosidase activity +/- standard deviation of triplicate independent cultures.  
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specificity since the rprA promoter response to glucose is unaffected by the absence 
of Acs (Figure 14B).  However, it should be noted that these experiments were 
performed in two different E. coli strain backgrounds (AJW678 and BW25113). If 
strain differences are not responsible for the effect of Acs on glucose-induced 
transcription, then it is possible that Acs is a protein acetyltransferase that can 
target proteins besides CheY. Alternatively, Acs could be an indirect regulator, 
affecting metabolic flux, and impacting osmC transcription.  
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Summary 
 It was reported that RcsB can be acetylated in vitro, but it was not known if 
RcsB was acetylated in vivo nor was it known if acetylation had any physiological 
affect on RcsB activity. I hypothesized that RcsB was acetylated in vivo and that 
acetylation affected RcsB activity as a transcription factor. I screened various RcsB-
regulated transcriptional reporter constructs for a possible effect of acetylation. I 
predicted that manipulating global acetylation by growing E. coli in the presence of 
glucose may impact RcsB acetylation and that this change in acetylation may alter 
the RcsB-regulated transcriptional reporter construct. I demonstrated that PosmC 
and PrprA are most activated by glucose and activation occurs through a mechanism 
that requires a high AcCoA:CoA ratio, consistent with an acetylation-regulated 
phenotype that involves the acetyl donors AcCoA or AcP. The glucose-induced, 
AcCoA:CoA ratio-sensitive activation of PosmC does not require RcsB, RcsC, or the 
αCTD of RNAP, but does require Acs, suggesting that, if acetylation regulates osmC 
transcription, then acetylation of an unknown protein is critical and Acs is involved 
through an unknown mechanism. 
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 The Effect of Acetylation on RcsB-dependent rprA Transcription in E. coli  
Introduction 
RcsB is proposed to be regulated by acetylation. Biochemical evidence 
suggests that the KAT YfiQ, AcCoA, and the KDAC CobB can regulate RcsB 
acetylation (49). It was not, however, demonstrated if RcsB acetylation occurs in 
vivo nor was the effect of acetylation on RcsB activity determined. I hypothesize that 
acetylation of RcsB occurs and that this acetylation affects RcsB activity as a 
transcription factor.  
Because glucose-induced PosmC activity did not require RcsB, I chose to 
monitor the effect of acetylation on RcsB activity using the canonical RcsB-
dependent promoter rprA, whose activity I had established as sensitive to the 
AcCoA:CoA ratio, consistent with an effect of acetylation on RcsB function. If RcsB 
does become acetylated, then it is possible that AcP, an emerging global regulator of 
acetylation (202), may also affect RcsB. To identify acetylated RcsB, we used mass 
spectrometry. To analyze the function of the observed acetylation, we analyzed the 
activity of RcsB lysine mutants at the rprA promoter. 
The rprA promoter, however, is known to be regulated by the 
phosphorylation status of RcsB. Therefore, in order to use PrprA activity as a tool to 
study the effect of RcsB acetylation, I had to clarify the role of RcsB phosphorylation 
in transcription from PrprA. Like other RRs, RcsB is phosphorylated on a conserved 
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aspartyl residue (D56). Biochemical evidence shows that phosphorylation of D56 
occurs via the Rcs phosphorelay, while genetic evidence suggests that RcsB 
phosphorylation status can be regulated by either AcP or the Rcs phosphorelay 
(125,156). Furthermore, the Rcs phosphorelay can either phosphorylate or 
dephosphorylate RcsB due to the bifunctionality of the SK RcsC (125,157,158). 
Under conditions in which RcsC has net phosphatase activity, it is proposed that AcP 
may act as a phosphoryl group donor to RcsB (125). At the rprA promoter, it is 
unknown whether D56 is required and the roles of RcsC and AcP are not fully 
understood. Finally, there is no biochemical evidence to support the genetic 
evicence that RcsB can autophosphorylate in the presence of AcP. By disrupting the 
Rcs phosphorelay and the Pta-AckA pathway, I was able to test the roles of these 
proposed sources of RcsB activation at the rprA promoter. Using a phosphate-
binding molecule (Phos-Tag) that can detect the labile phosphoryl aspartate of 
phospho-RRs, I tested if AcP can donate phosphoryl groups to RcsB in vitro and if 
phosphorylation affects RcsB acetylation. 
The role of D56 and RcsC in RcsB-dependent rprA transcription 
I first tested if activity from PrprA required RcsB. WT PrprA-lacZ lysogen 
(AJW3759) and the isogenic rcsB null mutant (AJW4884) were grown at 37°C in TB7 
in the presence or absence of glucose. PrprA activity depended on RcsB under both 
conditions (Figure 15A). Importantly, we noticed that the peak of PrprA activity 
that occurred during exponential growth even in the absence of glucose and this 
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activity depended on RcsB (Figure 15). Although glucose-induced PrprA activity 
was sensitive to a high AcCoA:CoA ratio, and thus was a reasonable means to study 
the possible effect of acetylation on RcsB, glucose is not necessary for RcsB-
dependent regulation of rprA transcription in exponential phase. I therefore decided 
to simplify my experimental approach and analyze the possible effect of acetylation 
on RcsB activity during exponential phase in the absence of glucose.  
First, I tested whether exponential phase PrprA activity required D56. 
Overexpression of WT RcsB in an rcsB null mutant did not recapitulate WT behavior 
(Figure 16A). Therefore, I cloned rcsB into a single copy plasmid (pLIH001, which is 
a derivative of pVEC) and used site-directed mutagenesis to generate various rcsB 
alleles. From this single copy plasmid, I expressed WT rcsB (pLIH002, Table 1) or 
the mutant rcsB-D56A (pLIH003, Table 1) in an rcsB null mutant of the PrprA-lacZ 
lysogen (strain AJW4884) and found that WT rcsB complemented exponential phase 
PrprA activity, while the rcsB-D56A allele did not (Figure 16B). I tried to verify that 
pLIH003 expresses RcsB-D56A using polyclonal anti-RcsB antibodies obtained from 
Dr. Sandy Thao in Dr. Jorge Escalante-Semerena laboratory. I was not successful, 
however, probably because the single copy of the gene does not express a detectable 
amount of RcsB. Instead, therefore, I used genetics to demonstrate that this plasmid 
expresses RcsB, showing that the activity of endogenous WT RcsB is inhibited when 
WT cells are transformed with pLIH003 (Figure 16C). Therefore, I conclude that 
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RcsB-D56A is expressed and I propose that exponential phase rprA transcription 
requires D56 of RcsB, and thus active phosphorylated RcsB. 
  
93 
 
 
 
 
 
 
 
 
 
 
 
 
 
94 
 
 
 
Figure 15. The effect of glucose and RcsB at the rprA promoter. 
A) PrprA activity of WT (AJW3759) and the isogenic rcsB mutant (AJW4884) when 
grown in TB7 in the presence and absence of glucose. Cells were harvested at 
multiple points throughout growth to measure β-galactosidase activity. The values 
represent the means of triplicate independent cultures with standard deviations. 
B) PrprA activity of WT cells (AJW3759) and the isogenic rcsB (AJW4884) mutant 
when grown in TB7. The values represent the means of triplicate independent 
cultures with standard deviations. 
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Figure 16. Testing if the activation of the rprA promoter requires the 
conserved aspartate residue 56 of RcsB  
A) PrprA activity of an rcsB null mutant (AJW4884) transformed with an IPTG-
inducible, His6-tagged RcsB overexpression plasmid (pHis6rcsB) and grown at 37°C 
in TB7 supplemented with 10 µM IPTG. The values represent the means of triplicate 
independent cultures with standard deviations. 
B) PrprA activity of an rcsB null mutant (AJW4884) transformed with a lacZ null 
derivative of the single-copy expression plasmid pVEC or with a variant of that 
vector that encodes WT RcsB (pLIH002) or RcsBD56A (pLIH003) aerated at 37°C in 
TB7 supplemented with 50 µM IPTG. The values represent the means of triplicate 
independent cultures with standard deviations. 
C) PrprA activity of WT cells (AJW3759) transformed with pVEC or pVEC encoding 
WT RcsB (pLIH002) or RcsBD56A (pLIH003) aerated at 37°C in TB7 supplemented 
with 50 µM IPTG. The values represent the means of triplicate independent cultures 
with standard deviations. 
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Because RcsC has been reported to function as either a kinase or a 
phosphatase (125,157,215), we assessed the influence of RcsC on PrprA activity. 
Consistent with RcsC activating rprA transcription, the rcsC null mutant exhibited 
reduced PrprA activity (Figure 17A). We conclude that endogenous RcsC functions 
as a kinase in this genetic background grown under these conditions. In contrast, 
overexpression of RcsC inhibited PrprA activity (Figure 17B) and reduced mucoidy 
on TB plates (Figure 17C), which is consistent with the report that RcsC 
overexpression decreases phospho-RcsB-dependent mucoidy (125). We propose 
that the equilibrium between RcsC kinase and phosphatase activities is sensitive to 
RcsC concentration. 
In vitro phosphorylation of RcsB by acetyl phosphate 
Using genetic approaches, AcP has been shown to activate the Asp-56-
dependent RcsB activity required for mucoidy and for inhibition of flagellar 
biogenesis (125). AcP also has been shown both biochemically and genetically to 
donate phosphoryl groups to RRs (215). However, there is no biochemical evidence 
that AcP donates phosphoryl group to RcsB. To test whether AcP can act as a 
phosphoryl group donor for RcsB, we used Phos-TagTM, a dinuclear metal complex 
(i.e. 1,3-bis[bis(pyridin-2-ylmethyl)amino]propan-2-olato dizinc(II)) that has 
affinity for phosphomonoester dianions, such as the one found in a phosphorylated 
RR. When included in an SDS-PAGE, Phos-TagTM slows the migration of the 
phosphorylated protein, allowing it to be distinguished from the non-
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phosphorylated protein by mobility shift. When purified RcsB was incubated with 
AcP, we observed a shifted band that was sensitive to heat (Figure 18), indicative of 
a heat-labile aspartyl phosphate. I have also confirmed that the shifted and 
unshifted bands contained His6-tagged RcsB by anti-His6 immunoblot analysis and 
mass spectrometry (data not shown). We conclude that this shifted band is 
composed of phosphorylated RcsB and that RcsB can catalyze its own 
phosphorylation using AcP as the phosphodonor.  
The effect of acetyl phosphate on PrprA activity 
Since AcP can donate its phosphoryl group to RcsB in vitro and AcP can 
activate various RcsB-regulated phenotypes (125), I asked whether AcP activates 
rprA transcription in vivo. The enzyme phosphotransacetylase (Pta) converts AcCoA 
to AcP, while acetate kinase (AckA) converts AcP to acetate (Figure 3). Deletion of 
both ackA and pta results in the lack of AcP (123). In contrast, deletion of ackA alone 
causes accumulation of AcP (123). If AcP activated the observed Asp-56-dependent 
rprA transcription, then PrprA activity would be expected to decrease in the ackA 
pta double mutant and increase in the ackA null mutant. As predicted, the ackA pta 
double mutant displayed a small but reproducible reduction in rprA transcription 
whether or not rcsC was intact (Figure 17A). These results support the hypothesis 
that both AcP and RcsC contribute to RcsB phosphorylation. Contrary to 
expectations, however, PrprA activity was reduced in the ackA mutant rather than 
increased (Figure 17A and 19A). This result suggests that the accumulation of some 
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metabolic intermediate in the ackA mutant inhibits RcsB activity. We reasoned that 
this inhibitory mechanism might involve protein acetylation because we have 
observed that a deletion of ackA changes the acetylation profile of RNA polymerase 
(48) and enhances global E. coli protein acetylation (Kuhn et al., in preparation). We 
thus considered the possibility that protein acetylation was involved in the reduced 
rprA transcription exhibited by the ackA mutant.   
The effect of the deacetylase CobB on PrprA activity 
Consistent with the hypothesis that acetylation may regulate rprA 
transcription, it was reported that RcsB could be acetylated in vitro on one lysine 
residue, that this acetylation reduces RcsB DNA binding affinity, and that this 
acetylation can be reversed by the KDAC CobB (49). I therefore tested if protein 
acetylation inhibited rprA transcription. In the absence of CobB, the only known E. 
coli KDAC, there was a strong reduction in rprA transcription compared to that of its 
WT parent (Figure 19A). To determine if CobB activity was important for PrprA 
activity,  WT cells were grown in the presence of nicotinamide, an inhibitor of 
sirtuin KDACs like CobB (216). Similar results were obtained with nicotinamide 
(Figure 19B), suggesting that CobB activity is a critical enhancer of rprA 
transcription. We propose that CobB enhances rprA transcription by deacetylating 
some protein, possibly RcsB, which inhibits rprA transcription in its acetylated form.   
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Determining if acetylated RcsB exists in vivo 
Since CobB affects an RcsB-dependent phenotype, I tested if RcsB was 
acetylated in vivo. At first, I was unable to detect endogenous RcsB because the 
concentration of RcsB was low. I therefore used pHis6rcsB (199) to overexpress 
RcsB in WT cells and grew the resultant transformants in TB7. I grew four biological 
replicates in parallel and prepared cell lysates. I excised RcsB protein from SDS 
polyacrylamide gels and our collaborators Dr. Haike Antelmann, Bui Khan Chi, 
Katrin Basell, and Dorte Becher from the Institute for Microbiology at Ernst-Moritz-
Arndt-University of Greifswald evaluated the acetylation status using Orbitrap Velos 
LC-MS/MS analysis. To ensure comparable protein abundances for tryptic digestion 
and MS analysis, RcsB protein obtained from all strains were processed in parallel 
and similar protein concentrations were loaded onto each SDS polyacrylamide gel. 
This allowed us to use the Scaffold software to perform a practical, label-free, semi-
quantitative comparison of abundances (given as spectral counts, SC; (217)) for 
each detected peptide that contained an acetylated lysine (Tables 2 and 3, Tables 
S1-S3 in (218)). 
We detected acetylated RcsB in vivo. In four parallel bioreplicates of the WT 
strain overexpressing RcsB, Orbitrap Velos mass spectrometry reproducibly 
detected acetylation of four lysine residues: Lys-72, Lys-125, Lys-128, and Lys-154. 
Each acetylated lysine was identified by at least 1 SC in at least 2 replicates, with an 
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average of 4.0 total SC over all four replicates (Tables 2 and 3, Table S1A-D in 
(218)).  
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Figure 17. The effect of the Pta-AckA pathway, RcsC, and RcsF on rprA 
promoter activity and ackA-induced mucoidy. 
A) PrprA activity of WT cells (AJW3759), ackA (AJW3981), ackA pta (AJW4030), rcsC 
(AJW3976), and ackA pta rcsC (AJW5187) aerated at 37°C in TB7. The values 
represent the means of triplicate independent cultures with standard deviations. 
 B) PrprA activity of WT cells (AJW3759) transformed with the RcsC expression 
plasmid prcsC (pPSG980), the RcsF expression plasmid (pMH300), or the vector 
control (pTrc99a) and aerated at 37°C in TB7 supplemented with 50 µM IPTG to 
induce rcsC or rcsF expression. The values represent the means of triplicate 
independent cultures with standard deviations. 
C) AJW678 WT or the isogenic ackA mutant (AJW1939) transformed with the vector 
control (pTrc99a), an RcsC overexpression plasmid (pPSG980), or an RcsF 
overexpression plasmid (pMH300) were grown on TB plates supplemented with 
ampicillin and 50 µM IPTG at 22°C for 2 days. The image was taken on a light box. 
“+” indicates mucoidy and “0” indicates no observable mucoidy. 
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Figure 18. AcP can induce a temperature-sensitive shift in RcsB migration 
through a Phos-Tag containing SDS-PA gel.  
Purified His6-RcsB peak 2 was incubated in the absence (lane 1) or presence of 5 
mM AcP (lanes 2, 3, 4) for 30 minutes at 30°C. A fraction of the reaction was heated 
at 95°C for 15 minutes to hydrolyze the phosphoryl group (lane 4). The reactions 
were separated in a Phos-TagTM SDS-PA gel and the gel was stained with coomassie 
brilliant blue. 
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Figure 19. The effect of CobB activity on rprA promoter activity. 
A) WT rprA cells (AJW3759) and the isogenic ackA (AJW3981) and cobB 
(AJW5011) mutants were aerated at 37°C in TB7. Cells were harvested at multiple 
points throughout growth to measure OD600 and β-galactosidase activity. The 
values represent the means of triplicate independent cultures with standard 
deviations. 
B) Peak β-galactosidase activity between OD600 0.6 – 0.8 of WT (AJW3759) cells 
aerated at 37°C in TB7 with and without increasing concentrations of nicotinamide 
(NAM). The values indicate the average of triplicate independent cultures with 
standard deviations. 
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Table 2. Spectral counts of lysine acetylated RcsB peptides isolated from WT 
cells, cobB mutants, and WT cells exposed to nicotinamide (NAM) 1,4 
 
 Average SC
2
 SC Ratio
2
 
Acetylated 
lysine 
WT cobB 
WT + 
NAM 
cobB/WT NAM/WT 
72 1.0 0.8 1.0 0.8 1.0 
118 0.0 3.0 2.3 >3.0
3
 >2.3 
125 1.5 2.0 1.5 1.3 1.0 
128 0.5
 
0.8 1.0 1.5 2.0 
140 0.0 2.0 0.8 >2.0 >0.8 
149 0.0 1.5 1.5 >1.5 >1.5 
154 1.0 2.0 2.0 2.0 2.0 
173 0.0 0.0 0.5 NA >0.5 
180 0.0 0.5 0.0 >0.5 NA 
Total SC 4.0 12.5 10.5 3.1 2.6 
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1Average spectral counts (SC) of detected lysine acetylation sites in the wild type 
(WT), its isogenic cobB mutant (cobB) and in the WT treated with NAM (WT+NAM). 
2Using data obtained from Scaffold 3 proteome software, the spectral counts of four 
biological replicates for each strain/condition were counted manually, were 
averaged over the four replicates, and were compared as ratios of the mutant or the 
treated WT relative to the untreated WT. 
3When the SC of a peptide with an acetylated lysine in the cobB mutant or in the 
NAM-treated WT is greater than the SC of the same peptide in the untreated WT 
control, the ratio is underlined. A ratio of >n refers to any acetylated peptide that 
was not detected in WT (SC=0), but detected in the cobB mutant or the NAM-treated 
WT (SC=n). 
4The spectral counts of the detected lysine acetylation sites in each replicate and the 
peptide scores and mass deviations as well as the complete MS/MS spectra and 
fragment ion series can be found in Tables S1A-D, S2A-D, and S3A-D, where A-D 
denote the four bioreplicates in (218). As an example of the information available in 
these supplemental tables, ‘Table S1A’ is provided in this study as Table 3. 
 
 
 
 
Table 3. Identity, MS-MS spectra and B & Y-fragment ion series for acetylated RcsB peptides detected in samples 
isolated from WT cells.  
 
 
 
 
 
Acetylated RcsB peptide data SEQUEST SEQUEST Neutral
Sequence Prob XCorr DCn NTT Modifications m/z Precursor Ion Molecular Mass Charge Delta AMU Delta PPM Start Stop Other Proteins Spectrum ID
(K)YGDGITLIk72(+42)YIK(R) 95% 3.3368 0.5606 2 Acetyl (+42) 713.4027 1424.7909 2 -0.0009687 -0.6794 64 75 110218_OV3_P3_KG_HA_LH1A.13352.13352.2.dta
(K)YGDGITLIk72(+42)YIK(R) 95% 4.3257 0.6152 2 Acetyl (+42) 713.4034 1424.7922 2 0.0003743 0.2625 64 75 110218_OV3_P3_KG_HA_LH1A.13315.13315.2.dta
(K)ALAALQk125(+42)GK(K) 95% 2.9464 0.6351 2 Acetyl (+42) 471.2923 940.5700 2 -0.0007547 -0.8015 119 127 110218_OV3_P3_KG_HA_LH1A.04990.04990.2.dta
(K)ALAALQk125(+42)GK(K) 95% 2.7962 0.6330 2 Acetyl (+42) 471.2923 940.5700 2 -0.0006937 -0.7368 119 127 110218_OV3_P3_KG_HA_LH1A.04949.04949.2.dta
(K)k128(+42)FTPESVSR(L) 95% 1.8227 0.2948 2 Acetyl (+42) 546.7877 1091.5608 2 -0.0003717 -0.3402 128 136 110218_OV3_P3_KG_HA_LH1A.05728.05728.2.dta
(K)k128(+42)FTPESVSR(L) 95% 1.9638 0.4599 2 Acetyl (+42) 546.7900 1091.5655 2 0.004389 4.017 128 136 110218_OV3_P3_KG_HA_LH1A.05645.05645.2.dta
(R)LSPk154(+42)ESEVLR(L) 95% 1.7692 0.4068 2 Acetyl (+42) 600.3368 1198.6590 2 0.003195 2.663 151 160 110218_OV3_P3_KG_HA_LH1A.06910.06910.2.dta
Acetylated RcsB peptide coverage 
All detected acetylated peptides are highlighted in yellow and the modified amino acids (Lys-acetyl and Met-oxidation) are marked in green. All acetylated peptides are listed in the Table above.
1
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Table 3 continued. 
 
RcsB was overexpressed from the pHis6-rcsB plasmid in WT cells in TB7 supllemented with 50 µM IPTG. Proteins from whole 
cell lysates were separated by SDS-PAGE and RcsB bands were tryptically digested as described (219). The resulting peptides 
were analyzed using LC-MS/MS analysis as described in the Methods and analyzed using the Scaffold software. Table 3 shows 
the Xcorr, deltaCn scores, m/z of the precursor ions, neutral molecular masses of the CID MS/MS spectrum of the acetylated 
MS/MS-spectra and B & Y-fragment ion series for acetylated RcsB peptides 
(K)YGDGITLIk72(+42)YIK(R)
(K)ALAALQk125(+42)GK(K)
(K)k128(+42)FTPESVSR(L)
(R)LSPk154(+42)ESEVLR(L)
1
11 
 
 
 
 
peptides are shown, in which the complete b and y ion series are cognizable and labeled in red and blue, respectively. Table 3 
is representative of the information provided in supplemental tables from (218).   
1
12 
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Determining if CobB affects RcsB acetylation in vivo. 
 CobB activity appears to increase rprA transcription and CobB was reported 
to deacetylate Lys-180-acetylated RcsB in vitro (49). We thus tested whether CobB 
affected RcsB acetylation in vivo. RcsB was prepared for mass spectrometry as 
described above except that RcsB was overexpressed either in the cobB mutant or in 
WT cells exposed to 20 mM nicotinamide grown in TB7.  
Consistent with CobB deacetylating RcsB in vivo, the cobB mutant exhibited 
an increase in the number of acetylated RcsB lysines. In the cobB mutant, mass 
spectrometry reproducibly detected acetylation of 8 lysine residues: the four listed 
above plus Lys-118, Lys-140, Lys-149, and Lys-180 (Table 2, Tables S2A-D in 
(218)). In the WT strain treated with NAM, mass spectrometry also reproducibly 
detected acetylation of 8 lysine residues: seven identified in the cobB mutant and 
Lys-173 (Table 2, Tables S3A-D in (218)). Furthermore, the acetylated peptides 
were more abundant in the cobB mutant (average total SC of 12.5) and in the NAM-
treated parent strain (average total SC of 10.5) than in the parent control (average 
total 4.0 SC). However, these increases in SC were not distributed evenly over all 
acetylated lysines, suggesting that CobB does not regulate all acetylated RcsB lysines 
similarly. For example, the average SC for peptides containing acetylated Lys-72 or 
Lys-125 did not differ significantly between strains/conditions; in contrast, we 
reproducibly detected acetylation of 3 residues (Lys-118, Lys-140, and Lys-149) in 
the cobB mutant and the NAM-treated parent that were not detected in the 
untreated parent (Table 2). Thus, CobB may promote deacetylation of certain RcsB 
lysines in vivo. 
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Determining if AckA impacts RcsB acetylation in vivo 
We hypothesized that an ackA mutation affects RcsB acetylation. We did so, 
in part, because Dr. Bruno Lima previously reported that the cpxP promoter 
response to glucose is reduced in the ackA mutant, that the acetylation profile of 
RNA polymerase is altered in the ackA mutant, and that this alteration is likely 
involved in the reduced transcription (48). I also observed that the ackA mutant 
phenocopies the cobB mutant (Figure 19A), a condition that affects RcsB 
acetylation (Table 2). We therefore tested if RcsB acetylation is enhanced in the 
absence of ackA. I overexpressed RcsB in the WT strain and its isogenic ackA and 
cobB mutants, separated the proteins by SDS-PAGE, and subjected the tryptic 
digests to mass spectrometry as described above. Once again, I performed replicate 
experiments in parallel, and processed the same amount of protein from all samples 
so that we could compare the spectral counts for each acetylated peptide in each 
mutant relative to WT. 
As predicted, the acetylation profile of RcsB isolated from the ackA mutant 
(Table 4, Tables S6A-B in (218)) generally resembled that of the cobB mutant 
(Table 4, Tables S5A-B in (218)). Of the 7 acetylated RcsB lysines from the cobB 
mutant, 6 lysines were reproducibly acetylated in the ackA mutant. Several 
acetylated lysines (Lys-118, Lys-128, and Lys-154) were detected more often in 
both mutants than in their WT parent. Like RcsB from the cobB mutant (average 
total 14.5 SC), acetylated peptides from the ackA mutant were two-fold more 
abundant (average total 17 SC) than the same peptides from WT cells (average total 
8.5 SC). We conclude that disruption of ackA promotes acetylation of some RcsB 
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lysines in vivo. We further propose that the reduction in rprA transcription in the 
ackA and cobB mutants results from the same mechanism, an increase in RcsB 
acetylation. 
When comparing the results of this experiment (Table 4) to those of the 
previously described experiment (Table 2), we noticed a general increase in the 
numbers of detected acetylated lysine residues and their spectral counts. We 
attribute this difference primarily to the larger amounts of RcsB analyzed in the 
second experiment and to the use of a different liquid chromatography (LC) column 
prior to Orbitrap Velos MS. The general pattern however, was reproducible: 
acetylated peptides were more abundant in the cobB mutant (average total SC of 
14.5) than in the parent control (average total 8.5 SC) (Table 4), supporting our 
conclusion that CobB may deacetylate RcsB in vivo. For the parent, we reproducibly 
detected acetylation of 5 lysine residues, each identified by 1-2 SC per replicate 
(Table 4, Tables S4A-B  in (218)). For the cobB mutant, we observed reproducible 
acetylation of 7 lysines, each identified by 1-4 SC per replicate (Table 4, Tables 
S5A-B in (218)). Moreover, some acetylated peptides were reproducibly more 
abundant than the same peptides from the parent, consistent with our previous 
observations and supporting the prediction that CobB deacetylates certain RcsB 
lysines in vivo.  
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Genetic analysis into the function of acetylated RcsB lysines in rprA 
transcription 
In the absence of ackA or cobB, PrprA activity was reduced and RcsB 
acetylation increased. One RcsB lysine (Lys-154) that was reproducibly more 
acetylated in the mutants relative to the WT parent (Tables 2 and 4) was found to 
be critical for RcsB activity. While there is a method that can generate site-specific 
acetylated proteins (220), we currently do not have this system functioning in our 
laboratory. Instead, to assess the effect of acetylation on RcsB function, we applied 
an approach commonly used in studies of acetylation in eukaryotes (221), 
converting this AckA- and/or CobB-sensitive lysine to a glutamine (which mimics a 
neutral, acetylated lysine) or to an arginine (which mimics a positive, non-
acetylatable lysine). We introduced these rcsB variants (carried by pVEC) into the 
rcsB null strain (AJW4884) and monitored PrprA activity. The acetylated and non-
acetylated mimics of Lys-154 exhibited opposite behaviors. The mimic of acetylated 
Lys-154 (RcsB-K154Q) exhibited a strong reduction in PrprA activity, a behavior 
that was indistinguishable from that of the vector control (Figure 20A), the non-
phosphorylatable mutant RcsB-D56A, and the RcsB-K154A mutant (data not 
shown). This contrasted with the behavior of the non-acetylated mimic (RcsB-
K154R), which more closely resembled that of the WT RcsB (Figure 20A). We next 
tested whether the inability of RcsB-K154Q to support PrprA activity was due to a 
lack of expression or a loss of function. I attempted to detect RcsB expressed from 
the pCC1 single copy plasmid system, but RcsB is not tagged, the anti-RcsB antibody 
(J. Escalante-Semerena laboratory) exhibited non-specific binding, and the amount 
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of RcsB expressed from the pCC1 plasmid is low. Instead, we took advantage of the 
report that RcsB inhibits migration through semi-solid agar by repressing 
transcription of flhDC, which encodes the master regulator of flagella biosynthesis 
(125,163). We asked if expression of the rcsB mutants could inhibit migration of the 
highly motile strain AJW3331 (AJW678 background). Indeed, each mutant rcsB 
allele (D56A, K154A, K154Q, and K154R) inhibited migration to a level similar to 
that of the WT allele (Figure 20B). We have not tested if growth was affected but 
the results are consistent with the expression of mutant RcsB and that they retain 
function. We therefore propose that the positive charge of Lys-154 is critical to 
RcsB-dependent activation of rprA transcription and that acetylation of Lys-154 
may regulate RcsB activity. We were intrigued with the observation that RcsB-D56A 
was able to inhibit migration since this mutant lacks the conserved phospho-
acceptor site. These results may suggest that binding to DNA does not require 
phosphorylation of RcsB and that phosphorylation impacts another step that is 
critical for RcsB activity. 
The effect of acetylation on phosphorylated RcsB 
Because an increase in the number of detectably acetylated RcsB lysine 
residues correlated with a reduction in phospho-RcsB dependent PrprA activity, I 
tested whether acetylation reduced the level of RcsB phosphorylation. I first 
acetylated purified RcsB using AcCoA alone or using both AcCoA and YfiQ, and then 
incubated the reaction mixtures with increasing amounts of AcP. We separated the 
mixtures by Phos-TagTM SDS-PAGE and compared the ratio of phosphorylated-to-
unphosphorylated RcsB with and without prior in vitro acetylation. When the AcP 
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concentration was physiologically relevant (≤5 mM; (123)), the percentage of 
phosphorylated RcsB following AcCoA- or AcCoA/YfiQ-mediated acetylation was 
reduced relative to the control that was not previously acetylated in vitro (Figure 
21). While the effect of acetylation on phosphorylation is small, this observation 
that acetylation reduces the amount of phosphorylated RcsB is highly reproducible. 
These results suggest that RcsB is regulated by more than one modification and that 
this may be an example of a bacterial post-translational modification code (21). 
These results are consistent with acetylation inhibiting RcsB activity at the rprA 
promoter by reducing RcsB phosphorylation.  
Summary 
Using a combination of genetics and biochemistry, I tested the hypothesis 
that RcsB acetylation exists in vivo and that acetylation affects RcsB activity as a 
transcriptional regulator. I identified that RcsB is acetylated in vivo and I verified 
that RcsB function is sensitive to CobB activity (49) and showed that CobB regulates 
the acetylation status of RcsB in vivo. Consistent with the observation that Dr. Bruno 
Lima made at another stress-responsive promoter, I showed that the Pta-AckA 
pathway influences protein acetylation. This is the first published evidence that in 
vivo acetylation of a bacterial transcription factor could regulate its activity. 
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Table 4. Spectral counts of lysine acetylated RcsB peptides isolated from WT 
cells or yfiQ, cobB, or ackA mutant cells 1,4 
 
  Average SC
2
 SC Ratio
2
 
Acetylated 
lysine 
WT cobB ackA yfiQ cobB/WT ackA/WT yfiQ/WT 
63 1.0 1.0 1.5 0.0 1.0 1.5 0.0 
72 2.0 0.5 4.5 2.0 0.3
3
 2.3
3
 1.0 
118 1.5 3.5 4.5 2.5 2.4 3.0 1.7 
125 1.5 1.5 2.0 1.5 1.0 1.4 1.0 
128 0.5 2.0 1.0 0.0 4.0 2.0 0.0 
140 0.0 1.5 0.5 0.0 >1.5 >0.5 0.0 
149 0.0 0.5 0.0 0.0 >0.5 0.0 0.0 
154 0.5 3.0 2.0 1.0 6.0 4.0 2.0 
173 1.5 0.0 0.0 1.5 0.0 0.0 1.0 
180 0.0 1.0 1.0 0.0 >1.0 >1.0 0.0 
Total SC 8.5 14.5 17.0 8.5 1.7 2.0 1.0 
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1Average spectral counts (SC) of detected lysine acetylation sites in the wild type 
(WT), and its isogenic cobB, ackA and yfiQ mutants.  
2Using data obtained from Scaffold 3 proteome software, the spectral counts of two 
biological replicates for each strain were counted manually, were averaged over the 
two replicates, and were compared as ratios of the mutants relative to the untreated 
WT.  
3When the SC of a peptide with an acetylated lysine in a mutant is less than the SC of 
the same peptide in the WT control, the ratio is italicized. When the SC of a peptide 
with an acetylated lysine in a mutant is greater than the SC of the same peptide in 
the WT control, the ratio is underlined. A ratio of >n refers to any acetylated peptide 
that was not detected in WT (SC=0), but detected in a mutant (SC=n).  
4The spectral counts of the detected lysine acetylation sites in each replicate and the 
peptide scores and mass deviations as well as the complete MS/MS spectra and 
fragment ion series can be found in Tables S4A-B, S5A-B, S6A-B and S7A-B in 
(218), where A-B denote the two bioreplicates. 
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Figure 20. Analyzing the role of Lys-154 on rprA transcription and migration.  
A) PrprA activity of rcsB mutant (AJW4884) transformed with the single copy 
plasmid pVEC or pVEC carrying WT and mutant rcsB-K154 alleles. Cells were 
aerated at 37°C in TB7 supplemented with 50 µM IPTG. 
B) Migration analysis of the highly motile WT strain (AJW3331) in the AJW678 
strain background transformed with pVEC or pVEC carrying WT and mutant rcsB 
alleles. The histogram shows the last measurement of an 8.5 hour time course 
experiment. These results are representative of the whole experiment.  
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Figure 21. The effect of RcsB acetylation on RcsB phosphorylation in vitro.  
A) In vitro acetylation followed by in vitro phosphorylation with increasing 
concentrations of AcP. 50 µl reactions of purified 20 µM RcsB were incubated in the 
absence of AcCoA (white bars), in the presence of 0.4 mM AcCoA (grey bars), or in 
the presence of AcCoA and 2 µM YfiQ (black bars) for 1 hour at 37°C. Fractions of 
these reactions were used for in vitro phosphorylation incubating each with AcP at 
0, 1.25 mM, 2.5 mM, and 5 mM for 30 minutes at 30°C. The proteins were resolved 
by 13% SDS-PAGE at 4°C and stained with Coomassie brilliant blue. The values 
represent the percent phosphorylated shift relative to the total signal intensity 
(shifted and unshifted bands). Quantification was performed using AlphaView. 
B) In vitro acetylation with AcCoA (grey bars) or AcCoA and YfiQ (black bars) 
followed by in vitro phosphorylation with 5 mM AcP. Reactions were performed in 
duplicate and set up as described for Figure 21A. The absence of in vitro acetylation 
(white bar) was set to 100%. The values represent the averages and the standard 
deviation.  
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 Biochemical and Functional Analysis of YfiQ on RcsB and rprA transcription 
Introduction 
 RcsB is acetylated in vivo and its acetylation is regulated by CobB and AckA 
(218). Since YfiQ was reported to acetylate RcsB on Lys-180 in the DNA binding 
domain, using AcCoA as the acetyl donor in vitro (49), YfiQ may regulate RcsB 
acetylation in vivo. However, Lys-180 was not the only acetylated site nor was Lys-
180 the most common or highly acetylated site. Therefore, I repeated the reported 
in vitro experiment, investigating the effect of purified YfiQ on the acetylation status 
of purified RcsB. To determine if YfiQ acetylated and thus regulated RcsB activity in 
vivo, I tested if the RcsB acetylation profile depended on YfiQ and determined if YfiQ 
regulated rprA transcription. 
In vitro acetylation of RcsB with YfiQ and AcCoA 
To investigate the effect purified YfiQ on the acetylation status of purified 
RcsB, Dr. Ekaterina Filippova, a post-doctoral fellow in the laboratory of our 
collaborator Wayne F. Anderson at Northwestern University, first purified His6-
tagged RcsB using gel filtration chromatography, finding that the 23.7 kDa RcsB 
purified from WT E. coli cells resolved into two peaks with estimated molecular 
mass values of 100 kDa (high molecular weight or peak 1 (RcsB-1)) and 60 kDa (low 
molecular weight or peak 2 (RcsB-2)) (Figure 22A). Dynamic light scattering 
revealed that monodisperse solutions of RcsB-1 and RcsB-2 have globular species 
with exclusion radii of 8.9 nm and 7.2 nm, respectively (Figures 22B and 22C). 
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Taken together, these results are consistent with the formation in solution of both 
tetramers (RcsB-1) and dimers (RcsB-2).  
To determine whether RcsB could be a substrate of YfiQ, Dr. Misty L. Kuhn, 
another post-doctoral fellow from Dr. Anderson’s laboratory, used a biochemical 
assay that detects AcCoA hydrolysis (188). For both oligomers, AcCoA hydrolysis 
increased as the concentration of RcsB was increased; incubation of 0.02 mM YfiQ 
with 15 times the concentration of RcsB (0.30 mM) hydrolyzed more AcCoA than in 
the presence of equimolar amounts of RcsB (0.02 mM) (Figure 23B). This behavior 
indicates that RcsB can be a substrate of YfiQ.  
To identify the RcsB lysines acetylated in the presence of YfiQ, we used mass 
spectrometric analysis (184,219). Following incubation of either RcsB oligomer 
with YfiQ and AcCoA, we observed acetylation of Lys-180, consistent with the 
previous report that YfiQ acetylates Lys-180 in vitro (49), but we also observed YfiQ-
dependent acetylation of several other RcsB lysines: Lys-125, Lys-127, Lys-149 and 
Lys-186 (Table 5, Tables S8C and F in (218)). Surprisingly, incubation with both 
AcCoA and YfiQ did not dramatically change the abundance of acetylated lysines 
relative to incubation with AcCoA alone (Table 5, Tables S8B and E in (218)). Anti-
acetyl-lysine immunoblot analysis yielded a similar result (Figure 23A, compare 
lanes 9 and 10 to lanes 5 and 6). Instead, the pattern of acetylation changed. For 
some residues, the level of acetylation increased relative to their status after 
incubation with AcCoA alone. For other residues, the acetylation decreased (Table 
5). For example, both RcsB-1 and RcsB-2 exhibited increased SC for acetylated Lys-
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125, Lys-180, and Lys-186. In contrast, the SC for acetylated Lys-140 of RcsB-1 
decreased by more than five-fold (Table 5).  
In vitro analysis of YfiQ and the effect of incubation with AcCoA 
Anti-acetyllysine immunoblot analysis detected acetylation of purified YfiQ 
(Figure 23A, lane 1). This suggests that YfiQ was acetylated under the conditions 
used for purification. Indeed, Orbitrap Velos mass spectrometric analysis (184,219) 
detected 8 acetylated lysines in YfiQ (Table 6).  
When YfiQ was incubated with AcCoA, YfiQ acetylation increased (Figure 
23A, compare lane 2 to lane 1, Tables S9D and E in (218)), suggesting that YfiQ 
might autoacetylate, consistent with reports that some KATs autoacetylate (222-
224). Mass spectrometry revealed 11 acetylated lysines, the eight that were 
acetylated with YfiQ alone plus three more: Lys-13, Lys-149 and Lys-447 (Table 6, 
Tables S9C-D in (218)). In the presence of AcCoA, an average of 39 total SC of 
acetylated lysines were detected, an increase of nearly two-fold relative to YfiQ 
without AcCoA (average total 20 SC). Most notably, the acetylated Lys-146 peptide 
was six-fold more abundant when AcCoA was included in the reaction. We conclude 
that YfiQ is acetylated on multiple residues and that, like some other protein 
acetyltransferases (224,225), YfiQ may be regulated by autoacetylation when 
provided with its acetyl donor AcCoA. 
In vitro analysis of RcsB and the effect of incubation with AcCoA 
Anti-acetyl-lysine immunoblot analysis also detected acetylation of RcsB-1 
and RcsB-2, but this acetylation was only visible after a long exposure (Figure 23C), 
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suggesting that the proportion of RcsB that is acetylated under the conditions used 
for purification is low. The number of acetylated lysines (10 acetylated lysines in 
RcsB-1 (Table 5, Table S8A in (218)) and 9 acetylated lysines in RcsB-2 (Table 5, 
Table S8D in (218)), the abundance of acetylation, or the average total SC of 
acetylated peptides (RcsB-1 (22 SC) and RcsB-2 (20 SC)), and the distribution of 
acetylation were similar between RcsB-1 and RcsB-2, suggesting that the oligomeric 
structure of RcsB plays a minor role in the regulation of acetylation.  
For both RcsB oligomers, incubation with AcCoA dramatically increased 
acetylation (Figure 23A, compare lanes 5 and 6 to lanes 3 and 4) and increased the 
abundance of acetylated RcsB peptides by about two-fold (Table 5, Tables S8B and 
E in (218)). This observation suggests that RcsB may autoacetylate in the presence 
of AcCoA, similar to what is reported for the chemotaxis RR CheY, one of the first 
bacterial proteins to be discovered as regulated by acetylation (46).  
  
129 
 
 
 
  
130 
 
 
 
Figure 22. Gel filtration and dynamic light scattering analysis of RcsB.  
Dr. Ekaterina Filippova performed these analyses on purified RcsB1 and RcsB2.  
A) Elution profile at 280 nm of the purified RcsB protein in 10 mM Bis–Tris, 500 mM 
Sodium Chloride, pH 8.3. Flow rate 3.2 ml/min on a gel filtration column (Superdex) 
attached to FPLC system.  
B) Distribution of scattering intensity for RcsB peak 1 (RcsB-1) at ~ 1.0 mg/ml. The 
estimated molecular weight of RcsB-1 is 110 kDa (tetramer).  
C) Distribution of scattering intensity for RcsB peak 2 (RcsB-2) at ~ 1.0 mg/ml. The 
estimated molecular weight of RcsB-2 is 67 kDa (dimer).   
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Figure 23. In vitro acetylation of RcsB  
A) In vitro acetylation reactions with RcsB, YfiQ, and AcCoA. 50 µl reactions of 21 µM 
RcsB-1 or -2, 2 µM YfiQ, and 0.4 mM AcCoA were incubated at 37°C for 2 hours. The 
reactions were quenched with 50 µl 2X SDS-PAGE loading buffer and heated at 95°C 
for 5 minutes. 15 µl was resolved by 13% SDS-PAGE, proteins were transferred, and 
acetylated proteins detected by Western immunoblot with anti-acetyl-lysine 
antibody. Lane 1: YfiQ alone, lane 2: YfiQ + AcCoA, lane 3: RcsB-1 alone, lane 4: RcsB-
2 alone, lane 5: RcsB-1 + AcCoA, lane 6: RcsB-2 + AcCoA, lane 7: YfiQ + RcsB-1, lane 
8: YfiQ + RcsB-2, lane 9: YfiQ + RcsB-1 + AcCoA, lane 10: YfiQ + RcsB-2 + AcCoA. 
These results are representative of three independent experiments. The high 
molecular weight signal in lanes 1, 2, 9 and 10 corresponds to acetylated YfiQ. The 
acetylated sites were determined using semi-quantitative mass spectrometry 
(Tables S9A-E, (218)). Mass spectrometry also identified the signal visible between 
the 37-50 kDa markers in lanes 2, 9 and 10 as the 43.3 kDa EF-Tu protein and 
determined the acetylated sites (Table S10, (218)). Mass spectrometry identified 
the signal between the 25-37 kDa markers in lanes 9 and 10 as the 29.9 kDa RplB 
protein and determined its acetylated sites (Table S11, (218)). 
B) Activity of YfiQ using different concentrations of RcsB1 and RcsB2. Reactions 
were performed using 0.02 mM YfiQ at 25°C for one hour in a 50 μl reaction volume. 
To initiate the reaction, 0.5 mM AcCoA was used. Activity (nmol/min/mg) is shown 
as the average of three separate trials.  Black bars correspond to 0.02 mM RcsB and 
red bars to 0.3 mM RcsB. Dr. Misty Kuhn at Northwestern University performed 
these experiments.   
C) Purified RcsB acetylation is detectable by anti-acetyl lysine Western immunoblot 
analysis. A longer exposure time (5 minutes) of the blot from Figure 23A, showing 
lanes 3 and 4, which contains purified RcsB peak 1 and peak 2, respectively.  
  
 
 
 
 
Table 5. Spectral counts of acetylated peptides of RcsB1,4 
 
 
Acetylated 
 lysine 
RcsB-1 RcsB-2 
Average SC
2
 SC Ratio
2
 Average SC SC Ratio 
Control AcCoA 
AcCoA+
YfiQ 
AcCoA 
/control 
AcCoA+YfiQ 
/AcCoA 
control AcCoA 
AcCoA+
YfiQ 
AcCoA 
/control 
AcCoA+YfiQ 
/AcCoA 
63 2.0 1.0 0.0 0.5
3
 0.0 0.0 0.0 0.0 NA NA 
72 2.0 2.0 1.5 1.0 0.8 0.5 2.5 1.5 5.0 0.6 
118 5.5 7.0 10.0 1.3 1.4 6.0 8.5 10.5 1.4 1.2 
125 2.0 4.0 13.5 2.0
3
 3.4 3.0 4.0 9.0 1.3 2.3 
127 0.0 1.0 2.0 >1.0 2.0 0.0 1.0 2.0 >1.0 2.0 
128 3.0 4.0 6.0 1.3 1.5 1.5 4.5 7.0 3.0 1.6 
140 0.5 19.0 3.0 38.0 0.2 0.0 3.0 3.5 >3.0 1.2 
149 1.0 2.0 5.0 2.0 2.5 2.5 5.0 5.0 2.0 1.0 
154 3.5 8.0 4.5 2.3 0.6 3.0 6.5 5.0 2.2 0.9 
173 2.0 2.0 2.5 1.0 1.3 1.0 2.5 2.0 2.5 0.8 
180 0.5 1.0 6.0 2.0 6.0 1.5 2.5 6.5 1.6 2.3 
186 0.0 1.0 3.0 >1.0 3.0 1.0 0.5 2.5 0.5 5.0 
 Total SC 22 52 57 2.4 1.1 20 40.5 54.5 2.0 1.3 
 
1
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1Average spectral counts (SC) of detected lysine acetylation sites in purified RcsB 
(control), and purified RcsB incubated with AcCoA (AcCoA) or purified RcsB 
incubated with AcCoA plus YfiQ (AcCoA+YfiQ).  
2Using data obtained from Scaffold 3 proteome software, the spectral counts of two 
replicates for each condition were counted manually, were averaged over the two 
replicates, and were compared as the ratio of SC detected for RcsB incubated with 
AcCoA or with AcCoA and YfiQ relative to SC detected with purified RcsB alone.  
3When the SC of a peptide with an acetylated lysine following AcCoA incubation is 
substantially more than the SC of the same peptide in the absence of AcCoA or if the 
SC of a peptide with an acetylated lysine following incubation with both AcCoA and 
YfiQ is substantially more than the SC of the same peptide in the presence of AcCoA 
alone, the ratio is underlined. If the ratio is substantially less, then the ratio is 
italicized. A ratio of >n refers to any acetylated peptide that was not detected in the 
absence of AcCoA (SC=0), but detected in the presence of AcCoA (SC=n).  
4The spectral counts of the detected lysine acetylation sites in each replicate and the 
peptide scores and mass deviations as well as the complete MS/MS spectra and 
fragment ion series can be found in Tables S10A-F (218), where A-C respectively 
denote RcsB-1 alone, RcsB-1 incubated with AcCoA, and RcsB-1 incubated with both 
AcCoA and YfiQ, and D-F respectively denote RcsB-2 alone, RcsB-2 incubated with 
AcCoA, and RcsB-2 incubated with both AcCoA and YfiQ. 
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Table 6. Spectral counts of acetylated peptides of purified YfiQ1,4 
 
Acetylated 
lysine 
Average SC
2
 SC Ratio
2
 
Control AcCoA AcCoA/Control 
13 0.0 0.5 >0.5 
23 3.5 4.0 1.1 
146 0.5 3.0 6.0
3
 
149 0.0 2.5 >2.5 
228 1.5 3.5 2.3 
234 5.5 8.5 1.6 
447 0.0 1.0 >1.0 
635 5.0 8.0 1.6 
637 1.0 3.0 3.0 
748 0.5 1.0 2.0 
819 2.5 4.0 1.6 
Total SC 20.0 39.0 2.0 
   
 
1Average spectral counts (SC) of detected lysine acetylation sites in purified YfiQ 
(Control), and purified YfiQ incubated with AcCoA (AcCoA).  
2Using data obtained from Scaffold 3 proteome software, the spectral counts of two 
replicates for each condition were counted manually, were averaged over the two 
replicates, and were compared as the ratio of SC detected for YfiQ incubated with 
AcCoA relative to SC detected with YfiQ alone.  
3When the SC of a peptide with an acetylated lysine following AcCoA incubation is 
more than the SC of the same peptide in the absence of AcCoA, the ratio is 
underlined. A ratio of >n refers to any acetylated peptide that was not detected in 
the absence of AcCoA (SC=0), but detected in the presence of AcCoA (SC=n).  
4The spectral counts of the detected lysine acetylation sites in each replicate and the 
peptide scores and mass deviations as well as the complete MS/MS spectra and 
fragment ion series can be found in Tables S9B-C and S9D-E (218), where B-C (YfiQ 
in the absence of AcCoA) and D-E (YfiQ in the presence of AcCoA) denote two 
replicates. 
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Additional acetylated proteins 
Although RcsB and YfiQ were relatively pure, both proteins included co-
purified proteins that were acetylated in the in vitro acetylation reactions. Since 
these acetylated proteins may be physiologically relevant, we used mass 
spectrometry to identify the protein and to determine the sites of acetylation. 
Incubation of YfiQ with AcCoA revealed two prominently acetylated bands, with 
molecular masses about 30 and 40 kDa (Figure 23A, lanes 2, 9, and 10). Mass 
spectrometry identified the smaller protein as the 50S ribosomal subunit protein L2 
RplB and the larger protein as the elongation factor EF-Tu (data not shown). RplB 
co-purified with RcsB and was acetylated on residues Lys-8, Lys-23, and Lys-156 
(Table S10 (218)). EF-Tu co-purified with YfiQ and was acetylated on Lys-177 
(Table S11 (218)), confirming the reports that EF-Tu is acetylated (34,35). 
Testing the effect of the lysine acetyltransferase YfiQ on PrprA activity 
 It was reported that YfiQ can acetylate RcsB in vitro on one lysine (Lys-180) 
and inhibit its ability to bind DNA (49) and we were able to independently 
corroborate these results. However, we found that RcsB is acetylated on multiple 
lysines in vivo. Of these acetylated residues, Lys-180 was not the most acetylated 
(Table 2). These results suggested that the regulation of RcsB by YfiQ in vivo may be 
different than in vitro and that YfiQ may not be a physiological regulator of RcsB 
acetylation. I therefore tested if YfiQ affected PrprA activity by deleting yfiQ. 
Contradicting the proposed inhibitory function of YfiQ on RcsB that was 
demonstrated in vitro (49), when yfiQ was deleted, PrprA activity was reduced 
(Figure 24A). This result suggests that YfiQ activates rprA transcription. I also 
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overexpressed YfiQ and monitored PrprA activity. When YfiQ was overexpressed, 
PrprA activity was inhibited, consistent with the reported inhibitory effect of YfiQ on 
RcsB activity (Figure 24B). These results could be explained if the concentration of 
YfiQ or the level of YfiQ acetyltransferase activity dictates whether rprA 
transcription, which requires RcsB, is inhibited or activated. The other possibility is 
that overexpression can lead to artifacts that may be misleading.  
Analysis of RcsB acetylation in the yfiQ null mutant 
 We propose that YfiQ activates rprA transcription. This proposal contradicts 
the previous report showing that YfiQ inhibits RcsB binding to DNA in vitro (49). To 
determine if YfiQ affects RcsB acetylation in vivo, I isolated RcsB from the yfiQ 
mutant and compared the acetylation profile to RcsB isolated from WT cells using 
mass spectrometry. While not identical, the lysine acetylation sites were quite 
similar between WT cells and the yfiQ mutant (Table 4, Tables S7A-B in (218)). 
Most notably, the overall SC for the yfiQ mutant and its parental strain were 
identical (average total 8.5 SC) and there was no substantial change in the SC for 
individual acetylated lysines. Thus the acetyltransferase appears to have no effect 
on the acetylation status of RcsB in vivo in this growth condition. We propose that 
YfiQ enhances rprA transcription by acetylating a protein other than RcsB. 
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Figure 24. The effect of YfiQ on rprA promoter activity  
A) PrprA activity of WT cells (AJW3759) and the isogenic yfiQ null mutant 
(AJW3797) were grown at 37°C in TB7 with shaking. Samples were harvested for 
OD600 and β-galactosidase activity measurements. The values represent the 
average promoter activity of triplicate independent cultures and error bars indicate 
standard deviations. 
B) PrprA activity of WT cells (AJW3759) transformed with the YfiQ expression 
plasmid pCA24n-yfiQ (pyfiQ) or the pCA24n (VC) were aerated at 37°C in TB7 
supplemented with 10 µM IPTG to induce yfiQ expression. Samples were harvested 
for OD600 and β-galactosidase activity measurements. Values represent triplicate 
independent cultures and standard deviations.  
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Summary 
I confirmed that RcsB is acetylated by YfiQ and AcCoA in vitro and that Lys-
180 was sensitive to YfiQ. However, I also showed that YfiQ does not appear to 
regulate RcsB acetylation in vivo. The acetylation of RcsB and YfiQ increased in the 
presence of AcCoA alone, suggesting that autoacetylation may regulate RcsB and 
YfiQ. Autoacetylation may regulate YfiQ activity, consistent with what has been 
reported for some eukaryotic acetyltransferases. If autoacetylation regulates RcsB, 
then RcsB would be the second bacterial protein known to be regulated by 
autoacetylation, along with the chemotaxis RR CheY (46).  
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The effect of the spermidine acetyltransferase SpeG on rprA regulation 
Introduction 
 GNATs possess conserved sequence motifs and can acetylate many 
substrates, including proteins but also aminoglycosides (e.g. amikacin), 
arylalkylamines (e.g. serotonin), and polyamines (e.g. spermidine) (63). In E. coli, 
there are 23 genes that encode GCN5 homologs. 8 are known acetyltransferases and 
15 are putative acetyltransferases. 4 of the known acetyltransferases are protein 
acetyltransferases: RimI, RimJ, and RimL, which are known to acetylate the N-
terminus of some ribosomal proteins; YfiQ is the only GNAT that has been reported 
to exhibit Nε-lysine acetyltransferase activity. YfiQ has been reported to acetylate 
RcsB in vitro (49,218). Despite these biochemical results, there was no physiological 
evidence for YfiQ acetylating RcsB (Table 4, Tables S7A-B, (218)). To determine if 
some other GNAT impacts rprA transcription, I performed a genetic screen of the 
known and putative GNAT and then determined the mechanism through which one 
candidate, the spermidine acetyltransferase SpeG, regulated rprA transcription. 
Determining the effect of overexpressing known and putative 
acetyltransferases on rprA promoter activity 
Since a cobB mutant increased RcsB acetylation and reduced PrprA activity 
compared to WT cells grown in TB7, I reasoned that if an acetyltransferase did 
regulate rprA transcription, then the acetyltransferase is likely an inhibitor that may 
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acetylate RcsB. I transformed the WT strain with an inducible plasmid (pCA24N 
vector) carrying each of the known or putative acetyltransferase genes, 21 of which 
are available from the ASKA plasmid library collection of E. coli open reading frames 
(185). With the help from a student from Kenyon College, Sarah Cook, these 
transformants were grown in TB7 and β-galactosidase activity from the PrprA-lacZ 
fusion was measured throughout growth and peak PrprA activity during exponential 
phase was analyzed. Compared to WT cells transformed with the vector control, we 
observed four general effects of overexpressing the known and putative GNATs on 
the rprA promoter. Overexpression of four known or putative GNATs (speG, rimJ, 
yiiD, and yfiQ) had the greatest impact on PrprA activity, reducing activity by almost 
80% (Figure 25, white bars). The overexpression of seven GNAT genes reduced 
average promoter activity by approximately 50% or more (Figure 25, light gray 
bars), while five of the GNATs reduced average promoter activity by 20% - 40% 
(Figure 25, dark gray bars). The remaining five genes did not reduce the average 
promoter activity (Figure 25, black bars). Whether the latter subset of genes are 
actually expressed remains to be determined.  
The effect of speG mutant on rprA promoter activity 
 The overexpression screen identified SpeG, RimJ, YiiD, and YfiQ as potential 
inhibitors of rprA transcription. Since the yfiQ mutation did not appear to affect RcsB 
acetylation in vivo (Table 4, Tables S7A-B, (218)), I considered the other three 
candidates. If one of these GNATs inhibits rprA transcription, then a null mutant 
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lacking that GNAT would be expected to exhibit higher promoter activity than WT 
cells. From a partial mutant screen, I observed that the speG mutant (AJW4589) 
exhibited increased PrprA activity compared to WT cells (AJW3759) (Figure 26). 
Peak exponential PrprA activity showed some variability, but the level of activity 
was always either equal to or greater than WT or the peak activity occurred earlier 
in the mutant cells than in the WT cells (data not shown). The results suggest that 
SpeG can be an inhibitor of rprA transcription. This SpeG-mediated inhibition may 
be a conserved function, since overexpression of the Vibrio cholerae SpeG homolog 
(VCA0947) in E. coli cells also inhibited PrprA activity (Figure 27). 
Determining the effect of spermidine on rprA transcription 
 SpeG is not known for acetylating proteins. Instead, SpeG is annotated as a 
spermidine acetyltransferase. Spermidine is a polyamine that is present in all 
organisms (226). In E. coli, spermidine is considered a toxic compound (227) that is 
neutralized by SpeG-mediated acetylation (spermidine metabolism pathway is 
shown in Figure 28, (228-230)). In the absence of speG, the level of spermidine 
increases (227). I therefore tested whether an increase in exogenous spermidine 
activates the rprA promoter by growing WT cells in the presence of increasing 
concentrations of spermidine. Instead of activating PrprA, exogenous spermidine 
inhibited (Figure 29A). This inhibition can occur through a SpeG-independent 
mechanism, as a speG mutant exhibited spermidine-mediated inhibition of PrprA 
activity (Figure 29B). In fact, in the absence of SpeG, PrprA may be more sensitive 
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to spermidine (compare Figures 29A and B). However, it should be noted that a 
direct comparison between WT and speG sensitivities to spermidine has not been 
performed. From these results, I propose that the activation of PrprA in a speG 
mutant is not due to an accumulation of spermidine.  
Investigating if SpeG can affect rprA transcription in the absence of 
spermidine 
 The only known function of SpeG is to acetylate spermidine. I therefore 
tested if the inhibitory effect of SpeG on PrprA activity required spermidine. To 
reduce the intracellular level of spermidine, I deleted the gene that encodes the 
spermidine synthase SpeE. SpeE synthesizes spermidine from putrescine and 
decarboxylated-S-adenosylmethionine and SpeG acetylates spermidine using AcCoA 
as the acetyl donor (Figure 28). I compared PrprA activity in WT cells and in the 
isogenic speG, speE, and speEG mutants. The speE mutant behaved like WT cells 
(Figure 26), suggesting that spermidine is not required for PrprA activity. The 
speEG double mutant exhibited reduced PrprA activity compared to WT cells. This 
result suggests that (1) SpeG inhibition of rprA requires spermidine, which is 
consistent with the finding that exogenous spermidine inhibits rprA promoter 
activity (Figure 29), and that (2) in the absence of spermidine, SpeG activates rprA 
transcription (Figure 26, dark triangles). I propose that the level of spermidine 
determines whether SpeG inhibits or activates rprA transcription. Since SpeG affects 
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PrprA activity in the absence of its known substrate spermidine, I further propose 
that SpeG has a novel function. 
SpeG does not appear to be a protein acetyltransferase 
 We originally hypothesized that the novel, spermidine-independent function 
of SpeG was protein acetylation. We based this hypothesis on the observation that 
spermidine and lysine have quite similar structures (Figure 30) and on the BLAST 
sequence analysis that suggests that SpeG is similar (e-value of 3e-0.6) to a human 
thialysine Nε-acetyltransferase called TLAT (or SSAT2), which can exhibit a 
spermidine-independent effect and can acetylate thialysines and lysines (231). 
However, I have not been able to provide evidence to support this hypothesis. First, 
mass spectrometry did not detect a change in RcsB acetylation when RcsB was 
isolated from the speG null mutant compared to WT cells (data not shown). Second, 
while our collaborator Dr. Misty Kuhn in the Anderson laboratory at Northwestern 
University demonstrated that purified, His6-tagged SpeG exhibited spermidine and 
spermine acetyltransferase activity, my immunoblot analysis did not detect an 
increase in RcsB acetylation when RcsB was incubated with purified SpeG and 
AcCoA (data not shown). Therefore, we concluded that SpeG is not a protein 
acetyltransferase and considered the possibility that the effect of SpeG on rprA 
transcription was independent of protein acetylation.  
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Figure 25. The effect of overexpressing putative or known GNATs on rprA promoter 
activity.  
WT λrprA cells (AJW3759) were transformed with either the pCA24n vector control 
(VC) or an IPTG-inducible plasmid carrying one of the 21 available putative or 
known acetyltransferase ORFs. Cells were grown in the presence of 5 μM IPTG and 
growth and promoter activity were assayed. The values represent the means of 
maximum early to mid-exponential growth +/- standard deviations of five 
independent experiments done in either duplicate, triplicate, or quadruplicate 
independent cultures standardized against the VC. 
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Figure 26. Analyzing the regulation of PrprA activity by the spermidine 
synthetase SpeE and the spermidine acetyltransferase SpeG  
WT λrprA cells (AJW3759) and isogenic speG (AJW4589), speE (AJW4533), or speE 
speG (AJW4592) strains were assayed for cell growth in TB7 and β-galactosidase 
activity. The values represent average promoter activity with standard deviations of 
triplicate independent WT, speE, and speE speG cultures and duplicate independent 
speG mutant culture. In the same experiment, three other, independently 
constructed speG mutants were tested in duplicate. Shown here is one clone that 
was representative of the four speG clones. 
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Figure 27. The effect of overexpressing E. coli or V. cholera SpeG on rprA 
promoter activity 
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A) PrprA activity of WT E. coli cells (AJW3759) transformed with the VC (pCA24n) 
or a plasmid that expresses E. coli SpeG under the control of an IPTG-inducible 
promoter (pCA24n-speG). The values represent average promoter activity at OD600 
~0.3  with standard deviation. This experiment was performed in duplicate. 
B) PrprA activity of WT E. coli cells (AJW3759) transformed with a plasmid that 
expresses Vibrio cholerae SpeG under the control of an arabinose-inducible 
promoter (pBAD24-Vc0947). The values represent promoter activity at OD600 ~0.5 
(+ 0.02% arabinose) and OD600 ~0.6 (no arabinose). 
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Figure 28. E. coli spermidine metabolism.  
Arginine metabolism leads to putrescine production. Spermidine synthase SpeE 
converts putrescine and decarboxylated (dc)-S-adenosylmethionine to spermidine. 
SpeG acetylates spermidine using acetyl-coenzyme A. Acetylated spermidine is then 
excreted from the cell.  
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Figure 29. The effect of exogenous spermidine on rprA promoter activity  
A) WT λrprA cells (AJW3759) were aerated in TB7 supplemented with increasing 
concentrations of spermidine (SPD). The values represent average promoter activity 
with standard deviations of triplicate independent cultures. 
B) The speG λrprA mutant (AJW4589) was grown in TB7 in the presence of 0, 1 mM, 
or 5 mM SPD. Samples were harvested at regular intervals and were assayed for 
OD600 and β-galactosidase activity. 
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Figure 30. The structures of lysine and spermidine. 
The boxed regions highlight the structural similarities between lysine and 
spermidine. 
 
 
Functional analysis of RcsB on SpeG acetyltransferase activity  
The possibility that SpeG affected rprA transcription led to a collaboration 
with Drs. Misty Kuhn and Ekaterina Filippova in the Anderson laboratory. The 
Anderson laboratory is part of the Center for Structural Genomics of Infectious 
Diseases and its primary goal is to determine the structures of proteins that can be 
representative of major protein families and then use structural analysis to 
understand biological function. They were able to crystallize SpeG from Vibrio 
cholerae, as a representative of the N-acyltransferase superfamily, and discovered 
that SpeG forms a dodecamer (Filippova et al. unpublished data). Kuhn measured 
SpeG spermine and spermidine acetyltransferase activity with Ellman’s reagent 
(5,5’-dithiobis(2-nitro-benzoic acid)), which reacts with the free sulfhydryl group of 
CoA (188). If SpeG can acetylate its substrates using AcCoA, free CoA is release and 
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detected spectrophotometrically. They found that SpeG could acetylate spermine 
and spermidine and that when RcsB was present, SpeG acetyltransferase activity 
was inhibited through a direct interaction with RcsB (Kuhn and Hu et al., 
unpublished). Together, we propose that RcsB and SpeG can inhibit each other and 
that this interaction may have consequences on spermidine metabolism and 
regulation of the Rcs regulon. 
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Summary 
I hypothesize that acetylation of RcsB inhibits rprA transcription. To identify 
acetyltransferases that could possibly regulate RcsB activity, I used a combination of 
overexpression and deletion analyses to screen more than 20 genes that had some 
sequence similarity to yeast KAT GCN5. While several GNAT family members 
inhibited PrprA activity, SpeG was the only candidate that, when deleted, activated 
the PrprA. From an epistasis analysis of SpeG and the spermidine synthase SpeE, I 
propose that SpeG inhibits rprA transcription when the level of spermidine is high 
and that SpeG can activate rprA transcription when spermidine is absent or low. 
However, SpeG inhibition of RcsB does not appear to involve protein acetylation; 
instead, SpeG and RcsB inhibit the other’s function through some other mechanism. 
This study revealed novel functions for SpeG and RcsB as regulators of transcription 
and metabolism, respectively. 
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Analysis of AcP as an Acetyl Donor for Protein Acetylation in E. coli 
Introduction 
Protein acetylation is proposed to occur when AcCoA donates an acetyl group 
to the amino terminus of a lysyl side chain. However, it was reported in 1975 that 
AcP could non-enzymatically donate an acetyl to histone proteins (201). More 
recently, I reported that several RcsB lysines exhibit increased acetylation when the 
intracellular concentration of AcP is high (218) and Dr. Bruno Lima reported that an 
AcP phenotype involved the acetylation of certain lysine residues on RNA 
polymerase (48). We therefore hypothesize that AcP is an acetyl donor for protein 
acetylation in E. coli. Bozena Zemaitaitis tested this hypothesis and found that 
acetylation is dramatically increased especially during exponential growth when the 
concentration of AcP accumulates and that this increase in acetylation depended on 
AcP. These results are consistent with a recent report that demonstrated that AcP 
regulates E. coli acetylation (202). To determine if protein acetylation can occur by 
AcP, I performed in vitro acetylation of purified proteins. To determine if the 
primary amino acid sequence may regulate acetylation by AcP, I studied the AcP-
sensitive sites identified by global quantitative mass spectrometry. 
In vitro analysis of protein acetylation by AcP 
 Since global protein acetylation increases in the absence of ackA, a condition 
that accumulates intracellular AcP, and since this increase in acetylation depends on 
AcP, we hypothesize that AcP is an acetyl donor for protein acetylation in E. coli. I 
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tested this hypothesis by determining if AcP can donate acetyl groups to proteins in 
vitro. I used LpdA, a metabolic enzyme, to study AcP as a regulator of protein 
acetylation because the members of the Anderson laboratory at Northwestern 
University have purified LpdA in abundance and LpdA has proven to provide highly 
reproducible results. LpdA was analyzed by Drs. Brad Gibson and Birgit Schilling, 
research associate Dylan Sorensen, and bioinformaticist Alexandria D’Souza at The 
Buck Institute for Research on Aging using semi-quantitative mass spectrometry, 
spectral counting. They determined that LpdA was between 80-85% pure (mass 
spectrometric data not shown, Figure 31A). I incubated various concentrations of 
purified LpdA, with increasing concentrations of AcP for 1 hour at 37°C in 150 mM 
Tris HCl (pH 7.3 at room temperature), 10% glycerol, 10 mM MgCl2, and 150 mM 
NaCl. To stop the reaction, an equal volume of 2X SDS loading buffer was added and 
the reactions were heated at 95°C for 10 minutes. I detected acetylation by anti-
acetyl lysine immunoblot analyses. In the absence of AcP, some acetylation was 
detectable, indicating that LpdA is acetylated in vivo (Figure 31). In vitro acetylation 
increased with AcP concentration. An increase in acetylation was detected with as 
low as 5 mM AcP, a concentration of AcP that is comparable to the level of AcP that 
has been measured in WT E. coli cells (123). I have repeated this analysis, and I have 
not been able to saturate LpdA acetylation, even at the highest concentration tested, 
80 mM AcP. Acetylation is also LpdA concentration-dependent, as an increasing 
amount of LpdA correlated with an increase in acetylation when AcP was held 
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constant at 80 mM (Figure 31B). This increase in acetylation is not due an artifact 
of basic pH, a condition that activates the lysine for acetylation through 
deprotonation, because pH decreases as AcP is hydrolyzed (Figure 32). Therefore, I 
conclude that AcP can donate acetyl groups to LpdA.  
We also have found that other proteins are acetylated when incubated with 
AcP. I have preliminary evidence to suggest that purified RcsB is acetylated when 
incubated with AcP and Robert Davis (a graduate student in the Wolfe laboratory) 
has similar evidence for the transcription factor CRP. Similarly, Dr. Bruno Lima 
detected that certain subunits of purified RNA polymerase are acetylated in the 
presence of AcP. Finally, Dr. Misty Kuhn was able to demonstrate acetylation of the 
central metabolic enzymes GapA and TpiA by X-ray crystallography. Therefore, we 
propose that AcP can acetylate many proteins. 
Kinetic analysis of LpdA acetylation in the presence of AcP 
 To study the reactivity of AcP with LpdA and its lysines, I characterized the 
kinetics of acetylation by AcP using LpdA. Physiologically relevant concentrations of 
AcP range between 3 mM in WT cells and 15 mM in the ackA mutant (123). 
Therefore, to study the kinetics of LpdA acetylation by AcP, I incubated 1.25 µM 
LpdA with increasing concentrations of AcP (0, 5, 10, 15, and 20 mM AcP) for 
various lengths of time at 37°C at pH 7. To accommodate the large number of 
samples and to avoid reduced reaction volumes due to condensation during long 
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incubation times, these in vitro protein acetylation reactions were performed using 
the PCR machine, which can hold many samples and has a hot lid. Acetylation was 
determined by both anti-acetyl lysine immunoblot analyses and quantitative mass 
spectrometry. The mass spectrometric analyses were performed in two technical 
replicates, on two independent experiments, by our collaborators at The Buck 
Institute for Research on Aging. LpdA acetylation was, again, AcP concentration-
dependent, with the highest level of acetylation in the presence of 20 mM. When 
LpdA was incubated with 5 mM AcP for less than 1 hour, LpdA acetylation was not 
detectable by immunoblot analysis (Figure 33A) or by mass spectrometry (data not 
shown). Instead, acetylation using 5 mM AcP appears to require at least 1 to 2 hours 
to be detectable. Acetylation with 10, 15, and 20 mM AcP was detectable within 30 
minutes to an hour (Figure 33). Using mass spectrometry, we monitored acetylated 
LpdA lysines over time with 10 and 20 mM AcP (Figure 34) and the fold increase in 
acetylation was measured relative to the no AcP control. Six LpdA lysine residues 
were detected to be acetylated in the presence of 10 mM AcP (Figure 34A). The 
kinetics of acetylation appear to be similar for each lysine, with acetylation 
occurring quickly within the first hour of incubation; from hours one to seven, the 
rates were similar and constant. The number of acetylated lysines and the rate of 
acetylation increased when LpdA was incubated with 20 mM AcP. In addition to five 
of the lysines that were detected to be acetylation with 10 mM AcP, six additional 
residues were acetylated with 20 mM AcP (Figure 34B). In contrast to the kinetics 
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of acetylation with 10 mM AcP, the rate of early acetylation (within the first hour) in 
the presence of 20 mM AcP, varied widely for each acetylated lysine: both Lys-229 
and Lys-339 exhibited the slowest early rates of acetylation, the kinetics of which 
were comparable to acetylation performed with 10 mM AcP, while Lys-85, Lys-220, 
Lys-256, and Lys-284 were amongst those lysines that reacted quickly with AcP. 
Generally, the rates of acetylation remained constant after the first hour since the 
abundance of acetylation after 1 hour correlated with the early rates of acetylation 
for each lysine.  
The amount of acetylation does not appear to be limited by AcP hydrolysis. 
Using a method (182) that I adapted from a published protocol (232,233), I 
measured the amount of AcP present in LpdA in vitro acetylation reactions. AcP 
acetylates hydroxylamine efficiently; the resultant acetyl hydroxamate reacts with 
ferric ions, which is detected spectrophotometrically at 540 nm. While AcP does 
deteriorate over time when incubated at 37°C, by 7 hours, the amount of remaining 
AcP is in excess relative to the number of available LpdA lysines in the reactions 
(Figure 35). For instance, after 7 hours, almost 4 mM AcP is present from a reaction 
that started with 10 mM AcP and 1.25 µM LpdA. 
These data suggest that the concentration of AcP regulates the number of 
acetylated lysines, the rate of acetylation, and the abundance of acetylation. 
Additionally, these reactions were performed in the absence of an acetyltransferase, 
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suggesting that acetyl transfer from AcP occurs directly to lysines on proteins 
through a non-enzymatic reaction. 
Analysis of the AcP-sensitive primary amino acid sequences  
The mechanism that regulates the specificity of the non-enzymatic 
acetylation of lysines by AcP was unknown. We considered that the 
microenvironment surrounding the lysine can affect the reactivity of the lysine side 
chain. Under physiological pH, lysine predominately exists in its non-reactive, 
protonated state. The capacity for lysine to act as a nucleophile and attack the 
carbonyl carbon on AcP is dependent on the deprotonation of the lysine side chain. 
Activating the lysine side chain can occur by the presence of neighboring amino 
acids acting as a general base at neutral pH. We thus determined whether specificity 
of acetylation is regulated by the primary amino acid sequence.  
I determined if an acetylation motif existed in vivo. I analyzed the acetylated 
sites identified by our collaborators at the Buck Institute using quantitative mass 
spectrometry, comparing 543 sites that were identified in at least 3 out of 4 
bioreplicates and exhibited at least a 2-fold increase in acetylation in the ackA 
mutant compared to its WT parent, with a P value <0.05. A sequence logo using the 
primary amino acid sequence, from -10 to +10 relative to the acetylated lysine, was 
generated using WebLogo, a web-based application developed at University of 
California-Berkley to identify consensus motifs (234). There was a high prevalence 
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of negatively charged residues (glutamate and aspartate) in the -1 position, adjacent 
to the acetylated lysine residue (Figure 36).  
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Figure 31. In vitro acetylation of LpdA with AcP 
A) Coomassie-stained SDS-polyacrylamide gel containing purified LpdA 
B) AcP and LpdA were incubated together for 1 hour at 37°C. Acetylation was 
detected by anti-acetyllysine immunoblot analysis and quantification was 
performed using AlphaView. 
C) 1.25 µM LpdA was incubated with 0 or 80 mM AcP and incubated at 37°C for the 
indicated length of time. Acetylation was detected by anti-acetyllysine immunoblot 
analysis and quantification was performed using AlphaView. 
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Figure 32. The effect of AcP hydrolysis on pH.  
The indicated concentrations of AcP was incubated at 37°C in 150 mM Tris-HCl pH 
7, 10mM MgCl2, 150 mM NaCl, and 10% glycerol. Approximately 5 µl was spotted 
onto a pH test strip at multiple points in time.  
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Figure 33. In vitro acetylation of LpdA using AcP as an acetyl group donor is 
sensitive to time of incubation and concentration of AcP.  
AcP (0, 5, 10, 15, 20 mM) was incubated with 1.25 µM LpdA for various lengths of 
time (5 minutes, 10 minutes, 15 minutes, 30 minutes, 1 hr, 2 hr, 3 hr, 4 hr, 5 hr, and 
7 hr) at 37°C. An anti-acetyllysine immunoblot analysis (A) and a quantification of 
acetylation was performed with AlphaView. The pixel densities were normalized to 
the signal in the absence of AcP (B).  
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Figure 34. Quantitative mass spectrometric analysis of AcP on LpdA 
acetylation.  
The experiment described in Figure 32 was performed in duplicate on separate 
days. These experimental duplicates were analyzed by Dr. Birgit Schilling, who 
analyzed the samples in technical duplicates by quantitative mass spectrometry. 
Fold-change in acetylation was plotted for each lysine as a ratio of acetylation in the 
presence of 10 mM AcP (A) or 20 mM AcP (B) compared to no AcP. 
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Figure 35. AcP measurements in in vitro acetylation reactions using 
hydroxylamine. 
A) AcP phosphate standard curve. 0, 0.625, 1.25, 2.5, 5, 10, and 20 mM AcP was 
suspended in in vitro transcription buffer in the absence of LpdA to a final volume of 
300 µl. 50 µl of neutralized hydroxylamine HCl was added and incubated at 60°C for 
5 minutes. 100 µl of development solution was added and the absorbance was read 
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spectrophotometrically at 540 nm. The hydroxylamine assay was adapted from 
Fowler et al., 2011 Journal of Visualized Experiments. 
B) The level of AcP was measured when the indicated concentration of AcP was 
incubated with 1.25 µM LpdA at 37°C for various lengths of time using the 
hydroxylamine assay. The concentration of AcP was determined by comparing the 
measured absorbance to the standard curve.  
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Figure 36. An analysis of the amino acid composition and position relative to 
acetylated lysines. 
Sequence logo (A) and frequency table (B) showing the amino acid composition and 
position relative to the acetylated lysine. 543 sites that exhibited significantly 
upregulated sites relative to WT with a P value < 0.05 were analyzed using 
WebLogo. Acetylated lysines that were within 10 amino acids of the start (28 sites) 
or stop codon (24 sites) were not part of this analysis. 
 
These results are in contrast to the AcP chemical acetylation profile obtained 
from a peptide-based array analysis called SAMDI (surface-assembled monolayers 
for matrix assisted laser desorption/ionization time-of-flight mass spectrometry) 
(235). A peptide library is immobilized onto a chip. The 5 or 6 amino acid peptides 
are lysine-containing sequences that randomize the -1 and +1 positions. Dr. Misty 
Kuhn and Dr. Michael Scholle (in Milan Mrksich’s lab at Northwestern University) 
incubated the peptide array with AcP at 30°C for 1 hour and detected acetylation by 
mass spectrometry. Using this assay, they found that positively charged residues 
enhanced the acetylation of the adjacent lysine, while negatively charged residues 
inhibited (data not shown).  
From these results, I propose that non-enzymatic acetylation of lysines by 
AcP is a balance between negatively and positively charged local residues, which 
activate the lysine for acetylation and increase the local concentration of AcP. 
Previous reports have demonstrated that two families of acetyltransferases (GNAT 
and MYST) utilize negatively charged glutamate or aspartate in their catalytic site to 
deprotonate and thus activate the lysine side chain for acetylation (64,236). 
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Therefore, negatively charged residues may promote lysine deprotonation at 
neutral pH for AcP dependent acetylation. The positively charge residues may 
increase the electrostatic interaction between the negative phosphate group of AcP 
and the positively charged lysine side chain, bringing AcP close to a potentially 
active lysine substrate.  
Summary 
 Since high AcP correlated with an increase in RcsB (218) and RNA 
polymerase acetylation (48), we hypothesized that AcP regulated global protein 
acetylation in E. coli. This hypothesis is consistent with a recent publication, which 
primarily studied the effect of AcP on starved and growth arrested E. coli cells (202). 
We have demonstrated that there is a substantial increase in global acetylation that 
is dependent on high intracellular level of AcP and that AcP can undergo direct 
acetyl transfer to lysine-containing proteins and peptides. We propose that 
acetylation with AcP is non-enzymatic and that the neighboring amino acids can 
influence lysine acetylation. This research contributes to the understanding of a 
potentially novel, global regulator of acetylation in E. coli and potentially other 
bacteria that exhibit AcP-dependent acetylation of proteins. 
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CHAPTER FOUR 
DISCUSSION 
What is the effect of non-enzymatic acetylation? 
 Acetylation, like all PTMs, can increase the functionality of the proteome by 
generating potentially different isoforms of a protein. Nε-lysine acetylation, like 
many other PTMs, is a reversible modification. This reversibility allows the protein 
to return to its original state and to turn off a response. The discovery that AcP and 
AcCoA can non-enzymatically donate acetyl groups to proteins implies that a 
separate enzyme may not be necessary for some acetylation to occur in vivo. 
Without the requirement for a KAT, the cell may by-pass the metabolic cost and time 
needed to activate transcription and translation of the enzyme. Non-enzymatic 
acetylation, therefore, could be a fast, initial cellular response by which the cell can 
adapt to particular stresses by altering the intracellular concentrations of these 
acetyl donors.  
If non-enzymatic modifications are not limited to lysines that are accessible 
to KATs, then some acetylated sites may be inaccessible to KDACs. If so, then some 
non-enzymatically acetylated lysines may not be reversible. Intuitively, acetylation 
that occurs non-enzymatically and irreversibly is a high risk situation. If proteins 
are prone to undergo modification then acetylation of certain sites may be 
deleterious to the cell. Thus, a mechanism to regulate non-enzymatic acetylation is 
necessary. Our results suggest that some of this control is at the level of the targeted 
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proteins. Other mechanisms of regulation could be through protein degradation, 
compensatory PTMs, or adaptive mutations that could suppress or limit the effect of 
the irreversible modification.  
What is the effect of multiple acetyl donors on bacterial physiology? 
 Multiple acetyl donors could allow for more levels of regulation, such as at 
the level of synthesis and degradation of the acetyl donor or mechanisms of acetyl 
transfer and removal specific for each acetyl donor. Since AcCoA and AcP are 
metabolic intermediates of the same pathway, it is possible that certain stimuli can 
affect both molecules and the cell can activate a more robust and rapid response 
than with either AcCoA or AcP alone. However, if there are stimuli that can 
differentially regulate the AcCoA and AcP pools, then distinct AcCoA- or AcP-
sensitive cellular responses are possible. 
The mechanisms that regulate acetylation by either AcCoA or AcP may 
impact the differences between these AcCoA- or AcP-sensitive responses. KATs are 
known to acetylate proteins by binding to the CoA moiety of AcCoA through their 
CoA binding motif. Since CoA and phosphate are structurally different, AcP is 
unlikely to depend on the known KATs for acetylation. This difference in 
mechanisms of acetylation by AcCoA and AcP may impact specificity of acetylation.  
The chemical structures of AcCoA and AcP are likely to affect specifity. The 
standard state free energies of hydrolysis for the thioester and phosphoester bonds 
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for AcCoA (-31.5 kJ/mol) and AcP (-43.3 kJ/mol), respectively, are different. Thus, 
expelling the phosphate group from AcP is thermodynamically more favorable than 
CoASH from AcCoA. This difference could impact the sites that are targeted for 
acetylation. However, given that KATs can bind AcCoA and catalyze the reaction, it is 
possible that certain KAT-dependent acetylations with AcCoA could be kinetically 
more favorable in vivo.  
 Due to these similarities and differences between AcCoA and AcP, the cell 
could coordinate appropriate responses to a variety of extra- and intracellular 
stimuli. 
What is the effect of acetylation on RcsB? 
I hypothesize that acetylation inhibits RcsB activity, at least in part, through 
acetylation of Lys-154. In the absence of AckA or the deacetylase CobB, PrprA 
activity was reduced (Figure 19A) and RcsB acetylation increased (Table 4). In 
particular, acetylation of Lys-154 increased. A genetic mimic of acetylated Lys-154 
(RcsB-K154Q) had no activity at the rprA promoter and the genetic mimic of non-
acetylated Lys-154 (RcsB-K154R) had WT levels of activity (Figure 20A), which 
suggests that acetylation of Lys-154 inhibits RcsB activity. Site-specific acetylation 
of Lys-154 (220) followed by in vitro transcription assays could directly test the 
effect of Lys-154 acetylation on rprA. 
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According to a reported structural analysis of E. amylovora RcsB carboxy 
terminal domain, Lys-154 is positioned in the amino terminus of the seventh alpha 
helix (172). Pristovsek and colleagues suggest that this is a supporting helix based 
on homology to similar structurally characterized RRs. They also found that, among 
several other residues in the effector domain, Lys-154 was involved in binding to an 
RcsA-RcsB heterodimer DNA sequence. Additionally, some RRs employ basic 
residues in the amino terminus of the supporting helix to interact with DNA (176). If 
acetylation of Lys-154 was responsible for the inhibited rprA transcription seen in 
the cobB or ackA mutants, then expressing a genetic mimic of non-acetylated Lys-
154 should suppress the inhibition. I tested this prediction by transforming the 
single copy plasmid that expressed WT RcsB or the RcsB(K154R) mutant into the 
ackA rcsB double mutant lysogenized with the PrprA-lacZ fusion. The RcsB(K154R) 
mutant had the same level of activity as WT RcsB in the absence of cobB instead of 
the expected higher activity (data not shown). This preliminary evidence suggests 
that Lys-154 is not solely responsible for the effects seen in the cobB mutant and, 
possibly, the ackA mutant. There are likely other targets within or outside of RcsB 
that are involved in regulating rprA transcription. 
Acetylation was also detected on several other residues on RcsB (Figure 4C). 
Mass spectrometry determined that several RcsB residues were acetylated in vivo or 
in vitro. Although the sites that were modified were not identical, acetylation did 
occur frequently in the region between Lys-72 and Lys-186. This region includes 
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several parts of the protein that are putatively important in RcsB function. 5 out of 
the 11 acetylated lysines centered on the linker region. The linker is critical for 
OmpR and PhoB effector function. The linker was reported to be important in 
regulating physical interactions between the REC and effector domains and 
transducing the activation signal from the REC domain to the effector domain (169). 
Acetylation of the linker could perturb some aspect of the REC-effector domain 
relationship. Although increased acetylation of the HTH (α8 - α9) occurred in the in 
vitro acetylation reactions only, it is possible that under certain conditions, an 
elevation in the intracellular concentration of AcCoA or AcP may lead to acetylation 
of these sites in the HTH. Acetylation of Lys-180 effectively eliminated RcsB binding 
to the flhD DNA (49). This mechanism of acetylating the HTH may be part of a stress 
response in which activation of the RcsB regulon is not preferable for the cell and 
RcsB activity is quickly turned off. 
The ability of the RcsB-K154 mutants to inhibit migration on semi-solid agar 
plates as well as WT RcsB is intriguing (Figure 20B). RcsB is a repressor of the 
master regulator of flagellar biosynthesis flhDC transcription. A DNase I protection 
assay found that a mimic of phosphorylated RcsB(D56E) protected a 20 nucleotide 
region centered at +12 and RcsB repression of flhDC promoter activity required this 
region (163). Therefore, RcsB repression of flhDC transcription requires DNA 
binding. Lys-154 is a DNA-binding residue but Lys-154 mutants were capable of 
binding and inhibiting migration (Figure 20B). It is known that several other 
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transcription factors bind and regulate flhDC expression. RcsB-K154 mutants may 
be able to bind DNA in the presence of these transcription factors. This possibility is 
supported by reports showing that RcsB binding to DNA either requires or is 
enhanced by the addition of proteins such as RNAP (164) or RcsA (163,172). These 
results may implicate a role for an RcsB co-repressor. This co-repressor is probably 
not RcsA because it was reported that RcsA is not required for flagellar biosynthesis 
and affected migration only when overexpressed (125). Alternatively, RcsB-K154 
mutants may have no defect in binding to DNA but, instead, affect a later event in the 
initiation of rprA transcription, such as the recruitment of RNAP.  
From the inhibition of migration assays, I found that a mutant that lacked the 
phosphoryl acceptor site Asp-56 of RcsB was still capable of inhibiting migration 
(Figure 20B). These results suggest that phosphorylation is not required for RcsB 
repression of flhDC. Similar to the previous discussion, interaction with co-
regulators may suppress the need for phosphorylation in DNA binding. This 
hypothesis can be tested by mutating the known DNA binding sites for flhDC 
transcription factors and determine if RcsB(D56A) can repress flhDC promoter 
activity and migration. Another exciting possibility is that phosphorylation of RcsB 
is not required for binding to DNA, but is important in the activation of 
transcription, perhaps recruitment of RNAP to form the closed complex or 
isomerization to the open complex. This model is consistent with a previous report 
demonstrating that the phosphorylated genetic mimic RcsB(D56E) activates osmCp1 
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by recruiting RNAP to the DNA (164). Although this report did not show that Asp-56 
was required for DNA binding, the RcsB(D56E) mutant was incapable of binding to 
DNA alone, suggesting that phosphorylation is not sufficient to for RcsB DNA 
binding. Because I showed that the phosphorylation-deficient mutant RcsB(D56A) 
can inhibit migration (Figure 20B) but cannot activate rprA transcription (Figure 
16B), I hypothesize that for RcsB, phosphorylation is critical for activation of 
transcription independently of inducing DNA binding.  
Does autoacetylation regulate RcsB?  
Although YfiQ can acetylate RcsB in vitro (Figure 23, (49)), YfiQ does not 
appear to be the physiological regulator of RcsB acetylation because the acetylation 
status of purified RcsB from the yfiQ mutant was similar to that from WT cells 
(Table 4). However, it does seem that YfiQ can activate RcsB-regulated phenotypes 
because a deletion of yfiQ reduced PrprA activity (Figure 24A) and enhanced 
migration in semi-solid agar (J. Escalante-Semerena, personal communication). 
Members of the Wolfe laboratory have evidence to support the hypothesis that the 
function of YfiQ is predominately to regulate Acs activity and that this regulation 
could affect metabolism on gluconeogenic carbon sources. Therefore, the 
mechanism by which RcsB acetylation occurs in vivo remains unknown.  
Two scenarios are possible. RcsB acetylation could involve another protein 
acetyltransferease or RcsB acetylation occurs independently of an acetyltransferase. 
An unknown acetyltransferase is possible. Evidence from the Wolfe laboratory 
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suggests that YfiQ is not a significant regulator of global acetylation and there are 
over 20 GNAT homologs in E. coli. One could screen the requirement for any one of 
these GNATs in AcP-independent acetylation by constructing ackA pta gnat triple 
mutants and screening for changes in acetylation by anti-acetyllysine immunoblot 
analyses.  
Another possible mechanism of acetylation may be autoacetylation because 
purified RcsB is acetylated when incubated with AcCoA alone (Figure 23 and Table 
5, (49)) or AcP alone (data not shown). It is unlikely that purified RcsB was 
contaminated by an acetyltransferase, as in-solution mass spectrometric analysis 
did not detect a contaminating YfiQ or another acetyltransferase (data not shown). 
Autoacetylation of several other proteins have been reported (46,223,237,238), 
including proteins in the mitochondrion, where little is known about potential 
mitochondrial lysine acetyltransferase(s) and the conditions are favorable for 
AcCoA-dependent lysine acetylation, i.e., alkaline pH (~8.0) and high AcCoA 
concentration (~5 mM) (73,239,240). Also, RR CheY (46) and Acs (45) can 
autoacetylate with AcCoA. Seven lysines were acetylated when CheY was incubated 
with AcCoA alone (46).  
To determine if RcsB is regulated by autoacetylation in vivo is extremely 
difficult, if not impossible. One would have to know all the enzymes that regulate 
RcsB acetylation, which is unknown, and determine if acetylation occurs in the 
absence of these enzymes. Currently, we know that YfiQ is likely not involved in 
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acetylating RcsB. Acs can acetylate CheY with AcCoA or acetate (and ATP) as acetyl 
donors (45). One could test if Acs regulates RcsB acetylation by purifying RcsB in an 
acs mutant followed by in vitro acetylation reactions between RcsB, Acs, and acetate 
and ATP. Finding the answer to the general question of whether autoacetylation of 
proteins occurs in vivo may not be feasible. 
What mechanisms regulate RcsB deacetylation? 
When RcsB was acetylated only on Lys-180, CobB was reported to 
deacetylate RcsB in vitro (49). I found that the cobB mutant or nicotinamide-
exposed WT cells showed reduced PrprA activity (Figure 19). These results are 
consistent with CobB activating PrprA activity and suggest that CobB activates by 
deacetylating some inhibitory acetylated protein. The inhibitory acetylated protein 
may be RcsB because RcsB is hyperacetylated in the cobB mutant (Tables 2 and 4). I 
propose that CobB regulates the deacetylation of certain RcsB lysines in vivo. To 
determine if CobB can deacetylate RcsB, RcsB that is acetylated at CobB-sensitive 
lysines (e.g. Lys-118 and Lys-154) can be generated and incubated with CobB and 
NAD+. This method of site-specific acetylation can also contribute to understanding 
the functions of specific lysines when acetylated (220). Unfortunately, this approach 
has not yet been successful in our hands and may require optimization before 
application.  
Other lysines (e.g., Lys-72 and Lys-125) appeared to be insensitive to CobB, 
suggesting that CobB does not regulate these sites. Although one explanation would 
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be that some acetylated lysines are not deacetylated, it is unlikely to be the case. 
Lysine acetylation is known to be dynamic and, to the best of my knowledge, 
irreversible acetylation of internal lysines has not been reported. Another 
possibility is that CobB activity is relatively low under these experimental 
conditions (BW25113 strain in TB7 growth medium and aerated at 37°C) and a 
deletion of CobB reveals the preferred but not all of the substrates. It is possible to 
identify the suboptimal CobB substrates by activating CobB activity in WT cells, 
using a sirtuin-specific activator such as resveratrol (241), and then compare RcsB 
acetylation to the resveratrol-treated cobB mutant. This small-scale experiment 
could be adjusted to identify more targets of CobB in vivo on a global scale. The 
identification of novel CobB targets by mass spectrometry and structural biology 
has begun in collaboration with the Mrksich and Anderson laboratories at 
Northwestern University. known.  
Our lab has evidence to suggest that there may be other mechanisms of 
deacetylation in E. coli. However, this study into a novel deacetylase would need 
further analysis. We found that CobB is likely the only sirtuin deacetylase since the 
acetylation profile of the nicotinamide-exposed cobB mutant was identical to the 
non-treated cobB mutant. This is consistent with the sirtuin phylogenetic analyses 
identifying only CobB in E. coli (78,79). Kenyon College summer student Sarah Cook 
and I performed a screen for a HDAC-like E. coli enzyme using HDAC-specific 
inhibitors (i.e. butyrate and propionate). These inhibitors were able to induce an 
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increase in acetylation and the acetylation profile was different compared to the 
cobB mutant (data not shown). However, inconsistent with the presence of another 
KDAC in E. coli, no lysine deacetylation activity was detected when a cobB crude 
extract was incubated with acetylated peptides by SAMDI (unpublished data). We 
currently do not know how the HDAC inhibitors can induce acetylation. If the effect 
of these inhibitors is through a HDAC-like enzyme, one could screen for a HDAC-like 
enzyme by deleting genes that encode putative amidohydrolases and determine 
which mutant enhances acetylation.  
Could RcsB be co-regulated by phosphorylation and acetylation? 
I propose that the rprA promoter is regulated by phosphorylation and Nε-
lysine acetylation. It was reported that rprA transcription increases when RcsC 
kinase activity is stimulated by overexpressing the lipoprotein RcsF (157). The 
activation of rprA transcription required RcsB (157). My results are consistent with 
phosphorylation regulating and activating RcsB: PrprA activity requires the 
phosphoryl acceptor site Asp-56 of RcsB (Figure 16B), RcsF overexpression 
increased PrprA activity (Figure 17B), and RcsC when RcsC is not overexpressed 
(Figure 17A). It was also reported that AcP might activate RcsB when RcsC 
functions as a net phosphatase (125). I demonstrated that AcP is an activator of the 
PrprA (Figure 17A) and that AcP can donate phosphoryl groups to RcsB (Figure 
18). To confirm that AcP is a physiological phosphoryl donor for RcsB, in vivo 
detection of AcP dependent phosphorylation of RcsB would need to be performed. If 
184 
 
 
 
AcP can indeed act as a phosphoryl donor to RcsB then these results suggest that 
RRs like RcsB can be activated by both the SK and AcP, not just when the SK is acting 
as a net phosphatase. The implication of two phosphoryl donors co-regulating RcsB 
is unknown but presumably involves generating a robust RcsB response when the 
condition is appropriate. This genetic analysis of RcsB regulation by its SK and AcP 
are similar to a study of the Xenorhabdus OmpR, which is an inhibitor of antibiotic 
production upon phosphorylation. Either the deletion of the SK EnvZ or the absence 
of AcP led to increased antibiotic production (215,242). It would be important to 
test whether the absence of both EnvZ and AcP has an additive effect on antibiotic 
production. 
If AcP activates RcsB by donating phosphoryl groups to RcsB in vivo, then 
why is rprA transcription reduced in the ackA mutant? The answer appears to 
involve acetylation of RcsB. Because RcsB is regulated by phosphorylation at Asp-56 
and acetylation on multiple lysines, in what manner is RcsB co-regulated by both 
modifications? For example, p53 activity is inhibited if Lys-317 is acetylated (24) 
and Acs is inhibited if Lys-609 is acetylated (131,132). RcsB activity could be 
regulated by single ‘off-on’ modifications like p53 and Acs. Alternatively, PTM could 
occur sequentially. p53 is modified by multiple PTMs on many sites and p53 activity 
is differentially regulated depending on its modification(s). Phosphorylated Ser-15 
on p53 appears to initiate a sequential PTM relay (23,25-27). A kinetic 
characterization of RcsB autoacetylation using AcCoA or AcP would provide insight 
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into the chemistry of RcsB autoacetylation. By analyzing the relationship between 
the velocity of acetylation and the concentration of AcCoA or AcP, the shape of the 
curve would indicate whether acetylation of RcsB is cooperative, in which 
acetylation of one site might facilitate acetylation of other sites. Finally, acetylation 
and phosphorylation could occur simultaneously and these different combinations 
could result in various outcomes on RcsB activity. RcsB may be regulated by a 
combination of these three possibilities as well. Similar to p53 for eukaryotes, RcsB 
may become a prototype for the PTM code in bacteria.  
The possibility that RcsB is controlled by multiple PTMs suggests that there 
is an advantage to RcsB evolving such a complex regulatory program. RcsB regulates 
over 100 genes, involved in many aspects of bacterial physiology. I predict that RcsB 
acetylation affects other genes besides rprA. Intuitively, a simple phosphorylation-
dependent ‘on-off’ switch is not sophisticated enough to provide specific control 
over the RcsB regulon. The possibility of phosphorylation, multiple acetylated 
lysines, and different oligomeric states (dimers and possibly tetramers) regulating 
RcsB amplifies the number of functionally distinct forms of RcsB. This increased 
diversity could regulate RcsB affinity to promoters and to interacting proteins.  
What regulates glucose-induced osmC transcription?  
 While several research groups have performed thorough investigations into 
the regulation of osmC transcription, we may have discovered a novel mechanism 
that activates osmC transcription. osmC is reported to be regulated by two 
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overlapping promoters: osmCp1 and osmCp2. osmCp2 is closer to the translational 
start site and is dependent on the sigma factor that regulates stationary phase stress 
responses (σS), is activated by the leucine-responsive transcription factor LRP, and 
is indirectly inhibited by the nucleoid-associated protein H-NS. osmCp1 is activated 
by both RcsB and NhaR (165) and is repressed by both LRP and H-NS (243).  
 I have found that a high AcCoA:CoA ratio activates osmC transcription. This 
mechanism appears to not require the αCTD of RNAP, which is distinct from the 
glucose-induced, high AcCoA:CoA ratio-regulated response from the stress-
responsive cpxP promoter. The cpxP response to glucose in WT cells and the ackA 
mutant depended on specific lysine residues on the αCTD (47,48).  
Glucose activated a transcriptional promoter-lacZ fusion that included both 
osmCp1 and osmCp2. The targeted promoter is currently unknown and, from what is 
known about osmCp1 and osmCp2 regulation, glucose-induced osmC transcription 
appears to be similar in some aspects but there are differences. Glucose-exposed 
cells activated osmC transcription between late exponential and early stationary 
phase. Suggesting that a high AcCoA:CoA ratio is involved in glucose-induced 
transcription, reducing the AcCoA:CoA ratio using PHB or CoaA overexpression 
decreased this response. Glucose activated osmC independently of RR and its 
cognate SK RcsC. This Rcs-independent regulation is reminiscent of the RcsB-
independent osmotic response at osmCp1, in which the osmCp1 response to 0.5 M 
NaCl did not require RcsC, RcsB, or the co-activator RcsA (164). The osmCp1 
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response to osmotic shock in LB growth medium does, however, require the 
transcriptional regulator NhaR (166). One could test whether NhaR is required for 
the glucose-induced osmC response. However, there is a possibility that glucose 
does not activate through osmCp1 because the osmotically-induced response occurs 
during exponential phase (164), whereas the glucose-induced response occurs 
during the transition into stationary phase (Figure 5). RcsB-independent, stationary 
phase activation of osmC transcription is similar to the reported mechanism of 
osmCp2 activation. This promoter is activated in stationary phase by σS (244) which, 
together with the RNAP holoenzyme, can control genes under starvation conditions 
or upon transitioning into stationary phase. Since σS is largely responsible for 
osmCp2 induction in stationary phase and the gene rpoS that encodes σS is not 
essential, one could delete rpoS and determine if the glucose-activated osmC 
transcription requires σS. However, osmCp2 is transiently activated in lag phase 
when cells are grown in LB medium, which is not apparent when cells are grown in 
TB7 (Figure 5). Therefore, the high AcCoA:CoA activation of osmC transcription in 
stationary phase does not completely resemble the known regulation of either 
osmCp1 or osmCp2. In addition to screening mutants of known regulators, one could 
test the effect of glucose on the osmC promoter region that carries nucleotide 
substitutions that disrupt either osmCp1 or osmCp2, similar to studies of 
osmotically-induced osmC transcription (166).  
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Glucose-induced osmC transcription requires the acetyl-coenzyme A 
synthetase Acs (Figure 14A). It is reported that Acs activity is inhibited by the S. 
enterica KAT Pat (132), a homolog of E. coli YfiQ. Although YfiQ is not required for 
glucose-induced osmC transcription, osmC transcription is dampened in both the 
glucose-exposed yfiQ mutant and the non-treated-yfiQ mutant relative to the WT 
cells (Figure 13A). In the absence of YfiQ, Acs is not acetylated on Lys-609 (132). If 
the effect of YfiQ requires Acs, then I hypothesize that acetylated Acs activates 
and/or non-acetylated Acs inhibits the osmC transcription. This hypothesis that Acs 
directly regulates osmC transcription and that the acetylation state affects Acs 
transcriptional activity can be tested using in vitro transcription assays with RNAP, 
Acs, and a DNA template containing the osmC promoter. Acetylated Acs at Lys-609 
can be either purified from the cobB mutant or generated by site-specific acetylation 
(220). However, to the best of my knowledge, there are no reports that show Acs 
can function as a transcription factor. Another possibility is that Acs is indirectly 
affecting osmC transcription. Acs may either directly or indirectly modify proteins 
posttranslationally, in a manner that could control osmC transcription. Acs may alter 
the metabolism of either AcCoA or AcP, both of which can modify proteins. 
Alternatively, Acs may directly mediate the modification of proteins that directly or 
indirectly affect osmC transcription. For instance, Acs was reported to acetylate the 
chemotaxis RR CheY (45). To determine if Acs can affect protein acetylation, one 
could delete acs and compare the acetylation profile to WT cells by anti-acetyllysine 
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immunoblot analysis. If there is a difference, then mass spectrometry would 
determine the proteins that are acetylated through an Acs-regulated mechanism. 
 By understanding the effect of Acs at the osmC promoter, we can also have a 
better indication of its function in other Acs regulated functions. Robert Davis from 
the Wolfe laboratory has evidence to suggest that YfiQ has an important function in 
regulating cellular metabolism on gluconeogenic carbon sources. In the absence of 
yfiQ, cells grow poorly on certain gluconeogenic carbon sources and grow similar to 
WT cells on glycolytic carbon sources. This growth defect on gluconeogenic carbon 
requires Acs. It is possible that Acs is important when cells are grown on 
gluconeogenic carbon sources because Acs regulates the acetylation status of 
enzymes in gluconeogesis. We can test this hypothesis by performing immunoblot 
analysis and mass spectrometry on an acs mutant grown in the presence of 
gluconeogenic carbon sources compared to glycolytic conditions.  
What is the function of SpeG on RcsB activity? 
 The spermidine acetyltransferase SpeG appears to inhibit RcsB activity 
through a spermidine-dependent manner. The overexpression of SpeG inhibited 
RcsB-dependent PrprA activity (Figures 25 and 27), while the speG mutant 
enhanced PrprA activity (Figure 26). These results suggest that SpeG inhibits RcsB 
activity. SpeG inhibition of PrprA activity may be dependent on spermidine because 
PrprA in the speE speG double mutant that lacks SpeG and does not produce 
spermidine is lower than the speG mutant. Another interpretation could be that in 
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the absence of SpeG, spermidine activates rprA transcription; however, spermidine-
exposed speG mutant showed a concentration-dependent reduction in PrprA activity 
(Figure 29B).  
 Spermidine-mediated inhibition of RcsB activity may involve a direct 
interaction between the RcsB and SpeG. Our collaborators at the Anderson 
laboratory at Northwestern University have evidence to suggest that SpeG can 
acetylate spermidine in vitro. However, when RcsB is present, spermidine 
acetyltransferase activity is inhibited. Although a detailed mechanism still needs to 
be elucidated, RcsB inhibition of SpeG activity appears to be direct, by forming a 
spermidine acetyltransferase inactive complex. 
Furthermore, there are aspects of the epistasis experiment between SpeG 
and SpeE that add more intrigue to the relationship between spermidine, SpeG, and 
RcsB. In the absence of spermidine production (speE mutant), SpeG appears to be an 
activator of rprA transcription. PrprA in the absence of both spermidine and SpeG 
(speE speG double mutant) was reduced compared to the speE mutant (Figure 26).  
How does SpeG activate RcsB? The answer is unknown but there is evidence 
to suggest that RcsB binds poorly to its DNA targets unless a co-activator is present. 
For example, RcsB did not bind to the RcsB homodimer consensus DNA sequence in 
osmCp1 in the absence of RNAP in an electrophoretic mobility shift assay (164). 
Additionally, RcsB binding to three RcsB-regulated promoters, PamsG, Pwza, and 
PcpsA, was weak and unstable with KD values between 2 x 10-6 and 6 x 10-6 and half-
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lives less than a second. In the presence of the co-activator RcsA, stability increased 
and KD values were at least one order magnitude smaller (172). Therefore, the 
mechanism through which SpeG can activate rprA transcription may involve 
enhancing RcsB DNA affinity.  
Why does growth phase regulate glucose-induced rprA transciption? 
 The timing of glucose exposure affected the rprA response to glucose in 
stationary phase, suggesting that the phase of growth regulates glucose-induced 
rprA transcription. Only when cells were exposed to glucose early in growth (i.e. lag 
phase and early exponential phase) was there an rprA promoter response in 
stationary phase (Figure 7). These results have been independently reproduced by 
David Christensen, a graduate student in the Wolfe laboratory. The importance of 
exposure early in growth could suggest that lag phase and early exponential phase 
present some common factor(s) that is critical for the rprA response to glucose. It is 
understood that the transcriptomic and metabolic profiles change throughout 
different phases of growth. Therefore, an unknown early transcription factor(s), 
enzyme(s), or metabolite(s) might be important for a stationary phase rprA 
response. Similarly, one may wonder why the rprA response glucose occurs in 
stationary phase and not at any other point in growth. The dependence on early 
glucose exposure regulating a stationary phase response is not specific to rprA 
transcription; this effect is also seen in glucose-induced protein acetylation. The 
Wolfe laboratory has evidence for glucose stimulated acetylation in stationary 
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phase. David Christensen has tested whether the timing of glucose exposure affected 
the induction of stationary phase acetylation by anti-acetyllysine immunoblot 
analysis. He found that glucose-induced acetylation in stationary phase occurred 
only when cells were exposed to glucose early in growth. Currently, the mechanism 
of growth phase-dependent, glucose-induced rprA transcription and global protein 
acetylation is yet unclear. 
How does AcP non-enzymatically acetylate proteins? 
 In 1975, Ramponi and colleages reported that AcP can nonenzymatically 
donate acetyl groups to histone tails in vitro (201). However, there has been no 
evidence that this effect was relevant in vivo. The discovery that AcCoA is not the 
only physiologically relevant acetyl donor and that AcP contributes to acetylation in 
bacteria constitutes a significant shift in lysine acetylation dogma. While working on 
my thesis, which contributed to the hypothesis that that AcP is a novel 
physiologically relevant acetyl donor, a paper was published showing very similar 
results (202). Weinert and coworkers used a quantitative mass spectrometric 
approach and determined that the global level of E. coli lysine acetylation in 
stationary phase is significantly greater than in exponential phase, indicating that 
acetylation increases in cells that experience little to no growth, but only if provided 
with a carbon source (glucose or acetate) that can be metabolized to AcP. Indeed, 
exponential phase cells that were arrested for growth exhibited an increase in 
acetylation. Increased acetylation depended on the presence of the metabolite and 
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signaling molecule acetyl phosphate (AcP), was partially inhibited by the KDAC 
CobB, and was mostly independent of the KAT YfiQ. In the absence of a KAT, AcP 
could donate acetyl groups to purified adenylate kinase and bovine serum albumin, 
which suggests that AcP can modify proteins through a non-enzymatic mechanism. 
The ackA mutant accumulates AcP and acetylated proteins during 
exponential growth (Kuhn et al. in preparation). Since AcP is a highly reactive 
electrophile that can also donate phosphoryl groups to RRs, I tested whether this 
effect of AcP on acetylation is a direct chemical reaction by performing in vitro 
acetylation experiments with AcP and LpdA. AcP is an acetyl donor to LpdA 
(Figures 31, 33, and 34) and several other proteins. I found that acetylation of 
LpdA is concentration dependent. The number of acetylated lysines increased and 
the kinetics of lysine acetylation were more variable in the presence of higher 
concentrations of AcP.  
 An analysis of the modified sites in vivo and in vitro may have provided some 
insight into the regulation of AcP-dependent, non-enzymatic acetylation of proteins. 
We tested if the primary amino acid sequence influences the specificity of non-
enzymatic acetylation. Our collaborators Drs. Kuhn and Scholle incubated a peptide 
array with randomized residues flanking the lysine with AcP and acetylation was 
detected by mass spectrometry (235). This approach identifies sequence 
characteristics that provide the most favorable conditions for acetylation by AcP. 
They discovered that AcP donated acetyl groups preferentially to lysines that were 
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flanked by positively charged residues. In contrast, adjacent negatively charged 
residues were strictly inhibitory (Kuhn et al., in preparation).  
We collaborated with Drs. Gibson and Schilling at The Buck Institute for 
Research on Aging, who performed label-free quantitative mass spectrometry (239) 
on WT cells and the ackA mutant. From their mass spectrometric data, I analyzed 
over 500 unique sites that were at least 2-fold more acetylated in the ackA mutant 
compared to WT cells. This analysis showed that the -1 and +1 positions tend to be 
negatively charged aspartate and glutamate, with a low frequency of positively 
charged lysine, arginine, and histidine (Figure 36). Specifically, 30% of the amino 
acids in the -1 position were aspartate or glutamate, and these residues represented 
20% of the amino acids in the +1 position. This is in contrast to 5% and 11% of 
amino acids in the -1 and +1 positions, respectively, being lysine, arginine, and 
histidine.  
 Taken together, the sequence preferences identified in vitro and in vivo may 
provide some understanding of the mechanism of acetylation using AcP. However, it 
is important to note that peptide array identified sequence preferences do not 
necessarily indicate physiologically relevant sequences. For example, peptide arrays 
have been used to determine KDAC-specific sequences. Acetylated peptide arrays 
were incubated with one of four KDACs and deacetylation was detected by mass 
spectrometry (235). The most frequently deacetylated peptides can, but do not 
always, represent the sequences of acetylated targets in vivo (29,235). Instead, these 
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peptide arrays indicate optimal substrates. To account for modified lysines that are 
adjacent to non-permissive residues, it has been hypothesized that physiological 
targets have suboptimal sequence characteristics to allow for regulation by enzymes 
(235).  
Since acetylation by AcP can occur non-enzymatically, our collaborators and I 
propose that chemical acetylation is regulated by residues that are either adjacent 
on the linear polypeptide sequence or close to the lysine in the tertiary structure. 
The outcome of acetylation is a balance of optimal, suboptimal, and inhibitory 
residues. I propose that these residues have different capacities to promote 
acetylation, depending on their ability to either activate the lysine for acetylation or 
increase the local concentration of AcP. It has been reported that KATs have 
mechanisms to activate lysines by deprotonation and residues that position AcCoA 
near the lysine. Deprotonation of lysines can occur through ‘proton wires’ that 
shuttle the positive charge away from the lysine side chain or through conserved 
catalytic residues that act as general bases. It is possible for adjacent negatively 
charged aspartate and glutamine to act as general bases on lysine. As for the 
positively charged residues, they may increase the concentration or the probability 
of AcP being near a potentially activated lysine through electrostatic interactions 
with the electronegative phosphoryl group. This hypothesis can be tested. Gcn5 Glu-
173 is a conserved residue that is essential for catalytic activity by functioning as a 
general base at physiological pH (68). The E173Q variant of Gcn5 was unable to 
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acetylate histone protein at neutral pH but was capable of acetylation at high pH, a 
condition that artificially deprotonates lysines. These results are consistent with 
Glu-173 acting as a general base. Similar experiments could be performed with 
acetylation substrates of AcP to test putative general base residues.  
Differences in pH could also explain the widely different results seen in the 
peptide array compared to the in vivo analysis of AcP-sensitive acetylated sites. The 
peptide array was performed at pH 8 and I have observed that acetylation with AcP 
and LpdA is pH-sensitive (data not shown). A basic condition is optimized for non-
enzymatic acetylation of lysines because the proportion of deprotonated and active 
lysines is greater than at neutral pH. The preference for positively charged residues 
adjacent to the acetylated lysine might indicate that at higher pH, the rate of 
acetylation is determined by the presence of AcP near the activated lysine. One 
could test whether the preferences for certain peptide sequences change at different 
pH.  
Concluding Remarks 
 Our collaborators and I have discovered that E. coli applies many different 
mechanisms to regulate cellular processes. Specifically, RcsB activity appears to be 
regulated by both phosphorylation and acetylation. Activation by phosphorylation 
can come from either Rcs signaling or from AcP. RcsB can exist in multiple 
oligomeric states and potentially affect cellular physiology independently of its 
transcriptional activity. Lastly, AcP is a novel, highly reactive, bifunctional molecule 
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that can modify proteins by functioning either as a phosphoryl donor or as an acetyl 
group donor. Although acetylation by AcP can occur non-enzymatically, the reaction 
appears to be regulated in part by the charges of neighboring residues. This study 
highlights the importance of non-enzymatic reactions in cellular physiology and 
advances our understanding of how the effects of reactive small molecules like AcP 
are regulated.  
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